Sentence,class,file
"[http://dx.doi.org/10.1097/00000542-199812000- 00023] [PMID: 9856720]  [114] Wu, H.H.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1097/00000542-200104000-00011]  [116] Deer, T.; Krames, E.S.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/00000542-200112000- 00025] [PMID: 11748404]  [123] Scholz, A. Mechanisms of (local) anaesthetics on voltage-gated  sodium and other ion channels.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1093/bja/aef163] [PMID: 12173241]  [124] Docherty, R.J.; Farmer, C.E.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/978-3-540-79090- 7_15] [PMID: 19655117]  [125] Stoney, S.D., Jr Limitations on impulse conduction at the   branch point of afferent axons in frog dorsal root ganglion.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/  BF00227992] [PMID: 2387351]  [126] Theile, J.W.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.3389/fphar.2011.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1186/1744-8069-7-16] [PMID: 21345196]  [128] Nieto, F.R.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.3390/md10020281] [PMID: 22412801]  [129] Aur ilio, C.; Pota, V.; P ace, M.C.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.2174/1389557515666150722112621] [PMID:  26202189]  [132] Waxman, S.G.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1111/jns5.12071] [PMID: 25250524]  [134] Yanagidate, F.; Strichartz, G.R.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1213/01.ANE.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1111/j.1476-5381.2009.00437.x] [PMID:  19845672]  [143] Clare, J.J.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/s00540-010-1046-7] [PMID: 21113631]  [147] Tan, A.M.; Samad, O.A.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.2119/molmed.2015.00063] [PMID:  26101954]  [148] Pan, J.; Lin, X.J.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S1995- 7645(14)60352-7] [PMID: 26003602]  [149] Yin, R.; Liu, D.; Chhoa, M.; Li, C.M.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1186/1744-8069-7-5] [PMID: 21219657]  [153] Du, X.; Gamper, N. Potassium channels in peripheral pain  pathways: expression, function and therapeutic potential.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.2174/  1570159X113119990042] [PMID: 24396338] [154] Tsantoulas, C.; McMahon, S.B.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.tins.2013.12.002]  [PMID: 24461875]  [155] Olivera, B.M.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1146/annurev.bi.63.070194.004135]  [PMID: 7979255]  [156] Chaplan, S.R.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0014-2999(02)02247-1] [PMID:  12242089]  [159] Snutch, T.P.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1111/j.1476-5381.2011.01781.x] [PMID:  22091786]  [161] Murali, S.S.; Napier, I.A.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1152/jn.00608.2014] [PMID: 25505111]  [162] Schroeder, C.I.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.2174/  157340606778250216] [PMID: 17017994]  [163] Malmberg, A.B.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0304- 3959(94)00094-U] [PMID: 7715945]  [164] Hama, A.; Sagen, J. Antinociceptive effects of the marine snail  peptides conantokin-G and conotoxin MVIIA alone and in  combination in rat models of pain.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/j.neuropharm.2008.10.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1124/jpet.104.082537]  [PMID: 15665136]  [166] Skov, M.J.; Beck, J.C.; de Kater, A.W.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1080/10915810701582970] [PMID: 17963128]  [167] Chu, Y.X.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1152/  physrev.00023.2013] [PMID: 24382884]  [170] Terashima, T.; Xu, Q.; Yamaguchi, S.; Yaksh, T.L.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/j.neuropharm.2013.06.018] [PMID:  23810829],OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.pain.2011.04.015]  [PMID: 21570770]  [174] Dogrul, A.; Garde ll, L.R.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/ALN.0b013e3182a10fbf]  [PMID: 23835590]  [180] Sluka, K.A.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1586/ecp.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1093/bja/aei158] [PMID: 15951328]  [183] Glasgow, N.G.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1113/jphysiol.2014.273763]  [PMID: 25556790]  [184] Mendell, L.M.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0014-4886(66)90068-9] [PMID: 5928985]  [185] Davies, S.N.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1186/1744-8069-9-6] [PMID: 23433248]  [188] Edelmayer, R.M.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/978-3-642-41588-3_6] [PMID:  24737234]  [190] Luo, X.Q.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0304-3959(92)90198-K] [PMID: 1594273]  [193] Coderre, T.J.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0304-3959(94)90021- 3] [PMID: 7708409]  [195] Rojas, A.C.; Alves, J.G.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1213/ANE.0b013e31823a5d1b] [PMID: 22167772]  [196] Walker, S.M.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/ALN.0b013e3181dcd71c]  [PMID: 20526188]  [197] Vranken, J.H.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/00000542-200610000-00028]  [PMID: 17006081]  [198] Yaksh, T.L.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1097/ALN.0b013e31816c902a] [PMID: 18431131]  [199] Hassenbusch, S.J.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1517/13543776.2012.728587] [PMID:  23009122]  [202] Kim, Y.; Cho, H.Y.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1111/  j.1748-1716.2007.01756.x] [PMID: 17970830],Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0304- 3959(02)00303-2] [PMID: 12507705]  [205] Kolhekar, R.; Meller, S.T.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0306- 4522(94)90560-6] [PMID: 7535397]  [206] Wallace, M.S.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0304-3959(99)00207- 9] [PMID: 10666522]  [208] Chanimov, M.; Cohen, M.L.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1111/j.1365-2044.1997.034-az0057.x]  [PMID: 9124662]  [209] Mebazaa, M.S.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.annfar.2010.12.005]  [PMID: 21236623]  [210] Roberts, J.C.; Grocholski, B .M.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1124/jpet.105.086173] [PMID:  15933157]  [211] Tong, C.K.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/00000542-199811000-00005]  [PMID: 9821993]  [215] Sorkin, L.S.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/  00001756-199911260-00011] [PMID: 10619637]  [216] Jones, T.L.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1124/jpet.103.064741] [PMID: 15007101]  [217] Dirig, D.M.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1016/S0304-3959(96)03249-6] [PMID: 9106805] [220] Malan, T.P.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1089/neu.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0024-3205(86)90164- 5] [PMID: 3022091]  [223] Di Lio, A.; Benke, D.; Besson, M.; Desmeules, J.; Daali, Y.; Wang,  Z.J.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.pain.2011.09.028]  [PMID: 22054599]  [225] Svensson, E.; Persson, J.; Fitzsimmons, B.; Yaksh, T.L.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/  j.neulet.2013.05.027] [PMID: 23707652]  [226] Juif, P.E.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.neuropharm.2014.12.022] [PMID:  25545681]  [227] Whitwam, J.G.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0140-6736(82)  91368-X] [PMID: 6129540]  [228] Serrao, J.M.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0304-3959(92)90125- U] [PMID: 1531383]  [229] Tucker, A.P.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1213/01.ANE.0000087075.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1213/01.ANE.0000112434.68702.E4]  [PMID: 15155300]  [231] Ho, K.M.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.2174/  156802611794863562] [PMID: 21189125]  [235] Wang, M. Neurosteroids and GABA-A Receptor Function.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.3389/  fendo.2011.00044] [PMID: 22654809]  [236] Carver, C.M.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/s00213-013-3276-5] [PMID: 24071826]  [237] Bohlhalter, S.; Weinmann, O.; Mohler, H.; Fritschy, J.M.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1213/01.ANE.0000122638.41130.BF] [PMID:  15155302]  [244] Yaksh, T.L.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1213/01.ANE.0000121768.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/j.neuropharm.2008.08.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.conb.2013.12.001] [PMID: 24650505]  [250] Petersen, J.G.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.1495- 14.2014] [PMID: 25471566] [253] Wilson, P.R.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.pmrj.2013.12.005] [PMID: 24355547]  [255] Gu illaume, D.; Van Havenbergh, A.; Vloeberghs, M.; Vidal,   J.; Roeste, G. A clinical study of intrathecal baclofen using a  programmable pump for intractable spasticity.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/  j.ejphar.2012.03.015] [PMID: 22449374]  [259] Liu, P.; Guo, W.Y.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0006-8993(96)  00100-X] [PMID: 8773775]  [265] Aran, S.; Hammond, D.L.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1213/01.ane.0000196523.06573.10] [PMID:  16492839]  [269] Enna, S.J.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/00000542-199902000- 00025] [PMID: 9952157]  [273] Hartvig, P.; G illberg, P.G.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0014-2999(83)90379-5] [PMID:  6688587]  [283] Bonner, T.I.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/s12031- 010-9377-2] [PMID: 20446119]  [288] Cai, Y-Q.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1111/j.1471-4159.2009.06396.x] [PMID:  19780895]  [289] Chen, S.R.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1111/j.1469-7793.1998.083br.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/00000542-199502000- 00012] [PMID: 7856900]  [293] Greig, N.H.; Reale, M.; Tata, A.M. New pharmacological  approaches to the cholinergic system: an overview on muscarinic  receptor ligands and cholinesterase inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.2174/  1574889811308020003] [PMID: 23597304]  [294] Sosnowski, M.; Stevens, C.W.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/j.neuroscience.2014.,OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/00000542-200210000- 00028] [PMID: 12357162]  [302] Belfrage, M.; Segerdahl, M.; Arnér, S.; Sollevi, A.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/S0304- 3959(03)00158-1] [PMID: 14499421],OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0301-0082(03)00050-9] [PMID:  12787573]  [308] Schulte, G.; Robertson, B.; Fredholm, B.B.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0014- 2999(97)01605-1] [PMID: 9650842]  [310] Li, J.; Perl, E.R.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/  01.wnr.0000239949.37825.e9] [PMID: 17001280]  [314] Chiari, A.; Yaksh, T.L.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1213/00000539-199310000- 00013] [PMID: 8214657]  [316] Loram, L.C.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1523/JNEUROSCI.3447-09.2009] [PMID: 19890011]  [317] Dai, S.S.; Zhou, Y.G.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1111/nan.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.2174/  157015906775203048] [PMID: 18615137]  [323] Harvey, R.J.; Depner, U.B.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1213/ane.0b013e318163f602] [PMID:  18292448]  [326] Malmberg, A.B.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1213/01.ANE.0000093226.75543.90]  [PMID: 14693610]  [330] Eisenach, J.C.; Curry, R.; Hood, D.D.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0304-3959(02)00208-7] [PMID: 12406536]  [331] Eisenach, J.C.; Curry, R.; Tong, C.; Houle, T.T.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.4103/0970-9185.119155] [PMID: 24249988]  [333] Eisenach, J.C.; Curry, R.; Rauck, R.; Pan, P.; Yaksh, T.L.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1113/expphysiol.2012.069922] [PMID:  23002244],Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.3109/10799893.2014.885049]  [PMID: 24495291]  [339] Shigemoto, R.; Kinoshita, A.; Wada, E.; Nomura, S.; Ohishi, H.;  Takada, M.; Flor, P.J.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1111/ejn.12398] [PMID: 24494684]  [341] M ills, C.D.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1089/  089771502753460213] [PMID: 11852976]  [342] M ills, C.D.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/j.pain.2008.03.,OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/  00001756-199611040-00067] [PMID: 8981459]  [345] Fisher, K.; Coderre, T.J.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0304- 3959(96)03212-5] [PMID: 9121812]  [346] Zeilhofer, H.U.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/j.pain.2007.08.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/  ALN.0b013e31823de68d] [PMID: 22123524]  [349] Acher, F.; Goudet, C. Therapeutic potential of group III  metabotropic glutamate receptor ligands in pain.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/j.coph.,OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/s12264-012-1219-5] [PMID: 22466124]  [353] Watkins, L.R.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.coph.2012.06.002] [PMID:  22748800]  [356] Lucas, K.; Maes, M. Role of the Toll Like receptor (TLR) radical  cycle in chronic inflammation: possible treatments targeting the  TLR4 pathway.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1039/c3cs60039d] [PMID: 23503527]  [358] Vasileiou, I.; Fotopoulou, G.; Matzourani, M.; Patsouris, E.;  Theocharis, S. Evidence for the involvement of cannabinoid  receptors polymorphisms in the pathophysiology of human diseases.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/j.neulet.2010.,OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1002/brb3.44] [PMID: 22574283]  [364] Burnstock, G. Physiology and pathophysiology of purinergic  neurotransmission.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/  j.tins.2008.10.001] [PMID: 19008000]  [366] Kobayashi, K.; Yamanaka, H.; Noguchi, K. Expression of ATP  receptors in the rat dorsal root ganglion and spinal cord.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/s12565-012- 0163-9] [PMID: 23179910]  [367] Bianco, F.; Fumaga lli, M.; Pravettoni, E.; DAmbrosi, N.;   Volonte, C.; Matteoli, M.; Abbracchio, M.P.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.tins.2009.10.003] [PMID: 19914722]  [370] Clark, A.K.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1002/glia.21042] [PMID: 20629190]  [371] Donnelly-Roberts, D.; McGaraughty, S.; Shieh, C.C.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1124/jpet.106.105890]  [PMID: 18042830]  [372] Tsuda, M.; Shigemoto-Mogami, Y.; Koizumi, S.; Mizokoshi, A.;  Kohsaka, S.; Salter, M.W.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1038/nature01786]  [PMID: 12917686]  [373] Chessell, I.P.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1007/s11481-012-9428-2] [PMID: 23242694]  [378] Opal, S.M.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.ejphar.2007.10.049] [PMID: 18021769]  [380] Milligan, E. D.; Penzkover, K. R.; Soderquist, R. G.; Mahoney, M.  J. Spinal interleukin-10 therapy to treat peripheral neuropathic pain.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1126/science.228392] [PMID: 228392]  [382] Jhamandas, K.; Yaksh, T.L.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0006-8993(84)90371-8] [PMID:  6205719]  [383] Szolcsanyi, J. Capsaicin and sensory neurones: a historical perspective.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1213/ANE.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/  j.pneurobio.2014.06.001] [PMID: 24915026]  [399] Carroll, I.; Fischbein, N.; Barad, M.; Mackey, S. Human response  to unintended intrathecal injection of botulinum toxin.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/978-1-60327-323-7_22] [PMID: 20336430]  [403] Molet, J.; Pohl, M. Gene-based approaches in pain research and  exploration of new therapeutic targets and strategies.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/  j.ejphar.2013.01.073] [PMID: 23500201]  [404] Kim, D.S.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.6494-11.2012] [PMID:  22745497]  [405] Hua, X.Y.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1038/sj.gt.3302376]  [PMID: 15470478]  [408] Fundytus, M.E.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.ejphar.2013.11.024] [PMID: 24296320]  [411] Barclay, J.; Patel, S.; Dorn, G.; Wotherspoon, G.; Moffatt, S.;  Eunson, L.; Abdelal, S.; Natt, F.; Hall, J.; Winter, J.; Bevan, S.;  Wishart, W.; Fox, A.; Ganju, P. Functional downregulation of  P2X3 receptor subunit in rat sensory neurons reveals a significant  role in chronic neuropathic and inflammatory pain.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/  WNR.0b013e32833774bf] [PMID: 20134354]  [418] Kim, D.H.; Fitzsimmons, B.; Hefferan, M.P.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.neuroscience.2008.04.033] [PMID:  18511207]  [419] Lai, J.; Gold, M.S.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0304- 3959(01)00391-8] [PMID: 11790477]  [420] Parada, C.A.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1038/sj.emboj.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.pain.2013.10.015]  [PMID: 24145208]  [424] Storek, B.; Reinhardt, M.; Wang, C.; Janssen, W.G.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1038/gt.2014.14]  [PMID: 24572785]  [426] Wu, F.; Xu, X.; Miao, X.; Chen, J.; Sun, Y.; Yu, W. Effect of  recombinant adenovirus coding for endomorphin-2 on neuropathic  pain in rats.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1186/1744-8069-1-9] [PMID:  15813997]  [430] Soderquist, R.G.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1038/gt.2014.96] [PMID:  25354684]  [432] Ndong, C.; Landry, R.P.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1186/1744-8069- 8-34] [PMID: 22540262]  [433] Fischer, G.; Pan, B.; Vilceanu, D.; Hogan, Q.H.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1038/gt.2013.56] [PMID: 24152582]  [434] Fan, L.; Guan, X.; Wang, W.; Zhao, J.Y.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1186/1744-8069-10-8]  [PMID: 24472174]  [435] Chattopadhyay, M.; Zhou, Z.; Hao, S.; Mata, M.; Fink, D.J.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1186/  1744-8069-8-17] [PMID: 22439790]  [436] Xu, Q.; Chou, B.; Fitzsimmons, B.; Miyanohara, A.; Shubayev,   V.; Santucci, C.; Hefferan, M.; Marsala, M.; Hua, X.Y.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1371/journal.pone.0032581] [PMID: 22403675]  [437] Beutler, A.S.; Banck, M.S.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.1002/cne.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1016/0006-8993(78)91146-0] [PMID: 98219]  [446] Yaksh, T.L.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/  00000542-198601000-00009] [PMID: 2867722]  [447] Sabbe, M.B.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/00000542-199410000- 00017] [PMID: 7943841]  [448] Nordberg, G.; Hedner, T.; Mellstrand, T.; Dahlström, B.  Pharmacokinetic aspects of intrathecal morphine analgesia.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/  00000542-198405000-00010] [PMID: 6546839]  [449] Lipman, J.J.; Blumenkopf, B.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/0304-3959(89)90037-7]  [PMID: 2616177]  [450] Suzukawa, M.; Matsumoto, M.; Collins, J.G.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/00000542-198306000- 00005] [PMID: 6859581]  [451] Homma, E.; Co llins, J.G.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/00000542-198303000- 00005] [PMID: 6829958]  [452] Bujedo, B.M.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1152/  physrev.00027.2007] [PMID: 18923183]  [454] Wolak, D.J.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/BF00588270] [PMID: 1289731]  [456] Schroth, G.; Klose, U. Cerebrospinal fluid flow.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1007/BF00588271] [PMID: 1289732]  [457] Bernards, C.M.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/  00000542-200607000-00027] [PMID: 16810009]  [458] Flack, S.H.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/ALN.0b013e3181c38da5] [PMID:  19996952]  [460] Wallace, M.; Yaksh, T.L.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1213/ANE.0b013  e3182645dfd] [PMID: 22822192]  [461] Yaksh, T.L.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S1773-2247(04)50061-8]  [467] Yaksh, T.L.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1016/j.ijpharm.2005.03.025] [PMID: 15919163]  [472] Lagarce, F.; Faisant, N.; Desfontis, J. C.; Marescaux, L.; Gautier,  F.; Richard, J.; Menei, P.; Benoit, J. P. Baclofen-loaded  microspheres in gel suspensions for intrathecal drug delivery: in  vitro  and in vivo evaluation.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0885-3924(03)00041-1] [PMID: 12727045]  [474] Classen, A.M.; Wimbish, G.H.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1016/j.jpainsymman.2004.04.011] [PMID: 15589086]  [475] Ward, K. W.; Nag illa, R.; Jolivette, L. J.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.jneumeth.2007.09.019] [PMID: 18054083]  [478] Watabiki, T.; Nagakura, Y.; Wegner, K.; Kakimoto, S.; Tozier,  N.A.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/j.gene.2013.11.091] [PMID: 24333346]  [482] Brimmo, O.A.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1055/s-0035-1549026]  [PMID: 25892003]  [483] McCarty, D.J., Jr; Phelps, P.; Pyenson, J. Crystal-induced  inflammation in canine joints.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1084/jem.124.1.99] [PMID: 4287616] [484] Lopez, M.J.; Kunz, D.; Vanderby, R., Jr; Heisey, D.; Bogdanske,  J.; Markel, M.D.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1016/S0736-0266(02)00132-8] [PMID: 12568952]  [485] Budsberg, S.C.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.2460/ajvr.74.12.1467] [PMID: 24274882]  [489] Lascelles, B.D.",OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1186/s12917-015- 0413-x] [PMID: 25926287]  [490] Hayashida, K. Substance P-saporin for bone cancer pain in dogs:  can mans best friend solve the lost in translation problem in analgesic  development?",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1002/9780470939956.ch21]  [493] Westin, B.D.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/ALN.0b013e3181dcd6ec]  [PMID: 20526189]  [494] Yahalom, B.; Athiraman, U.; Soriano, S.G.; Zurakowski, D.;  Carpino, E.A.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/10.1097/ALN.0b013e31828fc7e7] [PMID:  23514721]  [497] Yaksh, T.L.",Non-OADS,/arxiv_data1/oa_pdf/a3/f7/CN-15-232.PMC5412694.pdf
"[http://dx.doi.org/  10.1126/science.285.5435.1870] [PMID: 10489359] [2] Lømo, T. The discovery of long-term potentiation.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.3389/fnmol.2014.00098]  [PMID: 25538559]  [6] Hayashi, Y.; Shi, S.H.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/  j.neuron.2004.09.012] [PMID: 15450156]  [9] Whitlock, J.R.; He ynen, A.J.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/  j.brainresbull.2013.09.005] [PMID: 24076105]  [11] Volk, L.J.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/nature11803] [PMID:  23283171]  [13] Ryan, B.; Joilin, G.; Williams, J.M.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/  10.3389/fnmol.2015.00004] [PMID: 25755632]  [14] Harris, K.M.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/  10.1016/j.neuroscience.2012.04.044] [PMID: 22546337]  [16] Mendoza-Naranjo, A.; Contreras-Vallejos, E.; Henriquez, D.R.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1074/jbc.M111.234005] [PMID: 21454543]  [20] Kelleher, R.J., III; Bear, M.F.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/  j.cell.2008.10.017] [PMID: 18984149],OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1177/  1073858404268768] [PMID: 15911868]  [22] Calabrese, B.; Wilson, M.S.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1 152/physiol.00042.2005]  [PMID: 16443821]  [23] Newey, S.E.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1002/neu.20153] [PMID:  15884002]  [24] Tashiro, A.; Minden, A.; Yuste, R. Regulation of dendritic spine  morphology by the rho family of small GTPases: antagonistic roles  of Rac and Rho.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1111/j.1471-4159.2004.02475.x]  [PMID: 15198662]  [28] Chen, C.; Wirth, A.; Ponimaskin, E. Cdc42: an important regulator  of neuronal morphology.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.7554/eLife.02839] [PMID:  25006034]  [30] Hill, J.J.; Hashimoto, T.; Lewis, D.A.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/j.brainresbull.,OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/nature09271] [PMID:  20622856]  [38] Schmelzle, T.; Hall, M.N.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/S0896- 6273(01)00551-7] [PMID: 11754834] [40] Kumar, V.; Zhang, M.X.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.2284-05.2005] [PMID:  16339024]  [41] Jaworski, J.; Spangler, S.; Seeburg, D.P.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1523/JNEUROSCI.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/  10.1111/j.1471-4159.2004.02949.x] [PMID: 15773910]  [46] Tramutola, A.; Triplett, J.C.; Di Domenico, F.; Niedowicz, D.M.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/  10.1111/jnc.13037] [PMID: 25645581]  [47] Sharma, A.; Hoeffer, C.A.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/j.celrep.2015.08.028] [PMID:  26344767]  [55] Nellemann, C.; Abell, K.; Nørremølle, A.; Løkkegaard, T.; Naver,  B.; Röpke, C.; Rygaard, J.; Sørensen, S.A.; Hasholt, L. Inhib ition  of Huntington synthesis by antisense oligodeoxynucleotides.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/S1474-4422(11)70286-1] [PMID: 22265214]  [60] Ambros, V. The functions of animal microRNAs.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/nature02871] [PMID:  15372042]  [61] Bartel, D.P.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/ng1253] [PMID: 14528307]  [65] Kawase-Koga, Y.; Otaegi, G.; Sun, T. Different timings of Dicer  deletion affect neurogenesis and gliogenesis in the developing  mouse central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1084/jem.20070823] [PMID: 17606634]  [67] Hébert, S.S.; De Strooper, B. Molecular bi ology.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1126/science.1148530] [PMID: 17761871]  [68] Kim, J.; Inoue, K.; Ishii, J.; Vanti, W.B.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/j.devcel.,OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/j.devcel.2012.03.003] [PMID: 22595676]  [72] Leucht, C.; Stigloher, C.; Wizenmann, A.; Klafke, R.; Folchert, A.;  Bally-Cuif, L. MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/j.conb.2005.08.015] [PMID:  16150588]  [77] Kapsimali, M.; Kloosterman, W.P.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/  10.1186/gb-2007-8-8-r173] [PMID: 17711588]  [78] Makeyev, E.V.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/j.molcel.2007.,OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/  10.1038/nn.2294] [PMID: 19287386]  [81] Brenes, J.C.; Lackinger, M.; Hoglinger, G.U.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1002/stem.431] [PMID:  20506192]  [83] Sun, G.; Ye, P.; Murai, K.; Lang, M.F.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/  ncomms1532] [PMID: 22068596]  [84] Szulwach, K.E.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1083/jcb.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/  j.neulet.2012.08.065] [PMID: 22982201]  [88] Green, M.J.; Cairns, M.J.; Wu, J.; Dragovic, M.; Jablensky, A.;  Tooney, P.A.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1038/mp.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1111/j.1460-9568.2012.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/j.bbr.,OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/nn2010] [PMID: 17994015]  [95] Hansen, K.F.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1371/journal.pone.0015497] [PMID: 21124738]  [96] Numakawa, T.; Yamamoto, N.; Ch iba, S.; Richards, M.; Ooshima,  Y.; Kishi, S.; Hashido, K.; Adachi, N.; Kunugi, H. Growth factors  stimulate expression of neuronal and glial miR-132.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/nature04367] [PMID: 16421561]  [101] Siegel, G.; Obernosterer, G.; Fiore, R.; Oehmen, M.; Bicker, S.;  Christensen, M.; Khudayberdiev, S.; Leuschner, P.F.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.7554/eLife.04263] [PMID: 25556700]  [104] Busto, G.U.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/  10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;  2-Q] [PMID: 10723069]  [107] Hardy, J.A.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/  10.1126/science.1566067] [PMID: 1566067],Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/  S0962-8924(98)01368-3] [PMID: 9854307]  [109] Hébert, S.S.; Horré, K.; Nicolaï, L.; Papadopoulou, A.S.;  Mandemakers, W.; Silahtaroglu, A.N.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1093/  hmg/ddr330] [PMID: 21807765]  [113] Wong, H.K.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1093/hmg/ddt164] [PMID:  23585551]  [114] Grasso, M.; Piscopo, P.; Confaloni, A.; Denti, M.A.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/j.tins.2009.11.003] [PMID: 19963289]  [117] Samii, A.; Nutt, J.G.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/S0140- 6736(04)16305-8] [PMID: 15172778]  [118] Junn, E.; Lee, K.W.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1074/jbc.M109.086827] [PMID:  20106983]  [120] Zhang, Z.; Cheng, Y. miR-16-1 promotes the aberrant alpha- synuclein accumulation in parkinson disease via targeting heat  shock protein 70.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/j.molmed.2005.12.,OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/j.neuron.2009.05.,OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/  j.molcel.2011.04.018] [PMID: 21596314]  [127] Cho, H.J.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1093/hmg/  dds470] [PMID: 23125283]  [128] Alvarez-Erv iti, L.; Seow, Y.; Schapira, A.H.; Rodriguez-Oroz,  M.C.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/cddis.2013.73] [PMID: 23492776]  [129] Harrison, P.J.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/j.bbagen.2009.06.009]  [PMID: 19559755]  [131] Arnold, S.E.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1001/archpsyc.1989.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.2147/nedt.2006.2.4.531] [PMID:  19412501]  [136] Kim, A.H.; Reimers, M.; Maher, B.; Wi lliamson, V.; McMichael,  O.; McClay, J.L.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/  j.biopsych.2010.09.039] [PMID: 21183010]  [138] Santare lli, D.M.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/  j.biopsych.2010.09.030] [PMID: 21111402],OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/sj.mp.4001577] [PMID: 15381925]  [140] Perkins, D.O.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1186/gb-2007-8-2-r27] [PMID:  17326821]  [141] M iller, B.H.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1093/  hmg/ddn005] [PMID: 18184693]  [143] Beveridge, N.J.; Gardiner, E.; Carroll, A.P.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/mp.2009.84] [PMID: 19721432]  [144] Hansen, T.; Olsen, L.; Lindow, M.; Jakobsen, K.D.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1371/journal.pone.0000873] [PMID:  17849003]  [145] Aston, C.; Jiang, L.; Sokolov, B.P.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1002/  jnr.20208] [PMID: 15334603]  [146] Kwon, E.; Wang, W.; Tsai, L.H.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/  10.1038/mp.2011.170] [PMID: 22182936]  [147] Kim, A.H.; Parker, E.K.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/j.schres.2012.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1074/jbc.M113.535203]  [PMID: 24675081]  [149] Gong, Y.; Wu, C.N.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/j.euroneuro.2012.12.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1371/journal.pone.0056781] [PMID: 23451085]  [156] Abu-Elneel, K.; Liu, T.; Gazzaniga, F.S.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1186/gm144] [PMID: 20374639]  [158] Ghahramani Seno, M.M.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/j.brainres.2010.09.046]  [PMID: 20868653]  [159] W illemsen, M.H.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1136/jmedgenet-2011-100294] [PMID:  22003227]  [160] Nguyen, A.; Rauch, T.A.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/  srep03994] [PMID: 24500708]  [162] Gusella, J.F.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/1043-4682(95)  90011-X] [PMID: 7620118]  [163] Penney, J.B., Jr; Young, A.B.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/  10.1002/mds.870050202] [PMID: 2139171]  [164] Roos, R.A. Huntingtons disease: a clinical review.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1186/1750-1172-5-40]  [PMID: 21171977]  [165] Albin, R.L.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1002/ana.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1097/00005072-198511000-00003]  [PMID: 2932539]  [167] Guo, Z.; Rudow, G.; Pletnikova, O.; Codispoti, K.E.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.3390/ijms 141122558] [PMID: 24248060]  [172] Johnson, R.; Zuccato, C.; Belyaev, N.D.; Guest, D.J.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/j.nbd.2007.11.001] [PMID: 18082412]  [173] Lee, S.T.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1016/j.expneurol.2010.,OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
[http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1016/j.ajhg.2013.05.025] [PMID:  23810380]  [176] Hoss, A.G.; Labadorf, A.; Latourelle, J.C.; Kartha, V.K.",OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/  10.1038/cr.2008.282] [PMID: 18766170]  [179] Gaughwin, P.M.; Ciesla, M.; Lahiri, N.; Tabrizi, S.J.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/CN-15-260.PMC5412695.pdf
"[http://dx.doi.org/10.1038/nature05983] [PMID: 17589500]  [7] Kwak, P.B.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1038/nsmb.2232] [PMID:  22233755]  [8] Lee, I.; Ajay, S.S.; Yook, J.I.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1101/gr.082701.108]  [PMID: 18955434]  [10] Selbach, M.; Schwanhäusser, B.; Thierfelder, N.; Fang, Z.; Khanin,  R.; Rajewsky, N. Widespread changes in protein synthesis induced  by microRNAs.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/  10.1038/nature07228] [PMID: 18668040]  [11] Doxaki s, E. Post-transcriptional regulation of alpha-synuclein  expression by mir-7 and mir-153.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1074/jbc.M109.086827] [PMID:  20106983]  [12] Boutla, A.; Delidakis, C.; Tabler, M. Developmental defects by  antisense-mediated inactivation of micro-RNAs 2 and 13 in  Drosophila and the identification of putative target genes.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1371/journal.pbio.0020098] [PMID:  15024405]  [15] Krützfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K.G.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/  10.1038/nature04303] [PMID: 16258535]  [16] Pande, V.; Nilsson, L. Insights into structure, dynamics and  hydration of locked nucleic acid (LNA) strand-based duplexes from  molecular dynamics simulations.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1038/gt.2011.50]  [PMID: 21525952]  [20] Lanford, R.E.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1186/1758-907X-3-1]  [PMID: 22230293]  [23] Elmén, J.; Lindow, M.; Schütz, S.; Lawrence, M.; Petri, A.; Obad,  S.; Lindholm, M.; Hedtjärn, M.; Hansen, H.F.; Berger, U.; Gullans,  S.; Kearney, P.; Sarnow, P.; Straarup, E.M.; Kauppinen, S. LNA- mediated microRNA silencing in non-human primates.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1038/nature06783]  [PMID: 18368051]  [24] Thum, T.; Gross, C.; Fiedler, J.; Fischer, T.; Kissler, S.; Bussen,  M.; Galuppo, P.; Just, S.; Rottbauer, W.; Frantz, S.; Castoldi, M.;  Soutschek, J.; Koteliansky, V.; Rosenwald, A.; Basson, M.A.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.3389/fnins.2012.00196] [PMID: 23335878]  [27] Lu, Y.; Xiao, J.; Lin, H.; Bai, Y.; Luo, X.; Wang, Z.; Yang, B.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1093/nar/gkn1053] [PMID: 19136465]  [28] Kluiver, J.; Gibcus, J.H.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1158/0008-5472.CAN-10-2010] [PMID:  20807816]  [30] van Rooij, E.; Kauppinen, S. Development of microRNA  therapeutics is coming of age.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.15252/emmm.201100899] [PMID:  24935956]  [31] Prakash, T.P.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2006.02.049] [PMID: 16598842]  [33] Chen, P.Y.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1261/rna.789808]  [PMID: 18094121]  [34] Kitade, Y.; Akao, Y. MicroRNAs and their therapeutic potential for  human diseases: microRNAs, miR-143 and -145, function as anti- oncomirs and the application of chemically modified miR-143 as  an anti-cancer drug.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1254/jphs.10R12FM] [PMID: 20953119]  [35] Chorn, G.; Klein-McDowell, M.; Zhao, L.; Saunders, M.A.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1038/nrd2591] [PMID:  20616808]  [39] Hue, J.J.; Lee, H.J.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.4142/jvs.2013.14.4.473] [PMID: 24366671]  [40] Krützfeldt, J.; Kuwajima, S.; Braich, R.; Rajeev, K.G.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/  10.1146/annurev.neuro.22.1.11] [PMID: 10202530]  [42] Pardridge, W.M.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1023/A:1015960205409] [PMID: 2762222]  [44] Dhuria, S.V.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1002/  jps.21924] [PMID: 19877171]  [45] Dhamoon, M.S.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1016/j.addr.2011.11.010] [PMID: 22154620]  [48] Wei, G.; Wang, D.; Lu, H.; Parmentier, S.; Wang, Q.; Panter, S.S.;  Frey, W.H., II; Ying, W. Intranasal administration of a PARG  inhibitor profoundly decreases ischemic brain injury.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.2741/2443] [PMID:  17569625]  [49] Garcia-Rodriguez, J.C.; Sosa-Teste, I.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1007/s11916-015-0488-x]  [PMID: 26021753]  [53] Lobato, R.D.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1159/000017069] [PMID:  9701676]  [57] Augustinsson, L.E.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1172/  JCI25424] [PMID: 16878173]  [60] Kordasiewicz, H.B.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1016/  S0169-328X(98)00238-1] [PMID: 9838035]  [69] Yaida, Y.; Nowak, T.S., Jr Distribution of phosphodiester and  phosphorothioate oligonucleotides in rat brain after intraventricular  and intrahippocampal administration determined by in situ  hybridization.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1097/00004647- 199707000-00001] [PMID: 9270488]  [71] Billiau, A.; Heremans, H.; Ververken,  D.; van Damme, J.; Carton,  H.; de Somer, P. Tissue distribution of human interferons after  exogenous administration in rabbits, monkeys, and mice.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1007/BF01315163]  [PMID: 6166278]  [72] de Lange, E.C.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1016/0006-8993(94)90276-3] [PMID:  7889356]  [73] Tyler, B.M.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/  10.1038/nature05901] [PMID: 17572664]  [77] Alvarez-Erviti, L.; Seow, Y.; Yin, H.; Betts, C.; Lakhal, S.; W ood,  M.J.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1016/j.biomaterials.2011.03.047] [PMID:  21489620]  [79] Zou, L.L.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1093/hmg/ddr217] [PMID:  21576124]  [82] Caillé, I.; Alli nquant, B.; Dupont, E.; Bou illot, C.; Langer, A.;  Müller, U.; Prochiantz, A. Soluble form of amyloid precursor  protein regulates proliferation of progenitors in the adult subventri-  cular zone.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.org/10.1517/13543784.,Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1038/mp.2009.84] [PMID: 19721432]  [94] Javitt, D.C. Glutamate and schizophrenia: phencyclidine, N-methyl- D-aspartate receptors, and dopamine-glutamate interactions.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1016/  S0074-7742(06)78003-5] [PMID: 17349858]  [95] Kocerha, J.; Faghihi, M.A.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.3389/fncel.2014.00037] [PMID: 24592211]  [97] Luikart, B.W.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1371/  journal.pone.0019077] [PMID: 21611182]  [98] Pusic, A.D.; Kraig, R.P.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1002/  glia.22606] [PMID: 24339157]  [99] Zhang, J.; Hu, M.; Teng, Z.; Tang, Y.P.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.1165-14.2014] [PMID:  25378159]  [100] Miyazaki, Y.; Adachi, H.; Katsuno, M.; Minamiyama, M.; Jiang,  Y.M.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/  10.1038/nm.2791] [PMID: 22660636]  [101] Ai, J.; Sun, L.H.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.org/10.1093/brain/  awn096] [PMID: 18515322],Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1093/brain/awp300] [PMID:  19952055]  [106] Li, J.S.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1007/s12035-011-8231-z] [PMID: 22218763]  [107] Soukup, G. R.; Sperfeld, A.D.; Uttner, I.; Karitzky, J.; L udolph,  A.C.; Kassubek, J.; Schreiber, H. Frontotemporal cogn itive  function in X-linked spinal and bulbar muscular atrophy (SBMA):  a controlled neuropsychological study of 20 patients.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1006/mthe.2001.0324] [PMID: 11356070]  [111] Kaspar, B.K.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1038/mt.2012.261] [PMID: 23295949]  [114] Ujifuku, K.; Mitsutake, N.; Takakura, S.; Mats use, M.; Saenko, V.;  Suzuki, K.; Hayashi, K.; Matsuo, T.; Kamada, K.; Nagata, I.;  Yamashita, S. miR-195, miR-4553p and miR-10a(*) are implicated  in acquired temozolomide resistance in glioblastoma multiforme  cells.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1158/  1078-0432.CCR-09-1587] [PMID: 19996210]  [116] Me llios, N.; Huang, H.S.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1002/biot.201300510] [PMID:  25367631]  [119] Asseline, U.; Gonçalves, C.; Pichon, C.; Midoux, P. Improved  nuclear delivery of antisense 2-Ome RNA by conjugation with the  histidine-rich peptide H5WYG.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.org/10.1002/smll.,Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1038/  nbt.2612] [PMID: 23792630]  [122] Baril, P.; Ezzine, S.; Pichon, C. Monitoring the spatiotemporal  activities of miRNAs in small animal models using molecular  imaging modalities.",OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.3390/ijms 16034947] [PMID: 25749473]  [123] Mullokandov, G.; Baccarini, A.; Ruzo, A.; Jayaprakash, A.D.;  Tung, N.; Israelow, B.; Evans, M.J.; Sachidanandam, R.; Brown,  B.D.",Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
[http://dx.doi.org/10.1093/  nar/gkt797] [PMID: 24013565],Non-OADS,/arxiv_data1/oa_pdf/45/19/CN-15-276.PMC5412696.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2007.07.088] [PMID: 17673169]  [4] Hayashida, K.; Sano, M.; Ohsawa, I.; Shinmura, K.; Tamaki, K.;  Kimura, K.; Endo, J.; Katayama, T.; Kawamura, A.; Kohsaka, S.;  Makino, S.; Ohta, S.; Ogawa, S.; Fuk uda, K. Inhalation of  hydrogen gas reduces infarct size in the rat model of myocardial  ischemia-reperfusion injury.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2008.05.165]  [PMID: 18541148]  [5] Ohta, S. Molecular hydrogen as a preventive and therapeutic  medical gas: initiation, development and potential of hydrogen  medicine.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/  10.1016/j.pharmthera.2014.04.006] [PMID: 24769081]  [6] Ichihara, M.; Sobue, S.; Ito, M.; Ito, M.; Hirayama, M.; Ohno, K.  Beneficial biological effects and the underlying mechanisms of  molecular hydrogen - comprehensive review of 321 original  articles.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1186/  s13618-015-0035-1] [PMID: 26483953]  [7] Itoh, T.; Hamada, N.; Terazawa, R.; Ito, M.; Ohno, K.; Ichihara,  M.; Nozawa, Y.; Ito, M. Molecular hydrogen inhibits  lipopolysaccharide/interferon γ-induced nitric oxide production  through modulation of signal transduction in macrophages.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.bbamcr.2015.10.012]  [9] Xie, K.; Yu, Y.; Huang, Y.; Zheng, L.; Li, J.; Chen, H.; Han, H.;  Hou, L.; Gong, G.; Wang, G. Molecular hydrogen ameliorates  lipopolysaccharide-induced acute lung injury in mice through  reducing inflammation and apoptosis.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2009.05.117] [PMID: 19486890]  [12] Sies, H. Strategies of antioxidant defense.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1111/j.1600- 079X.1995.tb00133.x] [PMID: 7776173]  [15] Halliwell, B.; Gutteridge, J.M.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/0014-5793(92)  80911-Y] [PMID: 1322323]  [16] Lipinski, B. Hydroxyl radical and its scavengers in health and  disease.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/0163-7827(93)90006-I] [PMID: 8415800]  [19] Lin, M.T.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1080/13550280290168631]  [PMID: 12476342]  [21] Wilson, E.H.; Weninger, W.; Hunter, C.A.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1172/JCI41911] [PMID: 20440079]  [22] Banks, W.A.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.bbi.2014.08.007] [PMID: 25172555]  [23] Arima, Y.; Harada, M.; Kamimura, D.; Park, J.H.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1242/  jcs.01483] [PMID: 15483317]  [27] Ohsawa, I.; Nishimaki, K.; Yamagata, K.; Ishikawa, M.; Ohta, S.  Consumption of hydrogen water prevents atherosclerosis in  apolipoprotein E knockout mice.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1038/npp.2008.95]  [PMID: 18563058]  [29] Sobue, S.; Yamai, K.; Ito, M.; Ohno, K.; Ito, M.; Iwamoto, T.;  Qiao, S.; Ohkuwa, T.; Ichihara, M. Simultaneous oral and  inhalational intake of molecular hydrogen additively suppresses  signaling pathways in rodents.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/  10.1186/2045-9912-1-15] [PMID: 22146222]  [31] Zhai, X.; Chen, X.; Shi, J.; Shi, D.; Ye, Z.; Liu, W.; Li, M.; Wang,  Q.; Kang, Z.; Bi, H.; Sun, X. Lactulose ameliorates cerebral  ischemia-reperfusion injury in rats by inducing hydrogen by  activating Nrf2 expression.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.freeradbiomed.2013.08.004] [PMID:  23954468]  [32] Ayer, R.E.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
[http://dx.doi.org/  10.1007/978-3-211-75718-5_7] [PMID: 18456995]  [33] GBD 2013 Morta lity and Causes of Death Collaborators.,Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1161/01.STR.0000182241.07096.06] [PMID:  16166574]  [36] Higashi, Y.; Jitsuiki, D.; Chayama, K.; Yoshizumi, M. Edaravone  (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical  scavenger, for treatment of cardiovascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/  10.2174/157489006775244191] [PMID: 18221078]  [37] Nagatani, K.; Wada, K.; Takeuchi, S.; Kobayashi, H.; Uozumi, Y.;  Otani, N.; Fujita, M.; Tachibana, S.; Nawashiro, H. Effect of  hydrogen gas on the survival rate of mice following global cerebral  ischemia.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1097/  SHK.0b013e31824ed57c] [PMID: 22392146]  [38] Huang, G.; Zhou, J.; Zhan, W.; Xiong, Y.; Hu, C.; Li, X.; Li, X.;  Li, Y.; Liao, X.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/S0005-2728(98)00112-1] [PMID:  9714796]  [40] Cui, Y.; Zhang, H.; Ji, M.; Jia, M.; Chen, H.; Yang, J.; Duan, M.  Hydrogen-rich saline attenuates neuronal ischemiareperfusion  injury by protecting mitochondrial function in rats.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.jss.2014.05.060]  [PMID: 24969549]  [41] Nagatani, K.; Nawashiro, H.; Takeuchi, S.; Tomura, S.; Otani, N.;  Osada, H.; Wada, K.; Katoh, H.; Tsuzuki, N.; Mori, K. Safety of  intravenous administration of hydrogen-enriched fluid in patients  with acute cerebral ischemia: initial clinical studies.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1186/2045-9912-3-13] [PMID:  23799921]  [42] Ono, H.; Nishijima, Y.; Adachi, N.; Tachibana, S.; Chitoku, S.;  Mukaihara, S.; Sak amoto, M.; Kudo, Y.; Nakazawa, J.; Kaneko,  K.; Nawashiro, H. Improved brain MRI indices in the acute brain  stem infarct sites treated with hydroxyl radical scavengers,  Edaravone and hydrogen, as compared to Edaravone alone.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/  10.1186/2045-9912-1-12] [PMID: 22146068]  [43] Zhan, Y.; Chen, C.; Suzuki, H.; Hu, Q.; Zhi, X.; Zhang, J.H.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"Available from: http://dx.doi.org/10.1007/s12035-015-9242-y  [45] Hong, Y.; Guo, S.; Chen, S.; Sun, C.; Zhang, J.; Sun, X.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1002/jnr.22739] [PMID:  22589232]  [46] Hong, Y.; Shao, A.; Wang, J.; Chen, S.; Wu, H.; McBride, D.W.;  Wu, Q.; Sun, X.; Zhang, J. Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain  injury following subarachnoid hemorrhage: possible role of the  Akt/GSK3β signaling pathway.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1371/journal.pone.0096212] [PMID: 24763696]  [47] Shimura-Miura, H.; Hattori, N.; Kang, D.; Miyako, K.; Nakabeppu,  Y.; Mizuno, Y.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
[http://dx.doi.org/10.1002/1531-8249  (199912)46:6<920::AID-ANA17>3.0.,Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.3389/fnana.2015.00091] [PMID: 26217195]  [49] Hald, A.; Lotharius, J. Oxidative stress and inflammation in  Parkinsons disease: is there a causal link?",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.expneurol.2005.01.013]  [PMID: 15869932]  [50] Wang, J.; Xiong, S.; Xie, C.; Markesbery, W.R.; Lovell, M.A.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1006/exnr.2002.7891] [PMID: 12061862]  [54] Liberatore, G.T.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.neulet.2009.02.016] [PMID: 19356598]  [56] Fujita, K.; Seike, T.; Yuts udo, N.; Ohno, M.; Yamada, H.;  Yamaguchi, H.; Sakumi, K.; Yamakawa, Y.; Kido, M.A.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1002/mds.25375] [PMID:  23400965]  [58] Querfurth, H.W.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1056/NEJMra  0909142] [PMID: 20107219]  [59] Li, J.; Wang, C.; Zhang, J.H.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.5409/wjcp.v5.i1.67] [PMID:  26862504]  [62] Lee, A.C.; Kozuki, N.; Blencowe, H.; Vos, T.; Bahalim,   A.; Darmstadt, G.L.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1038/pr.2013.206] [PMID:  24366463] [63] Kriz, J. Inflammation in ischemic brain injury: timing is important.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.brainres.2008.11.048] [PMID: 19063869]  [66] Domoki, F.; Oláh, O.; Zimmermann, A.; Németh, I.; Tóth-Szuki,  V.; Hugyecz, M.; Temesvári, P.; Bari, F. Hydrogen is  neuroprotective and preserves cerebrovascular reactivity in  asphyxiated newborn pigs.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1159/000348445] [PMID: 23859876]  [68] Mano, Y.; Kotani, T.; Ito, M.; Nagai, T.; Ichinohashi, Y.; Yamada,  K.; Ohno, K.; Kikkawa, F.; Toyokuni, S. Maternal molecular  hydrogen administration ameliorates rat fetal hippocampal damage  caused by in utero ischemia-reperfusion.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
[http://dx.doi.org/10.1016/j.freeradbiomed.,OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1097/  ALN.0b013e31819c7124] [PMID: 19293699]  [70] Wilder, R.T.; Flick, R.P.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1097/  ALN.0b013e3181974fa2] [PMID: 19212262]  [75] Yonamine, R.; Satoh, Y.; Kodama, M.; Araki, Y.; Kazama,   T. Coadministration of hydrogen gas as part of the carrier gas  mixture suppresses neuronal apoptosis and subsequent behavioral  deficits caused by neonatal exposure to sevoflurane in mice.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1097/  ALN.0b013e318275146d] [PMID: 23221861]  [76] Takaenoki, Y.; Satoh, Y.; Araki, Y.; Kodama, M.; Yonamine, R.;  Yufune, S.; Kazama, T. Neonatal exposure to sevoflurane in mice  causes deficits in maternal behavior later in adulthood.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1097/  ALN.0000435846.28299.e7] [PMID: 24061597]  [77] Gotsch, F.; Romero, R.; Kusanovic, J.P.; Mazaki-Tovi, S.; Pineles,  B.L.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/  j.freeradbiomed.2015.12.015] [PMID: 26709014]  [80] Osborne, N.N.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.preteyeres.2003.12.001] [PMID:  14766318]  [81] Oharazawa, H.; Igarashi, T.; Yokota, T.; Fujii, H.; Suzuki, H.;  Machide, M.; Takahashi, H.; Ohta, S.; Ohsawa, I.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1097/WNR.0b013e32832a5c68]  [PMID: 19339905]  [83] Kikkawa, Y.S.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
[http://dx.doi.org/10.1097/01.aud.0000191942.36672.,Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.neuroscience.2012.02.028]  [PMID: 22387110]  [86] Rubiano, A.M.; Carney, N.; Chesnut, R.; Puyana, J.C.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.jss.2011.12.038] [PMID: 22475349]  [89] Dohi, K.; Kraemer, B.C.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
[http://dx.doi.org/10.1016/j.brainres.2010.12.,OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
[http://dx.doi.org/10.1016/j.brainres.2013.04.,OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.brainres.2014.09.030] [PMID:  25251596]  [96] Sun, Q.; Cai, J.; Zhou, J.; Tao, H.; Zhang, J.H.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1097/CCM.0b013e318206bf44]  [PMID: 21200321]  [97] Ito, M.; Hirayama, M.; Yamai, K.; Goto, S.; Ito, M.; Ichihara, M.;  Ohno, K. Drinking hydrogen water and interm ittent hydrogen gas  exposure, but not lactulose or continuous hydrogen gas exposure,  prevent 6-hydorxydopamine-induced Parkinsons disease in rats.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1186/2045- 9912-2-15] [PMID: 22608009]  [98] Matsumoto, A.; Yamafuji, M.; Tachibana, T.; Nak abeppu, Y.;  Noda, M.; Nakaya, H. Oral hydrogen water induces neuro-  protective ghrelin secretion in mice.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1038/srep03273] [PMID: 24253616]  [99] Andrews, Z.B.",Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1152/ajplung.00164.2012] [PMID:  23475767]  [102] Chen, C.H.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/  10.1016/j.neuroscience.2010.04.043] [PMID: 20423721]  [103] Buchholz, B.M.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
"[http://dx.doi.org/10.1016/j.it.2004.09.015] [PMID: 15530839]  [105] Iuchi, K.; Imoto, A.; Kamimura, N.; Nishimaki, K.; Ichimiya, H.;  Yokota, T.; Ohta, S. Molecular hydrogen regulates gene expression  by modifying the free radical chain reaction-dependent generation  of oxidized phospholipid mediators.",OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
[http://dx.doi.org/10.1038/srep18971] [PMID: 26739257],Non-OADS,/arxiv_data1/oa_pdf/40/08/CN-15-324.PMC5412697.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/  10.1097/01.anes.0000299838.13368.6e] [PMID: 18212577]  [4] McCarthy, K.F.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1038/sc.2014.81] [PMID: 25082383]  [5] Woolf, C.J.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
[http://dx.doi.org/10.1213/01.ANE.0000177101.,Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
[http://dx.doi.org/10.1111/j.1525-1403.2012.,Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1097/ALN.0b013e3181c43103] [PMID:  20124882]  [9] Kotani, N.; Kushikata, T.; Hashimoto, H.; Kimura, F.; Muraoka, M.;  Yodono, M.; Asai, M.; Matsuki, A. Intrathecal methylprednisolone  for intractable postherpetic neuralgia.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1056/NEJM200011233432102] [PMID: 11087880]  [10] Brennan, P.M.; Whittle, I.R.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1111/ner.12235] [PMID: 25250852]  [13] Prager, J.; Deer, T.; Levy, R.; Bruel, B.; Buchser, E.; Caraway, D.;  Cousins, M.; Jacobs, M.; McGlothlen, G.; Rauck, R.; Staats, P.; Stearns, L. Best practices for intrathecal drug delivery for pain.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1007/s00216-012-6203-4] [PMID: 22772140]  [16] Sui, P.; Watanabe, H.; Ossipov, M.H.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1021/pr500241q] [PMID:  24933149]  [17] Perkins, D.N.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1002/(SICI)1522-2683(19991201)20:18<3551::  AID-ELPS3551>3.0.CO;2-2] [PMID: 10612281]  [18] Yates, J.R.; Ruse, C.I.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1146/annurev- bioeng-061008-124934] [PMID: 19400705]  [19] Eyrich, B.; Sickmann, A.; Zahedi, R.P.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/  10.1002/pmic.201000489] [PMID: 21226000]  [20] Lee, S.C.; Yoon, T.G.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
[http://dx.doi.org/10.1023/B:BILE.,Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/  10.1016/j.brainres.2011.12.046] [PMID: 22284620]  [22] Singh, O.V.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1002/pmic.200800636] [PMID: 19206110]  [23] Huang, H.L.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/  10.1186/1744-8069-4-33] [PMID: 18700027]  [24] Melemedjian, O.K.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/  10.1186/1744-8069-9-14] [PMID: 23531341]  [25] Oki, G.; Wada, T.; Iba, K.; Aiki, H.; Sasaki, K.; Imai, S.; Sohma,  H.; Matsumoto, K.; Yamaguchi, M.; Fujimiya, M.; Yamashita, T.;  Kokai, Y. Metallothionein deficiency in the injured peripheral  nerves of complex regional pain syndrome as revealed by proteomics.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
[http://dx.doi.org/10.1016/j.pain.,OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1097/ALN.0b013  e3181b64ab8] [PMID: 20029253]  [27] Deer, T.R.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1002/pmic.200900848] [PMID: 21182190]  [29] Brown, J.N.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
[http://dx.doi.org/10.1074/mcp.,Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1002/pmic.200600699]  [PMID: 17295356]  [31] Liaw, W.J.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
[http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/  10.1371/journal.pone.0042068] [PMID: 22860055]  [33] Wen, Z.H.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
[http://dx.doi.org/10.1007/BF03016590] [PMID: 11698319],Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1097/  00001503-200410000-00015] [PMID: 17023903]  [37] Rijsdijk, M.; van Wijck, A.J.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
[http://dx.doi.org/10.1213/ANE.,Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1097/  00002508-199909000-00002] [PMID: 10524468]  [40] Veizi, I.E.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1016/j.ejphar.2009.04.044] [PMID: 19397906]  [43] Roh, D.H.; Kim, H.W.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1213/ANE.0b013e3181c8afc1] [PMID:  20007733]  [45] Li, X.; Eisenach, J.C. alpha2A-adrenoceptor stimulation   reduces capsaicin-induced glutamate release from spinal cord  synaptosomes.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1139/cjpp- 2013-0463] [PMID: 24988216]  [47] Bai, H.P.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1016/j.jns.2014.04.002] [PMID: 24787504]  [48] Wermeling, D.P.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1097/ALN.0b013  e31821950c2] [PMID: 21577088]  [50] McGivern, J.G.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.2147/nedt.2007.3.1.69] [PMID: 19300539]  [51] Vaudano, E. The innovative medicines initiative: a public private  partnership model to foster drug discovery.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.5936/  csbj.201303017] [PMID: 24688725]  [52] Latremoliere, A.; Woolf, C.J.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1016/j.jpain.2009.06.012]  [PMID: 19712899]  [53] Dong, H.; Zhang, P.; Song, I.; Petralia, R.S.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1016/  0006-8993(91)91468-G] [PMID: 1810630]  [56] Mao, J.; Price, D.D.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1016/0304-3959(92)  90116-S] [PMID: 1325049]  [57] Dastoor, Z.; Dreyer, J.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1021/cr2002992]  [PMID: 21942677]  [60] Yuan, A.; Rao, M.V.",OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1523/  JNEUROSCI.2580-06.2006] [PMID: 17005864]  [61] Shea, T.B.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1002/(SICI)1097-0169(1999)43:4<322::  AID-CM5>3.0.CO;2-B] [PMID: 10423273]  [62] Phillips, G.R.",Non-OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
[http://dx.doi.org/10.1002/jnr.20614] [PMID: 16047384],OADS,/arxiv_data1/oa_pdf/c5/55/CN-15-198.PMC5412698.pdf
"[http://dx.doi.org/10.1016/S0140- 6736(06)69418-X] [PMID: 16980119]  [3] Klein, D.F.",OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1126/science.1470919] [PMID: 1470919]  [6] Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.;  Kaminski, N.E.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/  10.1038/sj.bjp.0707133] [PMID: 17245363]  [9] Bisogno, T.; Hanus, L.; De Petroce llis, L.; Tchili bon, S.; Ponde,  D.E.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1007/s00213- 008-1168-x] [PMID: 18446323]  [11] Carrier, E.J.",OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1001/archgenpsychiatry.2008.519] [PMID: 19124693]  [14] Zuardi, A.W.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1007/BF00436092] [PMID: 6126900]  [18] Hofmann, S.G.; Dibartolo, P.M. An instrument to assess self- statements during public speaking: scale development and preliminary psychometric properties.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1016/S0005-7894(00)80027-1] [PMID:  16763666]  [19] Bergamaschi, MM; Queiroz, RH; Chagas, MH; de Oliveira, DC;  De Martinis, BS; Kapczinski, F Cannabidiol reduces the anxiety  induced by simulated public speaking in treatment-naive social phobia patients.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1038/npp.2011.6]  [20] Blanchard, C; Blanchard, R; Fellous, JM; Guimaraes, FS; Irwin,  W; Ledoux, JE The brain decade in debate: III.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1016/j.bbr.2010.05.004] [PMID: 20457188]  [24] Campos, A.C.; de Paula Soares, V.; Carvalho, M.C.",OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/  10.1007/s00213-012-2878-7] [PMID: 23007604]  [25] Dresler, T.; Guhn, A.; Tupak, S.V.",OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/  10.1002/hup.2349]  [27] Pfleiderer, B.; Zinkirciran, S.; Arolt, V.; Heindel, W.; Deckert, J.;  Domschke, K. fMRI amygdala ac tivation during a spontaneous  panic attack in a patient with panic disorder.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1080/  15622970701216673] [PMID: 17853295]  [28] Spiegelhalder, K.; Hornyak, M.; Kyle, S.D.",OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1080/13554790903066909] [PMID: 19657971]  [29] Dresler, T; Hahn, T; Plichta, MM; Ernst, LH; Tupak, SV; Ehlis,  AC; Warrings, B; Deckert, J; Fallgatter, AJ Neural correlates of  spontaneous panic attacks.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1016/  S0006-3223(98)00348-5] [PMID: 10202575]  [33] Fusar-Poli, P; Allen, P; Bhattacharyya, S; Crippa, JA; Mechelli, A;  Borgwardt, S Modulation of effective connectivity during emotional  processing by Delta 9-tetrahydrocannabinol and cannabidiol.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1001/  archgenpsychiatry.2009.17] [PMID: 19349314]  [38] Bhattacharyya, S; Morrison, PD; Fusar-Poli, P; Martin-Santos, R;  Borgwardt, S; Winton-Brown, T Opposite effects of delta-9- tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1177/  0269881110379283] [PMID: 20829306]  [40] Bhattacharyya, S.; Atakan, Z.; Martin-Santos, R.; Crippa, J.A.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1097/00001756-200506210-00010]  [PMID: 15931063]  [42] Del-Ben, CM; Graeff, FG Panic disorder: is the PAG involved?",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1155/2009/108135]  [43] Nashold, B.S., Jr; Wilson, W.P.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.3171/jns.1969.30.1.0014] [PMID:  4885810]  [44] Twardowschy, A.; Castiblanco-Urbina, M.A.",OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.2174/1871524911006030207]  [PMID: 20528764]  [46] Strauss, C.V.; Vicente, M.A.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1016/j.bbr.2013.03.005] [PMID: 23499701]  [47] de Bortoli, VC; Yamashita, PS; Zangrossi, H, Jr 5-HT1A and 5- HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
[http://dx.doi.org/10.1016/j.neulet.2010.,OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1124/mol.109.060079] [PMID: 19995940]  [56] Campos, AC; Ortega, Z; Palazuelos, J; Fogaca, MV; Aguiar, DC;  Diaz-Alonso, J The anxiolytic effect of cannabidiol on chronically  stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1016/  j.neuropharm.2011.08.013] [PMID: 21867717]  [61] Lemos, J.I.",OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1016/j.bbr.2013.04.045] [PMID:  23643693]  [67] Esposito, G.; Scuderi, C.; Valenza, M.; Togna, G.I.",OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1111/  j.1476-5381.2010.01063.x] [PMID: 20942863]  [70] Murillo-Rodríguez, E.; Millán-Aldaco, D.; Palomero-Rivero, M.;  Mechoulam, R.; Drucker-Colín, R. The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1037/a0013278] [PMID:  19045957]  [71] Katsidoni, V.; Anagnostou, I.; Panagis, G. Cannabidiol inhibits the  reward-facilitating effect of morphine: i nvolvement of 5-HT1A  receptors in the dorsal raphe nucleus.",Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
[http://dx.doi.org/10.1111/j.1369-1600.2012.00483.x]  [PMID: 22862835],Non-OADS,/arxiv_data1/oa_pdf/e6/14/CN-15-291.PMC5412699.pdf
"[http://dx.doi.org/10.1016/j.brainresrev.2009.03.002] [PMID:  19328213]   [3] Halpin, L.E.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
[http://dx.doi.org/10.1016/j.l fs.2013.07.,OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1007/s11481 - 008-9121 -7]  [6] Ricaurte, G.A.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/0006 -8993(82)   90198 -6] [PMID: 6145488]   [7] Betteridge, D.J.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/S0026 -0495(00)80077 - 3] [PMID: 10693912]   [8] Wells,  P .",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/j.taap.2005.01.061] [PMID:  16081118]   [9] Guo, C -H.; Chen, P -C. Mitochondrial Free Radicals, Antioxidants,  Nutrient Substances, and Chronic Hepatitis .",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1111/joim.12049] [PMID:   23600399]   [13] Johnson, Z.; Venters, J.; Guarraci, F.A.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1111/1440 -1681.12404] [PMID: 25867833]   [14] Wagner, G.C.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/0028 -3908(89)   90130 -5] [PMID: 2554183]   [16] Hirata,  H.; Ladenheim, B.; Rothman, R.B.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/j.bbr.2014.11.021]  [PMID: 25449844]   [18] da-Rosa, D.D.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1007/s00702 - 011-0691 -9]  [19] da-Rosa, D.D.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/S0304 -3940(98)00711 -3] [PMID:  9839724]   [21] Mori, T.; Ito, S.; Kita, T.; Narita, M.; Suzuki, T.; Matsubayashi, K.;  Sawaguchi, T. Oxidative stress in methamphetamine -induced   self-injurious behavior in mice.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1097/FBP.0b013e328153dae1] [PMID:   17426488]   [22] Thrash -Williams, B .",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1007/s11064 -013-1117 -x] [PMID: 23918203]   [23] Gluck, M.R.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/   10.1046/j.1471 -4159.2001.00549.x] [PMID: 11595767]   [24] Yamamoto, B.K.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/ 10.3109/   15376516.2012.730561] [PMID: 22992185]   [26] Banerjee, A.; Zhang, X.; Manda, K.R.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/j.freeradbiomed.2010.02.023]   [PMID: 20188164]   [27] Toborek, M.; Seelbach, M.J.; Rashid, C.S.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1186/1750 -1326 - 8-22] [PMID: 23799892]   [28] Zhang, X.; Tobwala, S.; Ercal , N. N -acetylcysteine amide protects  against methamphetamine -induced tissue damage in CD -1 mice.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/   S0014 -2999(00)00392 -7] [PMID: 10913590]   [30] Flora, G.; Lee, Y.W.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1385/   NMM:2: 1:71] [PMID: 12230306]   [31] Acikgoz, O; Gonenc, S; Kayatekin, BM; Pekcetin, C; Uysal, N;  Dayi, A The effects of single dose of methamphetamine on lipid  peroxidation levels in the rat striatum and prefrontal cortex.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/   j.neuro.2013.02.007] [PMID: 23462569]   [35] Zhang, F.; Chen, L.; Liu, C.; Qiu, P.; Wang, A.; Li, L.; Wang, H.  Up-regulation of protein  t y r o s i n e  n i t r a t i o n  i n  m e t h a m p h e t a m i n e - induced neurotoxicity through DDAH/ADMA/NOS pathway.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1007/s00213 -011-2619 - 3] [PMID: 22200890]   [37] Kita, T.; Shimada, K.; Mastunari, Y.; Wagner, G.C.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.2174/157015911795016967]  [PMID: 21886575]   [39] Shin, E.J.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/j.bbr.2012.04.001] [PMID: 22512859]   [40] Pang, X; Panee, J; Liu, X; Berry, MJ; Chang, SL; Chang,   L Regional variations of antioxidant capacity and oxidative   stress responses in HIV -1 transgenic rats with and without  methamphetamine administration.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1016/j.pbb.2004.10.006] [PMID: 15582684]   [43] Collins, T.F.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/   10.1006/rtph.1999.1306] [PMID: 10464044]   [44] Solhi, H.; Malekirad, A.; Kazemifar, A.M.; Sharifi, F. Oxidative stress   and lipid peroxidation in prolonged u sers of methamphetamine.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.2174/   187231280702140520191324] [PMID: 24856264]   [45] Walker, J.; Winhusen, T.; Storkson, J.M.",OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"[http://dx.doi.org/10.1111/j.1471 -4159.2004.02434.x] [PMID:  15189342]   [48] Hashimoto, K; Tsukada, H; Nishiyama, S; Fukumoto, D; Kakiuchi,  T; Shimizu, E Protective effects of N -acetyl -L-cysteine on the  reduction of dopam ine transporters in the striatum of monkeys  treated with methamphetamine.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
[http://dx.doi.org/10.1016/j .pnpbp.2006.,OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
[http://dx.doi.org/10.1017/S0007114507791894] [PMID: 17640421],Non-OADS,/arxiv_data1/oa_pdf/0b/7d/CN-15-300.PMC5412700.pdf
"https://www.england.nhs.uk/   commissioning/wp -content/uploads/sites/12/2015/10/d08pb -intra-pumps -trtmnt.pdf (Assessed February 1, 2016 ).",Non-OADS,/arxiv_data1/oa_pdf/3b/18/CN-15-196.PMC5412701.pdf
"[http://dx.doi.org/10.1097/  00000542-200607000-00027] [PMID: 16810009]  [2] Deer, T.R.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/  10.1111/j.1525-1403.2012.00450.x] [PMID: 22494357]  [3] Kumar, K.; Hunter, G.; Demeria, D. Spinal cord stimulation in  treatment of chronic benign pain: challenges in treatment planning  and present status, a 22-year experience.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
[http://dx.doi.org/10.1227/01.NEU.0000192162.,Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1111/  j.1526-4637.2010.00889.x] [PMID: 20642729]  [7] Veizi, I.E.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
", Available at: http://www.prnewswire.com/news- releases/flowonix-medical-inc-announces-fda-pmas-approval-of- prometra-ii-300022126.html   [10] Norn, S.; Kruse, P.R.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1097/  00003643-200309000-00002] [PMID: 12974588]  [12] Behar, M.; Magora, F.; Olshwang, D.; Davidson, J.T.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1016/j.brainresrev.2010.08.002] [PMID:  20817024]  [19] Henry-Feugeas, M.C.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1213/ANE.0b013  e318 2645dfd] [PMID: 22822192]  [21] McEvoy, G.K., Ed.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1016/0885-3924(93)90083-8] [PMID: 7525783]  [24] Perruchoud, C.; Eldabe, S.; Durrer, A.; Bovy, M.; Brookes, M.;  Madzinga, G.; Garner, F.; Batterham, A.M.; Menoud, C.; Jacobs,  M.; Gulve, A.; Buchser, E. Effects of flow rate modifications on  reported analgesia and quality of life in chronic pain patients  treated with continuous intrathecal drug therapy.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
[http://dx.doi.org/10.1111/j.1526-4637.2011.01088.,Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
[http://dx.doi.org/10.1111/j.1525-1403.2012.00476.,Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1517/14656566.2013.784269] [PMID:  2353 7340]  [32] Wang, Y.; Bowersox, S.S. Analgesic properties of ziconotide, a  selective blocker of N-type neuronal calcium channels.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
[http://dx.doi.org/10.1111/j.1527-3458.2000.,Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"Available at: http://www.accessdata.fda.gov/  drugsatfda_docs/label/2007/021060s003lbl.pdf   [38] Pope, J.E.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1016/S0196-9781(00)00175-3] [PMID:  10822104]  [40] Staats, P.S.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1001/jama.291.1.63] [PMID: 14709577]  [41] Wallace, M.S.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1111/j.1525-1403.2006.00055.x]  [PMID: 22151630]  [42] Rauck , R.L.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1016/j.pain.2011.10.002]  [PMID: 22082570]  [44] Ellis, D.J.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1213/  ane.0b013e3181606fad] [PMID: 18227325]  [48] Raffaeli, W.; Sarti, D.; Demartini, L.; Sotgiu, A.; Bonezzi, C.  Italian registry on long-term intrathecal ziconotide treatment.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1016/0024-3205(96)00456-0] [PMID: 8876660]  [55] Liu, S.; Carpenter, R.L.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1097/00000542-199503000-00010] [PMID:  7533484]  [56] Drakeford, M.K.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.2106/00004623-199173030-00013] [PMID:  1705938]  [57] Chaplan, S.R.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
[http://dx.doi.org/10.1111/j.1526-4637.2006.,Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1213/ane.0b013e3181605add]  [PMID: 18227300]  [63] Stanley, T.H.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
[http://dx.doi.org/10.1111/j.1365-2885.,Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1097/  00000542-199902000-00034] [PMID: 9952166]  [70] Mather, L.E.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1097/00000542-199101000-00007] [PMID: 1670913]  [75] Labroo, R.B.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.4155/fmc.13.215] [PMID: 24635521]  [77] Jaffe, R.A.; Rowe, M.A.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1126/science.1273597] [PMID: 1273597]  [80] Abram, S.E.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/  10.1097/00000542-199707000-00017] [PMID: 9232143]  [81] Bromage, P.R.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1097/  00001503-200410000-00015] [PMID: 17023903]  [83] Reina, M.A.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1097/  00000542-200003000-00018] [PMID: 10719953]  [85] Duarte, R.V.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1016/j.clineuro.2011.12.007] [PMID: 22204777]  [86] Gupta, A.; Martindale, T.; Christo, P.J.",OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1097/00115550- 199924030-00015] [PMID: 10338179]  [89] Duarte, R.V.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.1111/papr.12190] [PMID: 24690205]  [91] Pope, J.E.",Non-OADS,/arxiv_data1/oa_pdf/e4/68/CN-15-206.PMC5412702.pdf
"[http://dx.doi.org/10.2147/nedt.2007.3.1.69] [PMID: 19300539]  [4] Wallace, J.M.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1007/s11916-007-0192-6] [PMID: 17504648]  [5] Breivik, H.; Collett, B.; Ventafridda, V.; Cohen, R.; Gallacher, D.  Survey of chronic pain in Europe: prevalence, impact on daily life,  and treatment.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1185/03007990903090849] [PMID: 19563256]  [8] Eldabe, S. Ziconotide: a new option for intrathecal analgesia.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
[http://dx.doi.org/10.2217/14796708.,Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1046/j.1525-1403.2001.00121.x]  [10] Lux, E.A.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1097/AAP.0000000000000022] [PMID:  24310049]  [12] Kress, H.G.",OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1111/j.1525-1403.2007.00128.x]  [PMID: 22150890]  [15] Deer, T.R.",OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/  10.1111/j.1525-1403.2008.00150.x]  [18] Wallace, M.S.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1111/j.1525-1403.2006.00044.x]  [20] Vitale, V.; Battelli, D.; Gasperoni, E.; Monachese, N. Intrathecal  therapy with ziconotide: clinical experience and considerations on its  use.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"Available at: http://www.medicines.org.uk/EMC/  medicine/18393/SPC/Prialt+solution+for+infusion/   [22] Schmidtko, A.; Lötsch, J.; Freynhagen, R.; Geisslinger, G.  Ziconotide for treatment of severe chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
[http://dx.doi.org/10.2147/  TCRM.S4438] [PMID: 19707262]  [24] Medtronic.,Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1038/sj.sc.3102027] [PMID:  17310258]  [31] Saulino, M.; Burton, A.W.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.3109/  15360288.2012.703296]  [34] Brookes, M.; Eldabe, S. 320 Case Report: Efficacy of Ziconotide in  Mixed Neuropathic and Nociceptive Pain.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1016/j.ejpain.2007.03.335]  [35] Dworkin, R.H.; Backonja, M.; Rowbotham, M.C.",OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1053/sa.2000.6787]  [38] Atanassoff, P.G.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1001/jama.291.1.63] [PMID:  14709577]  [40] Wallace, M.S.",OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
[http://dx.doi.org/10.1111/j.1525-1403.,Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
[http://dx.doi.org/  10.1016/j.jpainsymman.2005.10.003] [PMID: 16716870]  [42] AVERT.,OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"Available at:  http://www.avert.org/aids-pain.htm   [43] Jadad, A.R.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1016/  0197-2456(95)00134-4] [PMID: 8721797]  [44] Schulz, K.F.",OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1016/S0140-6736(02)07750-4] [PMID:  11867132]  [45] A Pocket Guide to Good Clinical Practice, Including the  Declaration of Helsinki.",Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
"[http://dx.doi.org/10.1016/0002-9343(83)90878-1] [PMID:  6650552]  [49] Abs, R.; Verhelst, J.; Maeyaert, J.; Van Buyten, J.P.; Opsomer, F.;  Adriaensen, H.; Verlooy, J.; Van Havenbergh, T.; Smet, M.; Van  Acker, K. Endocrine consequences of long-term intrathecal  administration of opioids.",OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
[http://dx.doi.org/10.1111/  j.1525-1403.2011.00334.x]  [52] N.H.S.,Non-OADS,/arxiv_data1/oa_pdf/9d/b7/CN-15-217.PMC5412704.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/66/main.PMC5412714.pdf
A complete listing of ADNI investigatorscan be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_ apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/50/66/main.PMC5412714.pdf
E-mail address: marwan.sabbagh@dignityhealth.org http://dx.doi.org/10.1016/j.trci.2017.01.001 2352-8737/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/66/main.PMC5412714.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/66/main.PMC5412714.pdf
CLINICAL TRIAL REGISTRATION: URL: http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/c1/bb/cir-135-1705.PMC5412733.pdf
The online-only Data Supplement is available with this arti- cle at http://circ.ahajournals.org/lookup/suppl/doi:10.1161/ CIRCULATIONAHA.116.024279/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c1/bb/cir-135-1705.PMC5412733.pdf
Circulation is available at http://circ.ahajournals.org.REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/c1/bb/cir-135-1705.PMC5412733.pdf
"Oligonucleotideswere designed with QuantPrime (http://quantprime.mpimp-golm.mpg.de; Arvidsson et al, 2008) and used in final concentration of 0.5lM each (primers are listed in Appendix Table S2).",Non-OADS,/arxiv_data1/oa_pdf/7b/85/EMBJ-36-1279.PMC5412766.pdf
"Reac-tion-specific efficiencies were deduced using LinRegPCR 2015.2(http://LinRegPCR.nl; Ramakers et al, 2003; Ruijter et al, 2009).",OADS,/arxiv_data1/oa_pdf/7b/85/EMBJ-36-1279.PMC5412766.pdf
"Data were quality-controlled, normalized against at least two refer-ence genes, and statistically evaluated using qbasePLUS 3.0 (http://www.biogazelle.com/products/qbaseplus; Hellemans et al, 2007).",OADS,/arxiv_data1/oa_pdf/7b/85/EMBJ-36-1279.PMC5412766.pdf
Image processing Images were viewed and processed using open-source ImageJ/Fiji software (http://fiji.sc).,OADS,/arxiv_data1/oa_pdf/d7/71/EMBJ-36-1134.PMC5412767.pdf
Available at http://www.accessda ta.fda.gov/drugsatfda_docs/nda/2005/076790_ORIGINAL% 20APPROVAL_PACKAGE.pdf (accessed 8 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/0d/9c/CCR3-5-601.PMC5412800.pdf
"The English in this document has been checked by at leasttwo professional editors, both native speakers of English.For a certiﬁcate, please see: http://www.textcheck.com/certificate/bg0dOT and Wiley Editing Services (CertiﬁcateVeriﬁcation Key: 3C5A-6218-521D-18A5-B487).",Non-OADS,/arxiv_data1/oa_pdf/5f/af/CCR3-5-642.PMC5412801.pdf
"2. International Registry on Acquired Von Willebrand Syndrome, http://www.intreavws.com 3.",Non-OADS,/arxiv_data1/oa_pdf/7b/21/CCR3-5-664.PMC5412814.pdf
ASH guidelines at http://www.hematology.org/Clinicians/ Guidelines-Quality/3127.aspx 32.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/CCR3-5-664.PMC5412814.pdf
"[Cited 8 May 2014] Available from URL: http://sites.cardiff.ac.uk/dermatology/quality-of-life/der matology-quality-of-life-index-dlqi /dlqi-instructions-for-use-and- scoring/.19 Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY.",Non-OADS,/arxiv_data1/oa_pdf/2a/de/JDE-44-375.PMC5412823.pdf
"Available at https://www.pradaxapro.com/c linical-trials (accessed June 20, 2016).",Non-OADS,/arxiv_data1/oa_pdf/aa/e7/CCR3-5-636.PMC5412829.pdf
"Available at https://www.xareltohcp.com/clinical-trials/ clinical-trials.html (accessed June 20, 2016).",Non-OADS,/arxiv_data1/oa_pdf/aa/e7/CCR3-5-636.PMC5412829.pdf
"Available at https://www.eliquis.com/ eliquis/hcp/stroke-risk-reduction-nvaf/efficacy (accessed June 20, 2016) 5.",Non-OADS,/arxiv_data1/oa_pdf/aa/e7/CCR3-5-636.PMC5412829.pdf
"Available at http://www.savaysa hcp.com/clinical-trials/nvaf.html (accessed June 20, 2016) 6.",Non-OADS,/arxiv_data1/oa_pdf/aa/e7/CCR3-5-636.PMC5412829.pdf
The care bundle is freely available at (http://www.bsg.org.uk/care-bundles/care-bundles-general/decom pensated-cirrhosis-care-bundle- ﬁrst-24-hours.html).,Non-OADS,/arxiv_data1/oa_pdf/62/06/APT-44-1030.PMC5412833.pdf
"Right Care, 2013.Availabe at: http://www.rightcare.nhs.uk/index.php/atlas/ liver-disease-nhs-atlas-of-variation-in- healthcare-for-people-with-liver-disease/(accessed 1 July 2016).",Non-OADS,/arxiv_data1/oa_pdf/62/06/APT-44-1030.PMC5412833.pdf
Available at: http://www.hcvaction.org.uk/resource/liver- disease-todays-complacency-tomorrows-catastrophe-all-party-parliamentary- hepatology (accessed 1 July 2016).,Non-OADS,/arxiv_data1/oa_pdf/62/06/APT-44-1030.PMC5412833.pdf
Available at: http://www.ncepod.org.uk/ 2013report1/downloads/MeasuringTheUnits_FullReport.pdf (accessed 1 July 2016).,OADS,/arxiv_data1/oa_pdf/62/06/APT-44-1030.PMC5412833.pdf
Available at: http://www.ncepod.org.uk/ 2015report1/downloads/TimeToGetControlFullReport.pdf(accessed 1 July 2016).,Non-OADS,/arxiv_data1/oa_pdf/62/06/APT-44-1030.PMC5412833.pdf
"Whilst the licensed indication in the United States iscurrently restricted to treatment of skin manifestations ofCTCL (http://www.therakos.com/full-prescribing-informa tion) ECP is used in a number of other indications, most commonly the treatment of chronic GvHD followingallogeneic haematopoietic cell transplantation (HCT).",Non-OADS,/arxiv_data1/oa_pdf/a5/fc/BJH-177-287.PMC5412836.pdf
"First Edi- tion, Version 1.7, November 2014. http://www.ifeit.org/pdf/TAU%20Standards%201.7.pdfUK Photopheresis Society: ECP Consensus Statement Update ª2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a5/fc/BJH-177-287.PMC5412836.pdf
https://doi.org/10.1097/SAP.0b0 13e3181b0bb03.F.,Non-OADS,/arxiv_data1/oa_pdf/e4/49/RCR2-5-na.PMC5412839.pdf
Available from: http://www.wcrf.,Non-OADS,/arxiv_data1/oa_pdf/4f/4e/PON-26-428.PMC5412844.pdf
Available from: http://www.oecd- ilibrary.org/envir onment/test-no-203- ﬁsh-acute-toxicity- test_9789264069961-en 2.,Non-OADS,/arxiv_data1/oa_pdf/c8/d6/ETC-36-1389.PMC5412845.pdf
https://doi.org/10.1111/dom.12872HOROWITZ ET AL.,Non-OADS,/arxiv_data1/oa_pdf/64/7d/DOM-19-672.PMC5412849.pdf
"Available from URL: http://www.un.org/esa/population/publica tions/2012PopAgeingDev_Chart/2012PopAgeingandDev_WallChart.pdf12 Takao Y, Miyazaki Y, Okeda M et al.",OADS,/arxiv_data1/oa_pdf/28/af/JDE-44-414.PMC5412850.pdf
https://doi.org/10.1111/dom.12874704 DASGUPTA ET AL.,Non-OADS,/arxiv_data1/oa_pdf/0a/53/DOM-19-695.PMC5412851.pdf
The study was conducted in accordance with the Declaration of Helsinki (6th World Medical Assembly 2013) and was approved by the Clinical Research Ethics Committeeof the Balearic Islands (approval number IB 1616/11 PI) and registered at https://www.clinicaltrials.gov/ (NCT01374932).,Non-OADS,/arxiv_data1/oa_pdf/da/8b/ALL-72-802.PMC5412857.pdf
"Available from: http://www.ginasthma.org/local/uploads/ﬁles/ GINA_Report_2015_May19.pdf (accessed February 18, 2016).",OADS,/arxiv_data1/oa_pdf/da/8b/ALL-72-802.PMC5412857.pdf
"Available from: http://www.ginasthma.org/local/uploads/ﬁles/ GINA_Report_2010_1.pdf (accessed Febru- ary 18, 2016).",OADS,/arxiv_data1/oa_pdf/da/8b/ALL-72-802.PMC5412857.pdf
EASL recommenda- tions on treatment of hepatitis C 2015. http://www.easl.eu/research/ our-contributions/clinical-practice-g uidelines/detail/recommendations- on-treatment-of-hepatitis-c-2015 .,Non-OADS,/arxiv_data1/oa_pdf/3b/0a/HEP-64-370.PMC5412860.pdf
"Conse- quently, in silico analyses using various prediction programs such as PolyPhen-2 [http://genetics.bwh.harvard.edu/pph2/] and Mutation Taster [http://www.mu- tationtaster.org/] predict this variant to aﬀect protein function.",Non-OADS,/arxiv_data1/oa_pdf/13/35/AOS-95-e250.PMC5412861.pdf
Available at: http://www.wormbook.org.,Non-OADS,/arxiv_data1/oa_pdf/15/6c/DNEU-77-587.PMC5412865.pdf
"AEs werebased on published criteria (Common Terminology Criteriafor Adverse Events, Version 4.0, https://evs.nci.nih.gov/ftp1/ CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf).",OADS,/arxiv_data1/oa_pdf/be/8c/BJH-177-243.PMC5412890.pdf
"Infusion time for ublituximab, which decreased to an average of90 min in later administrations, compares favourably to thatseen with another anti-CD20 MAb, ofatumumab (https://www.pharma.us.novartis.com/si tes/www.pharma.us.novartis.",Non-OADS,/arxiv_data1/oa_pdf/be/8c/BJH-177-243.PMC5412890.pdf
"Classiﬁcation according to preferred term, Medical Dictionary forRegulatory Activities (MedDRA) version 18 (http://www.meddra.org/how-to-use/support-documentation).",Non-OADS,/arxiv_data1/oa_pdf/be/8c/BJH-177-243.PMC5412890.pdf
"2013. https://www.health-e.org.za/wp-content/uploads/ 2014/05/ASHIVHerp_Report2014_22May2014.pdf Bates M, Mudenda V, Mwaba P, Zumla A.",Non-OADS,/arxiv_data1/oa_pdf/e2/1b/JMV-89-1080.PMC5412894.pdf
"District health barometer 2012/13 Durban: Health SystemsTrust 2013. http://www.hst.org.za/publications/district-health-barometer-201213 Miller GG, Boivin G, Dummer JS, Mcconnell T, Becher MW, Kassim A, Tang YW.",Non-OADS,/arxiv_data1/oa_pdf/e2/1b/JMV-89-1080.PMC5412894.pdf
"Furthermore, protein residue conservation analysis was performed with the ConSurf Web site (Ashkenazy et al, 2010), which is publically available at http://consurf.tau.ac.il.",OADS,/arxiv_data1/oa_pdf/0d/81/EMBJ-36-1243.PMC5412902.pdf
"The EZH2mutation was identified in the Cosmic (catalog of somatic mutationsin cancer) Web site (Forbes et al, 2011), which is publically avail- able at http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/.",OADS,/arxiv_data1/oa_pdf/0d/81/EMBJ-36-1243.PMC5412902.pdf
http://www.google.com/patents/WO2012076877A1?cl=en.,Non-OADS,/arxiv_data1/oa_pdf/b8/7b/APHA-220-124.PMC5412918.pdf
https://clinicaltrials.gov/ct2/show/study/NCT01843062.,Non-OADS,/arxiv_data1/oa_pdf/cf/e9/JCPH-57-592.PMC5412920.pdf
http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2011/08/WC500109686.,Non-OADS,/arxiv_data1/oa_pdf/cf/e9/JCPH-57-592.PMC5412920.pdf
"http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation /Guidances/ucm070107.pdf.AccessedNovember25,2015.",Non-OADS,/arxiv_data1/oa_pdf/cf/e9/JCPH-57-592.PMC5412920.pdf
Available at: https://portal.uni-freiburg.de/imbi/Royston- Sauerbrei-book/index.html.,Non-OADS,/arxiv_data1/oa_pdf/f0/29/AOS-95-262.PMC5412929.pdf
2013. http://www.idf.org/ guidelines-older-people-type-2-diabetes.,Non-OADS,/arxiv_data1/oa_pdf/a8/4d/DOM-19-644.PMC5412932.pdf
2015. https://www.cprd.com/home/.,Non-OADS,/arxiv_data1/oa_pdf/a8/4d/DOM-19-644.PMC5412932.pdf
https://doi.org/ 10.1111/dom.12867GORDON ET AL.,OADS,/arxiv_data1/oa_pdf/a8/4d/DOM-19-644.PMC5412932.pdf
https://doi.org/ 10.1111/dom.12870HONG ET AL.,OADS,/arxiv_data1/oa_pdf/6c/90/DOM-19-654.PMC5412933.pdf
https://doi.org/10.1111/dom.12848YABE ET AL.,OADS,/arxiv_data1/oa_pdf/13/da/DOM-19-739.PMC5412941.pdf
Available at: http://www.eurogin.,Non-OADS,/arxiv_data1/oa_pdf/16/49/IJC-139-2812.PMC5412942.pdf
2015;2015: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1f/48/i2164-2591-6-3-1.PMC5412967.pdf
"MeSH Keywords:  Endoscopy • Materials Testing • Silicone Gels  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/899553Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Otorhinolaryngology, Medical School of Xi’an Jiaotong University,  Xi’an, Shaanxi, P.R.",Non-OADS,/arxiv_data1/oa_pdf/b7/05/medscimonit-23-1992.PMC5412971.pdf
"MeSH Keywords:  Genes, bcl-2 • Stomach Diseases • Toll-Like Receptor 7  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/900418Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Digestive System, Xinjiang Medical University Affiliated Tumor  Hospital, Urumqi, Xinjiang, P.R.",Non-OADS,/arxiv_data1/oa_pdf/18/77/medscimonit-23-1980.PMC5412972.pdf
"MeSH Keywords:  Apoptosis • Head and Neck Neoplasms • Puma  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901643Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing,  Jiangsu, P.R.",Non-OADS,/arxiv_data1/oa_pdf/30/72/medscimonit-23-1963.PMC5412973.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.04.0152211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
BMC Public Health14 (1):61. http://dx.doi.org/10.1186/1471-2458-14-61 .,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/ 10.1016/j.ypmed.2015.07.016 .,OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1542/peds.2013-3998 .,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
BMC Public Health 14:683. http://dx.doi.org/10.1186/1471-2458-14-683 .,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
10:54. http://dx.doi.org/10.1186/1479-5868-10-54 .,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
"http://dx.doi.org/10.1177/1524839910377966 .De Decker, E., De Craemer, M., De Bourdeaudhuij, I., et al., 2012.",Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1123/jpah.,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1007/s12187-013-9212-8 .,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1249/ MSS.0b013e318233763b .,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1016/j.ypmed.,OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1016/j.ypmed.2014.02.,OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1001/jamapediatrics.,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1016/j.amepre.2013.03.001 .,OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1139/ h2012-063.,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1111/cch.12304 .,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1038/oby.2011.348 .,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
66:39 –44.http://dx.doi.org/10.1016/j.ypmed.,OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1139/h2012-019 .,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.1177/0002764204271497 .344 T. Hinkley et al.,OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
34 (2):63 –71.http://dx.doi.org/10.1097/DBP.0b013e31827b163a .,Non-OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
2015: 546925. http://dx.doi.org/10.1155/2015/546925 .345 T. Hinkley et al.,OADS,/arxiv_data1/oa_pdf/b4/ec/main.PMC5413195.pdf
"The POLG Pathogenicity Prediction Server ( http://polg.bmb.msu.edu ) is targeted at clinicians and scientists studying POLG disorders, and aims to provide the most current available information regarding the pathogenicity of POLG mutations.",OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"Cluster 2 includes residues of the upstream DNA binding http://dx.doi.org/10.1016/j.bbacli.2017.04.001 Received 15 February 2017; Received in revised form 11 April 2017; Accepted 12 April 2017⁎Corresponding author at: Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA.",OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"The database and an online server, known as the “POLG Pathogenicity Prediction Server, ”are available at http://polg.bmb.msu.edu .",OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
[ http://www.ncbi.nlm.nih.gov/pubmed/17452231 ].,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
[ http://www.ncbi.nlm.nih.gov/pubmed/18504126 ].,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
[ http://www.ncbi.nlm.nih.gov/pubmed/24841123 ].,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
[ http://www.ncbi.nlm.nih.gov/pubmed/27111573 ].A.,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"The server represents a comprehensive, interactive database that complements and extends substantially the online Human DNA Polymerase gamma Mutation Database ( http://tools.niehs.nih.",OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"280 (36) (2005)31341 –31346, http://dx.doi.org/10.1074/jbc.M506762200 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"15 (23) (2006) 3473 –3483, http://dx.doi.org/10.1093/hmg/ ddl424 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"350 (1 –2) (2015) 93 –97,http://dx.doi.org/10.1016/j.jns.2015.02.011 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"Johnson, E ﬀect of the Y955C mutation on mitochondrial DNA polymerase nucleotide incorporation e ﬃciency and ﬁdelity, Biochemistry 50 (29) (2011) 6376 –6386, http://dx.doi.org/10.1021/bi200280r .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"39 (21) (2011) 9072 –9084, http://dx.doi.org/10.1093/nar/gkr618 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"114 (3) (2015) 388 –396, http://dx.doi.org/10.1016/j.ymgme.2014.",OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"1837 (7) (2014) 1113 –1121, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"11 (8) (2004) 770 –776, http://dx.doi.org/10.1038/nsmb805 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"15 (7) (2007) 779 –783, http://dx.doi.org/10.1038/sj.ejhg.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"77 (3) (2005) 430 –441, http://dx.doi.org/10.1086/444548 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
doi.org/10.1212/01.wnl.0000210486.32196.24 https://www.ncbi.nlm.nih.gov/ pubmed/16682683 .,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"44613 (512) (2001) 38090 –38096, http://dx.doi.org/10.1074/jbc.M106045200 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"73 (1) (2004) 293 –320, http://dx.doi.org/10.1146/annurev.biochem.72.121801.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"9238 (2016)1–12,http://dx.doi.org/10.3109/10409238.2015.1117056 https://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"134 (9) (2015) 951 –966, http://dx.doi.org/10.1007/s00439-015-1578-x .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"284 (29) (2009) 19501 –19510, http://dx.doi.org/10.1074/jbc.M109.011940 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"Yin, Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations, Cell 139(2) (2009) 312 –324, http://dx.doi.org/10.1016/j.cell.2009.07.050 .",OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"87 (4) (2007) 326 –335, http://dx.doi.org/10.1038/labinvest.3700523 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"276 (42) (2001) 38555 –38562, http://dx.doi.org/10.1074/ jbc.M105230200 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"2491 –2497, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
M411447200 https://www.ncbi.nlm.nih.gov/pubmed/1662214 .,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"Chalmers, ... A. Suomalainen, Parkinsonism, premature menopause, and mitochondrial DNA polymerase γmutations: clinical and molecular genetic study, Lancet 364 (9437) (2004) 875 –882, http://dx.doi.org/10.1016/S0140-6736(04)16983-3 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"14 (14) (2005) 1907 –1920, http://dx.doi.org/10.1093/hmg/ ddi196 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"6 (2015) 7303, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"[28] A. Niroula, S. Urolagin, M. Vihinen, PON-P2: prediction method for fast and reliable identiﬁcation of harmful variants, PLoS One 10 (2) (2015) 1 –17,http://dx.doi.org/ 10.1371/journal.pone.0117380 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
https://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"Acta 6 (2010) 545 –551, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
org/10.1016/j.bbadis.2010.02.003 https://www.ncbi.nlm.nih.gov/pubmed/ 20153822 .,OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"6 (2015) 1 –11,http://dx.doi.org/10.3389/ fgene.2015.00135 https://www.ncbi.nlm.nih.gov/pubmed/25914719 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"Woodward, ... S. Rahman, A clinical, neuropathological and genetic study of homozygous A467T POLG-related mitochondrial disease, PLoS One 11 (1) (2016) 1–16,http://dx.doi.org/10.1371/journal.pone.0145500 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"60 (3) (2006) 321 –326, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"22 (4) (2014) 542 –550, http://dx.doi.org/10.1038/ejhg.2013.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"37 (6) (2016) 540 –548, http://dx.doi.org/10.1002/humu.22974 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"68 (2011) 219 –233, http:// dx.doi.org/10.1007/s00018-010-0530-4 https://www.ncbi.nlm.nih.gov/pubmed/ 20927567 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"19 (18) (2010) 3516 –3529, http://dx.doi.org/10.1093/hmg/ddq267 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"34 (14) (2015) 1959 –1970, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"48 (10) (2011) 669 –681, http://dx.doi.org/ 10.1136/jmedgenet-2011-100222 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"Chinnery, Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrialrespiratory chain complex de ﬁciencies, JAMA 312 (2016) 68 –77,http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
org/10.1001/jama.2014.7184 https://www.ncbi.nlm.nih.gov/pubmed/25058219 .,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"http://dx.doi.org/10.1016/ S0,https://www.ncbi.nlm.nih.gov/pubmed/12565911 .",OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"Chinnery, Polymerase γgene POLG determines the risk of sodium valproate-induced liver toxicity, Hepatology 52 (2010) 1791 –1796, http://dx.doi.org/10.1002/hep.23891 https://www.ncbi.nlm.nih.gov/pubmed/21038416 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"39 (4) (2007) 540 –543, http://dx.doi.org/10.1038/ng1988 .",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"38 (2016) 52 –62,http://dx.doi.org/10.1016/j.gde.",OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
2016.03.005 https://www.ncbi.nlm.nih.gov/pubmed/27065468 .,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"150 (2007) 531 –534, http://dx.doi.org/10.1016/j.jpeds.2007.01.044 http://www.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"18 (2008) 465 –470, http://dx.doi.org/ 10.1016/j.nmd.2008.03.013 http://www.ncbi.nlm.nih.gov/pubmed/18504126 .",OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"76 (2014) 66 –81,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
1002/ana.24185 http://www.ncbi.nlm.nih.gov/pubmed/24841123 .,Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
"73 (2016) 668 –674, http://dx.doi.org/10.1001/jamaneurol.2016.0355 http://www.ncbi.nlm.nih.gov/pubmed/27111573 .A.",Non-OADS,/arxiv_data1/oa_pdf/e6/fd/main.PMC5413197.pdf
http://dx.doi.org/10.1016/j.nicl.2017.04.010 Received 23 December 2016; Received in revised form 24 March 2017; Accepted 14 April 2017☆Conﬂict of interest: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1046/j.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1038/ nn1209 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
4. http://dx.doi.org/10.3389/fpsyg.2013.00907 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.08.038 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1176/jnp.16.4.456 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.3022-12.2013 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1146/annurev- psych-010814-015044 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/S0193-953X(05)70074-5 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1111/1468-0262.00054 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1111/adb.12103 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1038/nn2067 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1279-09.2009 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1055/s-0028-1124107 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
1 –10.http://dx.doi.org/10.1111/ejn.12802 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"45, 9 –18.http://dx.doi.org/ 10.1016/j.neubiorev.2014.04.011 .",OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.07.032 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
Neurosci 3. http://dx.doi.org/10.3389/neuro.09.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1007/s00213- 005-2205-7 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1007/s00213-007-1051-1 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"18, 87 –98.http://dx.doi.org/10.1037/a0018058 .",Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1038/nn733 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/ 10.1126/science.1102941 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.jmp.,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1038/74899 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1093/cercor/bhp247 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1002/wcs.57 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1093/cercor/ bhn098 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"5, 10 –16.http://dx.doi.org/10.1016/S1364- 6613(00)01567-9 .",OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1038/nrn3119 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.09.017 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1010-06.2006 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.neuron.2007.07.022 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1111/j.1360-0443.1991.tb01879.x .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1176/appi.ajp.162.8.1414 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.neuron.2006.12.023 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.3109/ 10826088509056356 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1111/j.1530-0277.2008.00891.x .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.5227-06.2007 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/ 10.1016/j.biopsych.2008.01.018 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1001/jama.1993.03510180077038 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"16, 72 –80.http://dx.doi.org/10.1016/j.tics.2011.11.018 .",OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/S0140-6736(10) 61462-6 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/0028-3932(71) 90067-4 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.neuron.2013.08.030 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"5, 97 –98.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5587-09.2010 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.drugalcdep.2013.09.029 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"Neuropsychopharmacology 26, 53 –63.http://dx.doi.org/10.1016/S0893-133X(01)00334-7 .",Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1038/nrn2317 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
4. http://dx.doi.org/10.3389/fnins.2010.00017 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"125, 89 –94.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1146/annurev.neuro.23.1.473 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.neuron.2013.08.009 .,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1111/adb.12109 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"Neuropharmacology 56 (Supplement 1), 63 –72.http://dx.doi.org/10.1016/j.neuropharm.2008.07.019 .",OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.3758/BF03196629 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1038/nrn1666 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1176/appi.ajp.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"NeuroImage 89, 57 –69.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"16, 55 –61.http://dx.doi.org/10.1038/nrn3857 .",Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1038/npp.2011.251 .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1046/j.1460-9568.2003.02922.x .,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
"54, 14 –27.http://dx.doi.org/10.1016/j.jmp.2008.12.001 .",OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/49/4e/main.PMC5413198.pdf
(Cell Mol Gastroenterol Hepatol 2017;4:1 –17;http://dx.doi.org/10.1016/j.jcmgh.2017.01.011 ) Keywords: Oral Tolerance; Mucosal Immunity; Autoimmunity; Regulatory B Cell.,Non-OADS,/arxiv_data1/oa_pdf/c5/2c/main.PMC5413199.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/2c/main.PMC5413199.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2017.01.0112 Garber et al Cellular and Molecular Gastroenterology and Hepatology Vol.,OADS,/arxiv_data1/oa_pdf/c5/2c/main.PMC5413199.pdf
"Immgen data browser (available: http://www.immgen.org/databrowser/index.html , datagroup; human immune cells, Garvan) was used to quantify the relative amounts of B- and T-cell gene expression for 30 genes in the extended core B-cell gene module (as indicated) using an arbitrary scale from 1 to 5: 5, expressed in B cells 10-fold more than other leukocytes; 4,expressed in B cells 10-fold more than T cells; 3, expressed in B cells between 3- and 10-fold more than T cells; 2, expressedin B and T cells with less than 3-fold differential; 1, poorly measured.",OADS,/arxiv_data1/oa_pdf/c5/2c/main.PMC5413199.pdf
http://dx.doi.org/10.1016/j.redox.2017.04.028 Received 20 April 2017; Accepted 21 April 2017☆Featured Article: Classifying Oxidative Stress by F 2-Isoprostane Levels Across Human Disease: A Meta-Analysis.,OADS,/arxiv_data1/oa_pdf/88/c8/main.PMC5413206.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/88/c8/main.PMC5413206.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/main.PMC5413207.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.04.019 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/main.PMC5413207.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/9d/main.PMC5413209.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.018 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/9d/main.PMC5413209.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 135 e137,Non-OADS,/arxiv_data1/oa_pdf/95/9d/main.PMC5413209.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/bc/main.PMC5413211.pdf
600  mls  of  haemoserous  ﬂuid  into http://dx.doi.org/10.1016/j.ijscr.2017.04.013 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/aa/bc/main.PMC5413211.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/9e/main.PMC5413212.pdf
E-mail address: Myrlene.Sanon@otsuka-us.com http://dx.doi.org/10.1016/j.dadm.2017.04.001 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/9e/main.PMC5413212.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/9e/main.PMC5413212.pdf
Available at: https://www.alz.co.,Non-OADS,/arxiv_data1/oa_pdf/20/9e/main.PMC5413212.pdf
"http://dx.doi.org/10.1016/j.redox.2017.04.020 Received 30 January 2017; Received in revised form 10 April 2017; Accepted 10 April 2017☆This work was funded by National Institute of Health grants R01 HL107291, P30 GM103532, P20 GM103496, R01 HL133920, a UVM/State of Vermont Pre-Seed Fund grant (Grant no.",Non-OADS,/arxiv_data1/oa_pdf/b8/8c/main.PMC5413213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b8/8c/main.PMC5413213.pdf
Medicine (2017) 96:17(e6386)Received: 16 September 2016 / Received in ﬁnal form: 20 February 2017 / Accepted: 22 February 2017 http://dx.doi.org/10.1097/MD.0000000000006386Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4c/91/medi-96-e6386.PMC5413217.pdf
"Surveillance, Epidemiology and End Results 2013; http://seer.cancer.gov/stdpopula- tions/.",Non-OADS,/arxiv_data1/oa_pdf/4c/91/medi-96-e6386.PMC5413217.pdf
Medicine (2017) 96:17(e6417)Received: 13 October 2016 / Received in ﬁnal form: 19 February 2017 / Accepted: 26 February 2017 http://dx.doi.org/10.1097/MD.0000000000006417Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/82/79/medi-96-e6417.PMC5413218.pdf
We applied Omicsbean (http://www.omicsbean.com) to perform target gene prediction and pathway analysis.,OADS,/arxiv_data1/oa_pdf/82/79/medi-96-e6417.PMC5413218.pdf
Target gene prediction and pathway analysis OmicsBean (http://www.omicsbean.com) analyses were per- formed to predict the target genes of the 8 miRNAs differentially expressed between the SSH and SRH groups.,OADS,/arxiv_data1/oa_pdf/82/79/medi-96-e6417.PMC5413218.pdf
Medicine (2017) 96:17(e6436)Received: 6 November 2016 / Received in ﬁnal form: 6 February 2017 / Accepted: 25 February 2017 http://dx.doi.org/10.1097/MD.0000000000006436Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/14/18/medi-96-e6436.PMC5413219.pdf
Medicine (2017) 96:17(e6538)Received: 3 May 2016 / Received in ﬁnal form: 5 February 2017 / Accepted: 9 March 2017 http://dx.doi.org/10.1097/MD.0000000000006538Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9d/91/medi-96-e6538.PMC5413220.pdf
Medicine (2017) 96:17(e6585)Received: 24 January 2017 / Received in ﬁnal form: 16 March 2017 / Accepted: 20 March 2017 http://dx.doi.org/10.1097/MD.0000000000006585Economic Evaluation Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/84/c7/medi-96-e6585.PMC5413221.pdf
Available at: http://apps.who.int/gho/data/view.main.61640?lang=en2013.,OADS,/arxiv_data1/oa_pdf/84/c7/medi-96-e6585.PMC5413221.pdf
Medicine (2017) 96:17(e6607)Received: 28 September 2016 / Received in ﬁnal form: 12 February 2017 / Accepted: 23 March 2017 http://dx.doi.org/10.1097/MD.0000000000006607Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/30/d0/medi-96-e6607.PMC5413222.pdf
Medicine (2017) 96:17(e6615)Received: 29 September 2016 / Received in ﬁnal form: 7 February 2017 / Accepted: 24 March 2017 http://dx.doi.org/10.1097/MD.0000000000006615Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/43/44/medi-96-e6615.PMC5413224.pdf
Medicine (2017) 96:17(e6620)Received: 6 December 2016 / Received in ﬁnal form: 11 March 2017 / Accepted: 24 March 2017 http://dx.doi.org/10.1097/MD.0000000000006620Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ce/7f/medi-96-e6620.PMC5413225.pdf
"S1, http://links.lww.com/MD/B662).",Non-OADS,/arxiv_data1/oa_pdf/ce/7f/medi-96-e6620.PMC5413225.pdf
"S3, http://links.lww.com/MD/B662).",Non-OADS,/arxiv_data1/oa_pdf/ce/7f/medi-96-e6620.PMC5413225.pdf
"S4 and S5, http://links.lww.com/MD/ B662).",Non-OADS,/arxiv_data1/oa_pdf/ce/7f/medi-96-e6620.PMC5413225.pdf
Medicine (2017) 96:17(e6630)Received: 10 November 2016 / Received in ﬁnal form: 20 March 2017 / Accepted: 26 March 2017 http://dx.doi.org/10.1097/MD.0000000000006630Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c6/10/medi-96-e6630.PMC5413226.pdf
Medicine (2017) 96:17(e6637)Received: 7 October 2016 / Received in ﬁnal form: 23 March 2017 / Accepted: 27 March 2017 http://dx.doi.org/10.1097/MD.0000000000006637Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/46/31/medi-96-e6637.PMC5413227.pdf
Medicine (2017) 96:17(e6645)Received: 5 September 2016 / Received in ﬁnal form: 9 March 2017 / Accepted: 28 March 2017 http://dx.doi.org/10.1097/MD.0000000000006645Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/62/dc/medi-96-e6645.PMC5413229.pdf
"1,Supplemental Content, http://links.lww.com/MD/B664 which shows the results of propensity-score matching model and bias reduction between variables).",Non-OADS,/arxiv_data1/oa_pdf/62/dc/medi-96-e6645.PMC5413229.pdf
"As Table 2 shows, bacteremia caused by a surgical site infection showed the lowest percentage of multidrug resistance (20%) (see Table 2, SupplementalContent, http://links.lww.com/MD/B664 for additional de- scriptive results according to the causative organism and its antibiotic sensitivity).",Non-OADS,/arxiv_data1/oa_pdf/62/dc/medi-96-e6645.PMC5413229.pdf
"The largest difference in the mean observed cost according to antibiotic sensitivity was detected for bacteremia caused by a respiratory infection: multisensitive microorganisms were €12,081 more costly (see Table 3, Supplemental Content, http://links.lww.com/MD/B664 which summarizes distribution of ﬁxed, variable, and drug costs, according to the focus of bacteremia and antibioticsusceptibility).",Non-OADS,/arxiv_data1/oa_pdf/62/dc/medi-96-e6645.PMC5413229.pdf
Phoenix; 2013. http://www.infectioncontroltoday.com/digital-issues/2013/06/healthcare-associated-infections.aspx.,Non-OADS,/arxiv_data1/oa_pdf/62/dc/medi-96-e6645.PMC5413229.pdf
Medicine (2017) 96:17(e6674)Received: 5 December 2016 / Received in ﬁnal form: 5 March 2017 / Accepted: 3 April 2017 http://dx.doi.org/10.1097/MD.0000000000006674Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/bd/e9/medi-96-e6674.PMC5413231.pdf
Medicine (2017) 96:17(e6679)Received: 13 June 2016 / Received in ﬁnal form: 21 March 2017 / Accepted: 3 April 2017 http://dx.doi.org/10.1097/MD.0000000000006679Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/98/cc/medi-96-e6679.PMC5413232.pdf
Medicine (2017) 96:17(e6689)Received: 27 November 2016 / Received in ﬁnal form: 28 March 2017 / Accepted: 29 March 2017 http://dx.doi.org/10.1097/MD.0000000000006689Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/27/ac/medi-96-e6689.PMC5413235.pdf
2013;Available at: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/27/ac/medi-96-e6689.PMC5413235.pdf
Medicine (2017) 96:17(e6694)Received: 29 November 2016 / Received in ﬁnal form: 22 March 2017 / Accepted: 24 March 2017 http://dx.doi.org/10.1097/MD.0000000000006694Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d4/53/medi-96-e6694.PMC5413237.pdf
Medicine (2017) 96:17(e6699)Received: 28 October 2016 / Received in ﬁnal form: 1 April 2017 / Accepted: 3 April 2017 http://dx.doi.org/10.1097/MD.0000000000006699Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6d/4f/medi-96-e6699.PMC5413238.pdf
Medicine (2017) 96:17(e6700)Received: 19 October 2016 / Received in ﬁnal form: 17 February 2017 / Accepted: 1 April 2017 http://dx.doi.org/10.1097/MD.0000000000006700Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/85/40/medi-96-e6700.PMC5413239.pdf
Medicine (2017) 96:17(e6701)Received: 6 January 2017 / Received in ﬁnal form: 21 March 2017 / Accepted: 2 April 2017 http://dx.doi.org/10.1097/MD.0000000000006701Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c2/14/medi-96-e6701.PMC5413240.pdf
Medicine (2017) 96:17(e6703)Received: 27 September 2016 / Received in ﬁnal form: 22 February 2017 / Accepted: 4 April 2017 http://dx.doi.org/10.1097/MD.0000000000006703Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/dc/9c/medi-96-e6703.PMC5413241.pdf
Medicine (2017) 96:17(e6704)Received: 10 November 2016 / Received in ﬁnal form: 20 March 2017 / Accepted: 31 March 2017 http://dx.doi.org/10.1097/MD.0000000000006704Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/31/4d/medi-96-e6704.PMC5413242.pdf
"Data source Data were retrieved and downloaded from PubMed, a website (http://www.ncbi.nlm.nih.gov/pubmed/) that provides free accessto biomedical journal citations and abstracts mainly indexed byMedline.",OADS,/arxiv_data1/oa_pdf/31/4d/medi-96-e6704.PMC5413242.pdf
"Fourpackages for R (https://cran.r-project.org/web/packages/), in- cluding RISmed for extracting bibliographic content fromPubMed, SnowballC for collapsing words to a common root to aid comparison of vocabulary, tm for text mining, and rentrez for processing the results of PubMed searches were used.Descriptive analyses were conducted to calculate the frequencies of published articles for different journals and the origin of cancer sites among the studies.",OADS,/arxiv_data1/oa_pdf/31/4d/medi-96-e6704.PMC5413242.pdf
Available from: http://apps.who.int/gho/ data/node.main.CODWORLD?lang=en.,OADS,/arxiv_data1/oa_pdf/31/4d/medi-96-e6704.PMC5413242.pdf
Available from: http://www.nhi.gov.tw/Resource/webdata/13767_1_2015-2016%20NHI%20ANNUAL%20REPORT.pdf.,Non-OADS,/arxiv_data1/oa_pdf/31/4d/medi-96-e6704.PMC5413242.pdf
Available from: http://nhird.nhri.org.tw/en/Data_Subsets.html.,OADS,/arxiv_data1/oa_pdf/31/4d/medi-96-e6704.PMC5413242.pdf
Available from: https://www.nlm.nih.gov/pubs/factsheets/dif_med_pub.html.,Non-OADS,/arxiv_data1/oa_pdf/31/4d/medi-96-e6704.PMC5413242.pdf
"Available from: http://tcr.cph.ntu.edu.tw/main.php?Page=N2.Accessed February 14, 2017.",OADS,/arxiv_data1/oa_pdf/31/4d/medi-96-e6704.PMC5413242.pdf
Medicine (2017) 96:17(e6715)Received: 21 December 2016 / Received in ﬁnal form: 27 February 2017 / Accepted: 23 March 2017 http://dx.doi.org/10.1097/MD.0000000000006715Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8e/3f/medi-96-e6715.PMC5413247.pdf
Medicine (2017) 96:17(e6717)Received: 11 November 2016 / Received in ﬁnal form: 12 March 2017 / Accepted: 5 April 2017 http://dx.doi.org/10.1097/MD.0000000000006717Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9d/70/medi-96-e6717.PMC5413249.pdf
Medicine (2017) 96:17(e6719)Received: 30 January 2017 / Received in ﬁnal form: 3 April 2017 / Accepted: 5 April 2017 http://dx.doi.org/10.1097/MD.0000000000006719Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/db/d8/medi-96-e6719.PMC5413251.pdf
"004) was provided by the Ethical Committee of the Fourth Af ﬁliated Hospital of Harbin Medical University, Heilongjiang Province, China (Chairperson, Profes-sor Chang-jiu Zhao) on October 20, 2015, and this study isregistered at http://www.chictr.org.cn/registry.aspx (ChiCTR- IPR-15007287.",Non-OADS,/arxiv_data1/oa_pdf/db/d8/medi-96-e6719.PMC5413251.pdf
"These contradictory ﬁndings may be attributed to the use of propofol, which inhibits the organ-protective properties of RIPC, http://www.nejm.org/doi/full/10.1056/ NEJMc1514509 - ref7-SA1[18]or differences in the research objectives.",Non-OADS,/arxiv_data1/oa_pdf/db/d8/medi-96-e6719.PMC5413251.pdf
Medicine (2017) 96:17(e6721)Received: 20 May 2016 / Received in ﬁnal form: 23 March 2017 / Accepted: 5 April 2017 http://dx.doi.org/10.1097/MD.0000000000006721Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1a/f0/medi-96-e6721.PMC5413252.pdf
[20]Engauge Digitizer (version 3.0; http://digitizer.sourceforge.net) was usedto read survival rates on the Kaplan –Meier curves to reconstruct the HR estimate and its variance.,OADS,/arxiv_data1/oa_pdf/1a/f0/medi-96-e6721.PMC5413252.pdf
Medicine (2017) 96:17(e6723)Received: 5 February 2017 / Received in ﬁnal form: 22 March 2017 / Accepted: 4 April 2017 http://dx.doi.org/10.1097/MD.0000000000006723Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f0/fc/medi-96-e6723.PMC5413253.pdf
Medicine (2017) 96:17(e6725)Received: 1 September 2016 / Received in ﬁnal form: 3 April 2017 / Accepted: 5 April 2017 http://dx.doi.org/10.1097/MD.0000000000006725Meta-Analysis of Observational Studies in Epidemiology Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/63/42/medi-96-e6725.PMC5413254.pdf
Medicine (2017) 96:17(e6726)Received: 15 February 2017 / Received in ﬁnal form: 3 April 2017 / Accepted: 6 April 2017 http://dx.doi.org/10.1097/MD.0000000000006726Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fe/b1/medi-96-e6726.PMC5413255.pdf
Medicine (2017) 96:17(e6729)Received: 23 March 2017 / Received in ﬁnal form: 3 April 2017 / Accepted: 6 April 2017 http://dx.doi.org/10.1097/MD.0000000000006729Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/42/fa/medi-96-e6729.PMC5413256.pdf
Medicine (2017) 96:17(e6735)Received: 26 September 2016 / Received in ﬁnal form: 1 April 2017 / Accepted: 5 April 2017 http://dx.doi.org/10.1097/MD.0000000000006735Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/46/e9/medi-96-e6735.PMC5413257.pdf
Medicine (2017) 96:17(e6736)Received: 8 November 2016 / Received in ﬁnal form: 12 March 2017 / Accepted: 6 April 2017 http://dx.doi.org/10.1097/MD.0000000000006736Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d4/c7/medi-96-e6736.PMC5413258.pdf
"1, http://links.lww.com/ MD/B667) showed that there were signi ﬁcant correlations between the 18 genes and formed signi ﬁcant correlation module.",OADS,/arxiv_data1/oa_pdf/d4/c7/medi-96-e6736.PMC5413258.pdf
Medicine (2017) 96:17(e6739)Received: 28 December 2016 / Received in ﬁnal form: 16 March 2017 / Accepted: 22 March 2017 http://dx.doi.org/10.1097/MD.0000000000006739Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/98/16/medi-96-e6739.PMC5413260.pdf
Medicine (2017) 96:17(e6741)Received: 2 January 2017 / Received in ﬁnal form: 17 March 2017 / Accepted: 18 March 2017 http://dx.doi.org/10.1097/MD.0000000000006741Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/72/81/medi-96-e6741.PMC5413262.pdf
"For tumor stage, we used the European Network for the Study of Adrenal Tumors (ENSAT)staging system [13]to evaluate the ACC stage according to the codes of the Collaborative Stage (http://cancerstaging.org/cstage/ about/Pages/default.aspx).",Non-OADS,/arxiv_data1/oa_pdf/72/81/medi-96-e6741.PMC5413262.pdf
Medicine (2017) 96:17(e6745)Received: 26 December 2016 / Received in ﬁnal form: 7 March 2017 / Accepted: 24 March 2017 http://dx.doi.org/10.1097/MD.0000000000006745Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e1/ac/medi-96-e6745.PMC5413263.pdf
Medicine (2017) 96:17(e6750)Received: 6 January 2017 / Received in ﬁnal form: 1 April 2017 / Accepted: 6 April 2017 http://dx.doi.org/10.1097/MD.0000000000006750Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7e/3a/medi-96-e6750.PMC5413265.pdf
Medicine (2017) 96:17(e6752)Received: 16 January 2017 / Received in ﬁnal form: 15 March 2017 / Accepted: 17 March 2017 http://dx.doi.org/10.1097/MD.0000000000006752Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/02/34/medi-96-e6752.PMC5413266.pdf
Medicine (2017) 96:17(e6757)Received: 22 January 2017 / Received in ﬁnal form: 16 March 2017 / Accepted: 26 March 2017 http://dx.doi.org/10.1097/MD.0000000000006757Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e0/71/medi-96-e6757.PMC5413267.pdf
Medicine (2017) 96:17(e6759)Received: 30 January 2017 / Received in ﬁnal form: 29 March 2017 / Accepted: 31 March 2017 http://dx.doi.org/10.1097/MD.0000000000006759Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8c/82/medi-96-e6759.PMC5413268.pdf
"(See Supplementary Content Table 7, http://links.lww.com/MD/B676 for full results ofmultivariable regression models, including all covariates.)",Non-OADS,/arxiv_data1/oa_pdf/8c/82/medi-96-e6759.PMC5413268.pdf
"(See Supplementary ContentTable 8, http://links.lww.com/MD/B676 for full results of multivariable regression models, including total alcohol con- sumption [kgs] for each period of the HIV care continuum and allcovariates.",Non-OADS,/arxiv_data1/oa_pdf/8c/82/medi-96-e6759.PMC5413268.pdf
"See Supplementary Content Table 9, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/8c/82/medi-96-e6759.PMC5413268.pdf
"Femoral neck BMD, g/cm2,n=235Total hip BMD, g/cm2,n=235Lumbar Spine BMD (g/cm2)n=236Low bone density n =237 Main Independent VariableAdjusted beta (95% CI) PvalueAdjusted beta (95% CI) PvalueAdjusted Beta (95% CI) PValueaOR (95% CI) Pvalue Total lifetime alcohol use (100kg)/C00.000 ( /C00.002 –0.001) .62 /C00.000 ( /C00.002 –0.002) .83 0.001 ( /C00.002 –0.003) .65 0.98 (0.95 –1.01) .16 Past 30-day risky alcohol use.73 .86 .45 .04 Abstinent [ref] ––– – Low risk use /C00.019 ( /C00.071 –0.034) /C00.010 ( /C00.062 –0.043) /C00.015 ( /C00.078 –0.048) 4.32 (1.30 –14.33) High risk use /C00.012 ( /C00.052 –0.027) /C00.011 ( /C00.050 –0.029) /C00.030 ( /C00.077 –0.017) 1.94 (0.91 –4.12) aOR=adjusted odds ratio, BMD =bone mineral density, CI =conﬁdence interval; ref =reference group.∗Covariates included in all models, included: age, sex, race, BMI, current smoking status, menopause, ever opioid exposure, CD4 cell count, HIV Viral Load≥200 copies/mL, total 25(OH)D, ever tenofovir use, daily calcium intake, past-year loss of sex drive, years of HIV infection, weight-bearing physical activity, years of regular cocaine use, years of r egular heroin use, DXA machine/software version (see Supplemental Content Table 7, http://links.lww.com/MD/B676).",Non-OADS,/arxiv_data1/oa_pdf/8c/82/medi-96-e6759.PMC5413268.pdf
"†Lifetime alcohol consumption was not signi ﬁcantly associated with baseline FN, TH or LS T-score; statistical signi ﬁcance and direction of associations between all covariates and each T-score were similar to associations with BMD, with the exception of sex which was signi ﬁcantly associated with FN T-score (Adjusted b=0.50 SDs; P=.01) (see Supplemental Content Table 6, http://links.lww.com/ MD/B676).",Non-OADS,/arxiv_data1/oa_pdf/8c/82/medi-96-e6759.PMC5413268.pdf
"Femoral neck BMD, g/cm2,n=235Total hip BMD, g/cm2,n=235Total spine BMD (g/cm2)n=236Low bone density n=237 Independent variableAdjusted beta (95% CI) PvalueAdjusted beta (95% CI) PvalueAdjusted beta (95% CI) PvalueaOR (95% CI) Pvalue Period 1 drinking intensity, 10 kg/year 0.004 ( /C00.003 –0.011) .29 0.004 ( /C00.003 –0.011) .27 0.002 ( /C00.006 –0.009) .67 0.87 (0.76 –0.99) .04 Period 2 drinking intensity, 10kg/year /C00.006 ( /C00.012 –0.001) .02 /C00.007 ( /C00.012 –/C00.001) .02 /C00.006 ( /C00.013 –0.000) .05 1.18 (1.03 –1.36) .02 Period 3 drinking intensity, 10 kg/year 0.005 (0.0003 –0.010) .04 0.006 (0.001 –0.011) .02 0.009 (0.001 –0.013) .02 0.85 (0.75 –0.96) .01 Past 30-day risky alcohol use‡.71 .74 .39 .03 Abstinent [ref] ––– – Low risk use /C00.012 ( /C00.064 –0.040) /C00.002 ( /C00.054 –0.050) /C00.012 ( /C00.074 –0.050) 4.34 (1.26 –14.91) High risk use /C00.016 ( /C00.055 –0.023) /C00.014 ( /C00.053 –0.025) /C00.032 ( /C00.079 –0.015) 2.22 (1.01 –4.88) aOR=adjusted odds ratio, BMD =bone mineral density, CI =conﬁdence interval, ref =reference group.∗Covariates included in all models: age, sex, race, BMI, current smoking status, menopause, ever opioid exposure, CD4 cell count, HIV viral load ≥200 copies/mL, total 25(OH) D, ever tenofovir use, daily calcium intake, past-year loss of sex drive, years of HIV infection, weight-bearing physical activity, years of regular cocaine use, years of regular heroin use, DXA machine/software version (see Supplemental content Table 9, http://links.lww.com/MD/B676).",Non-OADS,/arxiv_data1/oa_pdf/8c/82/medi-96-e6759.PMC5413268.pdf
"†Total alcohol consumption (100 kg) during Period 1 (i.e., initiation of drinking to ﬁrst positive HIV test), Period 2 (i.e., ﬁrst positive HIV test to initiation of ART) and Period 3 (initiation of ART to time of assessment) were not signi ﬁcantly associated with TH, FN or LS BMD (g/cm2) or low baseline BMD in adjusted multivariable regression models that included all 3 periods (see Supplemental Content Table 8, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/8c/82/medi-96-e6759.PMC5413268.pdf
Available at: https://www.rethinkingdrinking.niaaa.nih.gov/.,Non-OADS,/arxiv_data1/oa_pdf/8c/82/medi-96-e6759.PMC5413268.pdf
Available from: http://search.proquest.com/docview/1697861433?accountid=9676.,Non-OADS,/arxiv_data1/oa_pdf/8c/82/medi-96-e6759.PMC5413268.pdf
Medicine (2017) 96:17(e6760)Received: 30 January 2017 / Received in ﬁnal form: 15 March 2017 / Accepted: 20 March 2017 http://dx.doi.org/10.1097/MD.0000000000006760Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/34/ae/medi-96-e6760.PMC5413269.pdf
Medicine (2017) 96:17(e6767)Received: 3 February 2017 / Received in ﬁnal form: 16 March 2017 / Accepted: 17 March 2017 http://dx.doi.org/10.1097/MD.0000000000006767Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/31/6b/medi-96-e6767.PMC5413273.pdf
Medicine (2017) 96:17(e6770)Received: 2 February 2017 / Received in ﬁnal form: 6 April 2017 / Accepted: 7 April 2017 http://dx.doi.org/10.1097/MD.0000000000006770Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e9/a4/medi-96-e6770.PMC5413275.pdf
Medicine (2017) 96:17(e6773)Received: 13 February 2017 / Received in ﬁnal form: 10 March 2017 / Accepted: 7 April 2017 http://dx.doi.org/10.1097/MD.0000000000006773Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/44/ae/medi-96-e6773.PMC5413276.pdf
Medicine (2017) 96:17(e6780)Received: 4 December 2016 / Received in ﬁnal form: 22 March 2017 / Accepted: 7 April 2017 http://dx.doi.org/10.1097/MD.0000000000006780Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c3/fe/medi-96-e6780.PMC5413278.pdf
Medicine (2017) 96:17(e6784)Received: 27 September 2016 / Received in ﬁnal form: 2 April 2017 / Accepted: 7 April 2017 http://dx.doi.org/10.1097/MD.0000000000006784Meta-Analysis of Observational Studies in Epidemiology Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c6/db/medi-96-e6784.PMC5413281.pdf
"Detailed characteristics of eligible studiesand nondiabetic patients with CAD are presented in Table 1 of Supplement 1, http://links.lww.com/MD/B678.",Non-OADS,/arxiv_data1/oa_pdf/c6/db/medi-96-e6784.PMC5413281.pdf
"Quality assess- ment of eligible studies according to the Newcastle –Ottawa scale criteria is available in Supplement 2, http://links.lww.com/MD/ B679 (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/c6/db/medi-96-e6784.PMC5413281.pdf
"1 of Supplement 2, http://links.lww.com/MD/B679).",Non-OADS,/arxiv_data1/oa_pdf/c6/db/medi-96-e6784.PMC5413281.pdf
"2 of Supplement 2, http://links.lww.com/MD/B679).",Non-OADS,/arxiv_data1/oa_pdf/c6/db/medi-96-e6784.PMC5413281.pdf
Medicine (2017) 96:17(e6789)Received: 9 February 2017 / Received in ﬁnal form: 25 March 2017 / Accepted: 7 April 2017 http://dx.doi.org/10.1097/MD.0000000000006789Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4b/29/medi-96-e6789.PMC5413283.pdf
Medicine (2017) 96:17(e6794)Received: 5 November 2016 / Received in ﬁnal form: 5 April 2017 / Accepted: 7 April 2017 http://dx.doi.org/10.1097/MD.0000000000006794Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3f/f4/medi-96-e6794.PMC5413284.pdf
"MeSH Keywords:  Lymphocyte Activation • Neutrophils • Stomach Neoplasms  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/900681Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of General Surgery, Erzincan University, Erzincan, Turkey 2 Department of General Surgery, Tepecik Training Research Hospital, Izmir, Turkey 3 Department of General Surgery, Izmir University, Izmir, Turkeye-ISSN 1643-3750 © Med Sci Monit, 2017; 23: 1973-1979 DOI: 10.12659/MSM.900681 1973 Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System]   [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica]   [Chemical Abstracts/CAS] [Index Copernicus]CLINICAL RESEARCH This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/31/2e/medscimonit-23-1973.PMC5413293.pdf
"MeSH Keywords:  Hypokalemia • Hypokalemic Periodic Paralysis • Trigger Points  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903139Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Internal Medicine, Southern Illinois University, Springfield, IL,  U.S.A. 2 Department of Pharmacy Practice, Southern Illinois University School of  Pharmacy, Edwardsville, IL, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 454-457 DOI: 10.12659/AJCR.903139 454 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/a5/21/amjcaserep-18-454.PMC5413294.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.03.007,Non-OADS,/arxiv_data1/oa_pdf/83/d1/main.PMC5413299.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,2 2 –23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/83/d1/main.PMC5413299.pdf
"27When prepared for histology (2011–2013) and uploaded to the Project MACULA Web site (http://projectmacula.cis.uab.edu, in the public domain), eyesunderwent additional multimodal ex vivo imaging.",OADS,/arxiv_data1/oa_pdf/ba/89/i1552-5783-58-4-2349.PMC5413303.pdf
"5 1351–1370 https://doi.org/10.1084/jem.20150237 The Journal of Experimental Medicine1351IntroductIon Neuroinflammation accompanies several diseases with or  without an immunological origin such as multiple sclerosis (MS), stroke, traumatic brain injury, Parkinson’s disease, and Alzheimer’s disease (Wyss-Coray, 2006; Rivest, 2009; Heneka et al., 2010; Kigerl et al., 2014).",Non-OADS,/arxiv_data1/oa_pdf/cb/f9/JEM_20150237.PMC5413320.pdf
"10, September 19, 2016. https://doi.org/10.1084/jem.20150282 The authors regret that in the original version of their paper, the following funding information was left out of the Acknowledgments section.“The financial support of the European Commission (FP7-HEALTH-2011-ADITEC-No.280873 and ERC-PHII-669415) to A. Mantovani  is gratefully acknowledged.” The online HTML and PDF versions of this article have been corrected.",Non-OADS,/arxiv_data1/oa_pdf/62/e5/JEM_2015028204172017c.PMC5413321.pdf
"5 1529–1546 https://doi.org/10.1084/jem.20150402 The Journal of Experimental Medicine1529IntroductIon Differentiation of naive CD4 T cells into specialized T helper  (Th) lymphocyte subsets is crucial to immune responses (O’Shea and Paul, 2010).",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/JEM_20150402.PMC5413322.pdf
"5 1411–1430 https://doi.org/10.1084/jem.20160412 The Journal of Experimental Medicine1411IntroductIon Glaucoma is the second leading cause of blindness world- wide, affecting an estimated 70 million people (Quigley, 2011; Pascolini and Mariotti, 2012).",Non-OADS,/arxiv_data1/oa_pdf/11/d4/JEM_20160412.PMC5413323.pdf
"5 1371–1386 https://doi.org/10.1084/jem.20160894 The Journal of Experimental Medicine1371IntroductIon Enteropathy-associated T cell lymphoma (EATL) is an un- common but lethal type of peripheral T cell lymphoma that appears to be rising in incidence (Swerdlow et al., 2008; Sharaiha et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/cb/b5/JEM_20160894.PMC5413324.pdf
"5 1387–1409 https://doi.org/10.1084/jem.20160935 The Journal of Experimental Medicine1387IntroductIon Primary liver cancer is the fifth and seventh most com- mon cancer in men and women, respectively, and hepato-cellular carcinoma (HCC), the most common histological subtype, accounts for 70–85% of cases (Jemal et al., 2011).",Non-OADS,/arxiv_data1/oa_pdf/ca/b9/JEM_20160935.PMC5413325.pdf
"5 1239–1248 https://doi.org/10.1084/jem.20161033 The Journal of Experimental Medicine1239IntroductIon Influenza A viruses pose a constant threat to humans because  zoonotic viral transmissions can cause severe disease and give rise to devastating pandemics (Watanabe et al., 2014; Y oon et al., 2014; Neumann and Kawaoka, 2015).",Non-OADS,/arxiv_data1/oa_pdf/64/6b/JEM_20161033.PMC5413327.pdf
"5 1313–1331 https://doi.org/10.1084/jem.20161076 The Journal of Experimental Medicine1313IntroductIon Chagas disease, characterized by chronic cardiomyopathy, is  caused by infection with the intracellular protozoan parasite  Trypanosoma cruzi  (Bonney et al., 2015).",Non-OADS,/arxiv_data1/oa_pdf/07/cb/JEM_20161076.PMC5413328.pdf
"5 1453–1469 https://doi.org/10.1084/jem.20161120 The Journal of Experimental Medicine1453IntroductIon T helper type 17 cells (Th17 cells) have been identified and  characterized as a distinct T cell lineage that maintains mu-cosal tissue homeostasis and contributes to the host defense against extracellular pathogens (Harrington et al., 2005; Park et al., 2005; Korn et al., 2009; Song et al., 2016).",Non-OADS,/arxiv_data1/oa_pdf/1e/77/JEM_20161120.PMC5413330.pdf
"5 1297–1311 https://doi.org/10.1084/jem.20161141 The Journal of Experimental Medicine1297IntroductIon Many bacterial species in the phylum Firmicutes produce  spores and depend on this dormant yet durable form of life for their survival and dispersal in adverse environments (McKenney et al., 2013; Paredes-Sabja et al., 2014).",Non-OADS,/arxiv_data1/oa_pdf/30/21/JEM_20161141.PMC5413331.pdf
"5 1471–1491 https://doi.org/10.1084/jem.20161149 The Journal of Experimental Medicine1471IntroductIon By detecting the presence of foreign nucleic acids, plasmacy- toid DCs (pDCs) play crucial roles in the induction of both innate and adaptive immune responses (Reizis et al., 2011a; Lewis and Reizis, 2012; Merad et al., 2013; Karrich et al., 2014; Mildner and Jung, 2014; Swiecki and Colonna, 2015).",Non-OADS,/arxiv_data1/oa_pdf/f4/f1/JEM_20161149.PMC5413332.pdf
"5 1249–1258 https://doi.org/10.1084/jem.20161238 The Journal of Experimental Medicine1249IntroductIon Innate immune recognition of invading pathogens by pat- tern-recognition receptors (PRRs) is important to initiate protective immune responses (Medzhitov, 2007; Kawai and Akira, 2011).",Non-OADS,/arxiv_data1/oa_pdf/46/4a/JEM_20161238.PMC5413333.pdf
"5 1281–1296 https://doi.org/10.1084/jem.20161375 The Journal of Experimental Medicine1281IntroductIon Most tissues are populated by macrophages, a cell type en- dowed with both immune and nonimmune tasks that preserve tissue integrity and proper function.",Non-OADS,/arxiv_data1/oa_pdf/bb/ad/JEM_20161375.PMC5413334.pdf
"5 1547–1555 https://doi.org/10.1084/jem.20161451 The Journal of Experimental Medicine1547IntroductIon The identification of a soluble factor that protects cells  from viral infection was first made by Isaacs and Linden‑mann in 1957 (Isaacs and Lindenmann, 1957; Isaacs et al., 1957).",Non-OADS,/arxiv_data1/oa_pdf/dc/a2/JEM_20161451.PMC5413335.pdf
5 1493–1507 https://doi.org/10.1084/jem.20161524 The Journal of Experimental Medicine1493IntroductIon The immune system is capable of launching robust responses  against invading pathogens while maintaining tolerance to self-antigens.,Non-OADS,/arxiv_data1/oa_pdf/26/fb/JEM_20161524.PMC5413337.pdf
"5 1259–1267 https://doi.org/10.1084/jem.20161533 The Journal of Experimental Medicine1259IntroductIon Germinal centers (GCs) are transient structures that form  around the follicular dendritic cell (FDC) networks located within secondary lymphoid organs 4–7 d after challenge with foreign T cell–dependent antigens (Gatto and Brink, 2010; Victora and Nussenzweig, 2012).",Non-OADS,/arxiv_data1/oa_pdf/85/d9/JEM_20161533.PMC5413338.pdf
"5 1333–1350 https://doi.org/10.1084/jem.20161621 The Journal of Experimental Medicine1333IntroductIon The spleen is important for protection against encapsulated  bacteria including Streptococcus pneumoniae , a major cause  of morbidity and mortality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0e/9d/JEM_20161621.PMC5413339.pdf
"5 1211–1226 https://doi.org/10.1084/jem.20162014 The Journal of Experimental Medicine1211Introduction ""Adaptation…could no longer be considered a static condi- tion, a product of a creative past, and became instead a con-tinuing dynamic process"" (Mayr, 1982).",Non-OADS,/arxiv_data1/oa_pdf/ae/50/JEM_20162014.PMC5413340.pdf
"5 1227–1238 https://doi.org/10.1084/jem.20162125 The Journal of Experimental Medicine1227INTRODUCTION Under normal conditions, tau is a highly soluble and na - tively unfolded microtubule-associated protein (Weingarten  et al., 1975; Witman et al., 1976).",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20162125.PMC5413341.pdf
"Washington,DC: U.S. Department of Health and Human Services, 2005.Available at: https://www.hrsa.gov/advisorycommittees/bhpradvisory/cogme/Reports/sixteenthreport.pdf.",Non-OADS,/arxiv_data1/oa_pdf/76/f3/e2016.00059.PMC5413356.pdf
Available at: http://www.nrmp.org/wp-content/uploads/2014/04/main-match-results-and-data-2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/f3/e2016.00059.PMC5413356.pdf
Available at: http://www.bhef.,Non-OADS,/arxiv_data1/oa_pdf/76/f3/e2016.00059.PMC5413356.pdf
2014; Available at: http://weill.cornell.edu/education/student/min_stu_nat.html.22.,Non-OADS,/arxiv_data1/oa_pdf/76/f3/e2016.00059.PMC5413356.pdf
"Results from microbiological testing were negative (including staining and culture for bacteria, @ERSpublications Three cases of pembrolizumab-induced pneumonitis are described, two being consistent with organising pneumonia http://ow.ly/Dvhc308QI39 Cite this article as: Leroy V, Templier C, Faivre J-B, et al.",Non-OADS,/arxiv_data1/oa_pdf/e2/1e/00081-2016.PMC5413357.pdf
ERJ Open Res 2017; 3: 00081-2016 [https://doi.org/10.1183/23120541.00081-2016].,Non-OADS,/arxiv_data1/oa_pdf/e2/1e/00081-2016.PMC5413357.pdf
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. https://doi.org/10.1183/23120541.00081-2016 ERJ Open Res 2017; 3: 00081-2016 ORIGINAL RESEARCH LETTER,Non-OADS,/arxiv_data1/oa_pdf/e2/1e/00081-2016.PMC5413357.pdf
https://doi.org/10.1183/23120541.00081-2016 2ORIGINAL RESEARCH LETTER | V. LEROY ET AL.,Non-OADS,/arxiv_data1/oa_pdf/e2/1e/00081-2016.PMC5413357.pdf
https://doi.org/10.1183/23120541.00081-2016 3ORIGINAL RESEARCH LETTER | V. LEROY ET AL.,Non-OADS,/arxiv_data1/oa_pdf/e2/1e/00081-2016.PMC5413357.pdf
https://doi.org/10.1183/23120541.00081-2016 4ORIGINAL RESEARCH LETTER | V. LEROY ET AL.,Non-OADS,/arxiv_data1/oa_pdf/e2/1e/00081-2016.PMC5413357.pdf
The significance of these studies lay not in the mere description  this is an open access article under the cc B y-nc-nd license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fe/42/acp-13-042.PMC5413468.pdf
"retrieved from https://nces.ed.gov/ pubs2015/2015011.pdf  United nations educational, scientific and cultural organization  (2009 ).",Non-OADS,/arxiv_data1/oa_pdf/fe/42/acp-13-042.PMC5413468.pdf
"retrieved from http://unesdoc.unesco.org/ images/0017/001778/177849e.pdf  Utley, c. A., hoehn, t. P ., soraci, s. A., Jr., & Baumeister, A.",Non-OADS,/arxiv_data1/oa_pdf/fe/42/acp-13-042.PMC5413468.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e4/82/copd-12-1269.PMC5413478.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1269–1277International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1269OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S12792 3 Pre- and post-bronchodilator airway obstruction  are associated with similar clinical characteristics  but different prognosis – report from a  population-based study sami sawalha1 linnea hedman2 eva rönmark2 Bo lundbäck3 anne lindberg1 1Department of Public health  and Clinical Medicine, Division of  Medicine, 2Department of Public  health and Clinical Medicine, The  OlIn Unit, Division of Occupational  and environmental Medicine,   Umeå University, Umeå, 3Krefting  research Center, Institution of  Medicine, University of gothenburg,   gothenburg, swedenIntroduction:  According to guidelines, the diagnosis of COPD should be confirmed by post- bronchodilator (post-BD) airway obstruction on spirometry; however, in clinical practice,  this is not always performed.",Non-OADS,/arxiv_data1/oa_pdf/e4/82/copd-12-1269.PMC5413478.pdf
"Keywords:  epidemiology, spirometry, chronic airflow obstructions, mortality Introduction Of the two major obstructive airway diseases, neither COPD nor asthma is considered  as single diseases, but heterogeneous and complex syndromes.1 According to the  Global Initiative for Chronic Obstructive Lung Disease (GOLD) document, respiratory  symptoms, exacerbations, and obstructive lung function impairment are evaluated when  assessing severity of COPD.2 GOLD recommends a post-bronchodilator (post-BD) Correspondence: sami sawalha Department of respiratory Medicine,  sunderby hospital, sjukhusvägen 10 se  95442, södra sunderbyn, sweden Tel +46 762 003 582 email samisawalha@yahoo.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sawalha et al Running head recto: Airway obstruction and mortality DOI: http://dx.doi.org/10.2147/COPD.S127923",Non-OADS,/arxiv_data1/oa_pdf/e4/82/copd-12-1269.PMC5413478.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e4/82/copd-12-1269.PMC5413478.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/82/copd-12-1269.PMC5413478.pdf
"Available from: http://www.socialstyrelsen.se/lists/artikelkatalog/ attachments/18394/2011-7-6.pd f. Accessed November 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/e4/82/copd-12-1269.PMC5413478.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c1/d2/ccid-10-147.PMC5413479.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c1/d2/ccid-10-147.PMC5413479.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2017:10 147–153Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 147 OrIg Inal researCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S128339 glutathione and its antiaging and  antimelanogenic effects sinee Weschawalit1 siriwan Thongthip2 Phanupong Phutrakool3 Pravit asawanonda1 1Department of Medicine, Division  of Dermatology, 2Chula Clinical  research Center, 3Chula Data  Management Center, Faculty of  Medicine, Chulalongkorn University,  Bangkok,  ThailandBackground: Previous studies showed that supplementation of reduced form of glutathione  (GSH, 500 mg/d) has a skin-lightening efficacy in humans.",Non-OADS,/arxiv_data1/oa_pdf/c1/d2/ccid-10-147.PMC5413479.pdf
"1 Furthermore, reduced glutathione  (GSH) acts as a hydrogen donor in the detoxification of hydrogen peroxide.2 As a  dietary supplement, GSH possesses various systemic effects such as improvement of liver abnormalities, 3,4 improvement of diabetic complication,5 protection from viral  infection,6 and antitumor activity.7,8 It is even used to treat autism.9Correspondence: Pravit asawanonda Department of Medicine, Division of Dermatology,King Chulalongkorn Memorial hospital, Bangkok 10330, ThailandTel +66 2 256 4253 (ext 103)Fax +66 2 287 4075Email fibrosis@gmail.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Weschawalit et alRunning head recto: Glutathione as a skin-whitening agentDOI: http://dx.doi.org/10.2147/CCID.S128339",Non-OADS,/arxiv_data1/oa_pdf/c1/d2/ccid-10-147.PMC5413479.pdf
"Clinical, Cosmetic and Investigational Dermatology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/c1/d2/ccid-10-147.PMC5413479.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 153 glutathione as a skin-whitening agent Conclusion In summary, we have shown that oral glutathione, 250 mg/d,  in both reduced and oxidized forms have various beneficial effects on skin properties and is possibly an antiaging agent, at least in middle-aged female subjects.",Non-OADS,/arxiv_data1/oa_pdf/c1/d2/ccid-10-147.PMC5413479.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8a/29/ccid-10-141.PMC5413480.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8a/29/ccid-10-141.PMC5413480.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2017:10 141–145Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 141 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S129187 Granuloma annulare: relationship to diabetes  mellitus, thyroid disorders and tuberculin skin test Pedram Alirezaei   Mahmood Farshchian Department of Dermatology, Psoriasis  Research Center, Farshchian Hospital,  Hamadan University of Medical Sciences, Hamadan, IranBackground: Granuloma annulare is a benign inflammatory disease of the skin.",Non-OADS,/arxiv_data1/oa_pdf/8a/29/ccid-10-141.PMC5413480.pdf
"2,3 Subcutaneous GA is characterized Correspondence: Pedram Alirezaei   Psoriasis Research Center, Farshchian  Hospital, Mirzadeh Eshghi Street, Hamadan, Iran   Tel/fax +98 81 3827 2154   Email prc@umsha.ac.irJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Alirezaei and FarshchianRunning head recto: GA: relationship to diabetes mellitusDOI: http://dx.doi.org/10.2147/CCID.S129187",Non-OADS,/arxiv_data1/oa_pdf/8a/29/ccid-10-141.PMC5413480.pdf
"Clinical, Cosmetic and Investigational Dermatology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/8a/29/ccid-10-141.PMC5413480.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 145 GA: relationship to diabetes mellitus,Non-OADS,/arxiv_data1/oa_pdf/8a/29/ccid-10-141.PMC5413480.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/7c/copd-12-1243.PMC5413481.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1243–1245International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1243Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S13845 2 Promoting the inclusion of vital-capacity data  in the bronchodilator response Helmi Ben Saad Laboratory of Physiology, Faculty  of Medicine of Sousse, University  of Sousse, tunisiaDear editor I read with interest the manuscript of Torén et al1 asking for a change in the interpreting  way of the reversibility test.",Non-OADS,/arxiv_data1/oa_pdf/62/7c/copd-12-1243.PMC5413481.pdf
"However, comparison with a subgroup of 76 COPD Correspondence: Helmi Ben Saad Laboratory of Physiology, Faculty  of Medicine of Sousse, University  of Sousse, Street Mohamed Karoui,  Sousse 4000, tunisia tel +216 9869 7024 Fax +216 7322 4899 email helmi.bensaad@rns.t n Journal name: International Journal of COPD Article Designation: Letter Y ear: 2017 Volume: 12 Running head verso: Ben Saad Running head recto: SVC and FVC and reversibility DOI: http://dx.doi.org/10.2147/COPD.S138452",Non-OADS,/arxiv_data1/oa_pdf/62/7c/copd-12-1243.PMC5413481.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/62/7c/copd-12-1243.PMC5413481.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/7c/copd-12-1243.PMC5413481.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/22/7b/bctt-9-287.PMC5413482.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/22/7b/bctt-9-287.PMC5413482.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 287–291Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 287 COMMENTARY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S131394 Breast cancer and amyloid bodies: is there a role  for amyloidosis in cancer-cell dormancy?",Non-OADS,/arxiv_data1/oa_pdf/22/7b/bctt-9-287.PMC5413482.pdf
"9 Also, patients with AD had a  lower likelihood of cancer-related surgery than patients without AD.Correspondence: Gerald J Mizejewski Wadsworth Center, New York State Department of Health, Empire State Plaza, PO Box 509, Albany, NY   12201-0509, USATel +1 518 486 5900Fax +1 518 402 5002Email gerald.mizejewski@health.ny.govJournal name: Breast Cancer - Targets and Therapy Article Designation: COMMENTAR YY ear: 2017V olume: 9Running head verso: MizejewskiRunning head recto: Breast cancer, Alzheimer’ s disease, and amyloidosisDOI: http://dx.doi.org/10.2147/BCTT.S131394",Non-OADS,/arxiv_data1/oa_pdf/22/7b/bctt-9-287.PMC5413482.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/22/7b/bctt-9-287.PMC5413482.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 291 Breast cancer, Alzheimer’s disease, and amyloidosis 12.",Non-OADS,/arxiv_data1/oa_pdf/22/7b/bctt-9-287.PMC5413482.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/21/b5/copd-12-1255.PMC5413483.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1255–1267International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1255OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12673 6 Pulmonary infection control window as a  switching point for sequential ventilation in the  treatment of COPD patients: a meta-analysis Yingying lv* Qiurong lv* Quanchao lv Tianwen lai Department of respiratory and  Critical Care Medicine, The affiliated  hospital, Institute of respiratory  Diseases, guangdong Medical  University, Zhanjiang, China *These authors contributed equally  to this workPurpose:  Choosing the appropriate time to switch to noninvasive positive-pressure ventilation  (NPPV) plays a crucial role in promoting successful weaning.",Non-OADS,/arxiv_data1/oa_pdf/21/b5/copd-12-1255.PMC5413483.pdf
"It is the fourth leading cause of chronic  morbidity and mortality in the US and is projected to rank fifth in 2020 in disease  caused throughout the world.1 In China, respiratory diseases (of which COPD is a  significant component) are the third leading cause of death in rural areas and the  fourth leading cause of death in urban areas, accounting for 1 million deaths and  over 5 million disabilities each year.2 Approximately 80% of COPD exacerbates due  to pulmonary infection, as well as some severe respiratory failure often requiring  endotracheal intubation (ETI) and mechanical ventilation (MV).3 ETI and MV can  help to drain sputum and reduce the respiratory workload, partially or even completely, Correspondence: Tianwen lai Department of respiratory and Critical  Care Medicine, The Affiliated Hospital,  Institute of respiratory Diseases,  guangdong Medical University,  57 Wenming road, Zhanjiang,  524001, China email laitianwen2011@163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Lv et al Running head recto: The PIC window for sequential invasive–noninvasive ventilator weaning DOI: http://dx.doi.org/10.2147/COPD.S126736",Non-OADS,/arxiv_data1/oa_pdf/21/b5/copd-12-1255.PMC5413483.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/21/b5/copd-12-1255.PMC5413483.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/21/b5/copd-12-1255.PMC5413483.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/b5/copd-12-1255.PMC5413483.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a4/fc/cia-12-721.PMC5413484.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 721–740Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  721RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S13249 6 Nonpharmacological interventions to treat  physical frailty and sarcopenia in older patients:  a systematic overview – the SeNATOR Project  ONTOP Series Isabel Lozano-Montoya1,* Andrea Correa-Pérez1,* Iosief Abraha2 Roy L Soiza3 Antonio Cherubini2 Denis O’Mahony4 Alfonso J Cruz-Jentoft1 1Servicio de Geriatría, Hospital  Universitario Ramón y Cajal  (IRYCIS), Madrid, Spain; 2Geriatrics  and Geriatric emergency Care,   Italian National Research Center  on Aging (IRCCS-INRCA), Ancona,   Italy; 3Department of Medicine  for the elderly, National Health  Service Grampian, Aberdeen, UK;   4Department of Medicine, University  College Cork, Cork, Ireland *These authors contributed equally  to this workBackground:  Physical frailty (PF) and sarcopenia are predictors of negative health outcomes  such as falls, disability, hospitalization, and death.",Non-OADS,/arxiv_data1/oa_pdf/a4/fc/cia-12-721.PMC5413484.pdf
"Colmenar viejo Km 9.1, 28034,  Madrid, Spain email andrea.correa@salud.madrid.or g Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Lozano-Montoya et al Running head recto: Nonpharmacological interventions to treat physical frailty and sarcopenia DOI: http://dx.doi.org/10.2147/CIA.S132496",Non-OADS,/arxiv_data1/oa_pdf/a4/fc/cia-12-721.PMC5413484.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a4/fc/cia-12-721.PMC5413484.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a4/fc/cia-12-721.PMC5413484.pdf
Available from: https://www.guideline.gov/ summaries/summary/47484.,Non-OADS,/arxiv_data1/oa_pdf/a4/fc/cia-12-721.PMC5413484.pdf
Available from: http://www.bgs.org.,Non-OADS,/arxiv_data1/oa_pdf/a4/fc/cia-12-721.PMC5413484.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8c/90/copd-12-1247.PMC5413485.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1247–1254International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1247OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13187 7 serum Il-1 β and Il-17 levels in patients with  COPD: associations with clinical parameters Y ong Zou1 Xi Chen1 Jie liu2 Dong bo Zhou1 Xiao Kuang1 Jian Xiao1 Qiao Yu1 Xiaoxiao lu1 Wei li1 Bin Xie1 Qiong Chen1 1Department of geriatrics,   respiratory Medicine, Xiangya  hospital of Central south University,   2Department of emergency, The  First People’s hospital of Changsha,   Changsha, People’s republic of ChinaAbstract:  COPD is a chronic airway inflammatory disease characterized mainly by neutrophil  airway infiltrations.",Non-OADS,/arxiv_data1/oa_pdf/8c/90/copd-12-1247.PMC5413485.pdf
"Interleukin (IL)-1 β, a typical innate immune cytokine  that has been correlated to COPD, plays an important role in initiating and maintaining Correspondence: Qiong Chen Department of geriatrics, respiratory  Medicine, Xiangya hospital of Central  south University, 136 Xiangya  road, Changsha, hunan 410008,  People’s republic of China email qiongch@163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zou et al Running head recto: Serum IL-1 β and IL-17 levels in patients with COPD DOI: http://dx.doi.org/10.2147/COPD.S131877",Non-OADS,/arxiv_data1/oa_pdf/8c/90/copd-12-1247.PMC5413485.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/8c/90/copd-12-1247.PMC5413485.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/90/copd-12-1247.PMC5413485.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/79/31/clep-9-231.PMC5413486.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/79/31/clep-9-231.PMC5413486.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 231–243Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 231 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S127775 Cardiovascular risks in smokers treated with  nicotine replacement therapy: a historical cohort  study Jens Dollerup1 Jørgen Vestbo2 Tarita Murray-Thomas3 Alan Kaplan4 Richard J Martin5 Emilio Pizzichini6 Marcia M M Pizzichini6 Anne Burden7 Jessica Martin7 David B Price7,8 1Dollerup Medical Consultancy,   Kongens Lyngby, Denmark;   2Division of Infection, Immunity and  Respiratory Medicine, School of  Biological Sciences, University of Manchester, Manchester, UK;  3Clinical  Practice Research Datalink, Medicines and Healthcare products Regulatory Agency, London, UK;  4Family Physician  Airways Group of Canada, Richmond Hill, ON, Canada;  5National Jewish  Health, Denver, CO, USA; 6Federal  University of Santa Catarina, Santa Catarina, Brazil;  7Observational and  Pragmatic Research Institute Pte Ltd, Singapore;  8Centre for Academic  Primary Care, University of Aberdeen,  Aberdeen, UKBackground: Previous research suggests exposure to nicotine replacement therapy (NRT) may  be associated with an increased risk of cardiovascular disease (CVD).",Non-OADS,/arxiv_data1/oa_pdf/79/31/clep-9-231.PMC5413486.pdf
"ENCePP registration  ENCePP/SDPP/4238 Keywords: smokers, cardiovascular, risk, nicotine replacement therapy, smoking cessation advice Background Tobacco smoking is the second leading risk factor for disease globally,1 killing approxi- mately six million people each year.2 The World Health Organization European Region  has one of the highest proportions of deaths caused by tobacco in the world.3 In the  United Kingdom (UK), statistics from 2013 estimated that smoking caused around  80,000 deaths in adults aged >35 years, accounting for 17% of all deaths.4 Given the substantial harm caused by smoking, public health policies have focused  on tobacco control measures.2 There have been large reductions in the prevalence of Correspondence: David B Price Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UKTel +44 1223 967 858Fax +44 8082 800 792Email dprice@opri.sgJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Dollerup et alRunning head recto: Cardiovascular events following exposure to nicotine replacement therapyDOI: http://dx.doi.org/10.2147/CLEP .S127775",Non-OADS,/arxiv_data1/oa_pdf/79/31/clep-9-231.PMC5413486.pdf
Available from: http://www.euro.who.int/en/health-topics/disease-prevention/tobacco/data-and-statistics.,Non-OADS,/arxiv_data1/oa_pdf/79/31/clep-9-231.PMC5413486.pdf
Available from: http://www.who.int/gho/tobacco/use/en/.,Non-OADS,/arxiv_data1/oa_pdf/79/31/clep-9-231.PMC5413486.pdf
Available from http://ash.org.uk/information-and-resources/fact-sheets/smoking-statistics-who-smokes-and-how-much/.,Non-OADS,/arxiv_data1/oa_pdf/79/31/clep-9-231.PMC5413486.pdf
Available from: http://www.cprd.,Non-OADS,/arxiv_data1/oa_pdf/79/31/clep-9-231.PMC5413486.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/79/31/clep-9-231.PMC5413486.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ceor-9-233.PMC5413487.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6e/a0/ceor-9-233.PMC5413487.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 233–239ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  233 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S130995Healthcare resource consumption and cost  of care among patients with polycystic kidney  disease in Italy Luca Degli Esposti1 Chiara Veronesi1 Valentina Perrone1 Stefano Buda1 Antonio Santoro2 1Clicon S.r.l.",Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ceor-9-233.PMC5413487.pdf
"Health, Economics & Outcomes Research, Via salara 36, 48100 Ravenna, ItalyTel +39 544 38393Fax +39 544 212 699Email luca.degliesposti@clicon.itJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Degli Esposti et alRunning head recto: Healthcare resource consumption among PKD patientsDOI: http://dx.doi.org/10.2147/CEOR.S130995",Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ceor-9-233.PMC5413487.pdf
"ClinicoEconomics and Outcomes Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ceor-9-233.PMC5413487.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 239 Healthcare resource consumption among PKD patients  9.,Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ceor-9-233.PMC5413487.pdf
Available from: https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_wysiwyg/files/CIRCULARS/Circular   %2031st%20May%202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ceor-9-233.PMC5413487.pdf
"Available from: http://www.pkdinterna-tional.org/eaf_adpkd_forum_policy_report_2015/ Accessed May 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ceor-9-233.PMC5413487.pdf
Available from: http://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua= italiano&id= 2244.,Non-OADS,/arxiv_data1/oa_pdf/6e/a0/ceor-9-233.PMC5413487.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/50/1b/clep-9-245.PMC5413488.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/50/1b/clep-9-245.PMC5413488.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 245–250Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 245 PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S129779 Clinical epidemiology in the era of big data: new  opportunities, familiar challenges Vera Ehrenstein Henrik Nielsen Alma B Pedersen Søren P JohnsenLars Pedersen Department of Clinical Epidemiology,   Aarhus University Hospital,  Aarhus  N, DenmarkAbstract:  Routinely recorded health data have evolved from mere by-products of health care  delivery or billing into a powerful research tool for studying and improving patient care through  clinical epidemiologic research.",Non-OADS,/arxiv_data1/oa_pdf/50/1b/clep-9-245.PMC5413488.pdf
"4 A recent article  summarizes 46 most influential studies conducted with big data in health care,1 while a  review from 2015 provides multiple examples of the “variety” V in big data for health.2 The notion of applying lessons from the clinical past to the clinical future is “as  old as medicine.”19 In a simplified form, evidence-based medical care means that a Correspondence: Vera Ehrenstein Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200 Aarhus N, DenmarkTel +45 8716 8063Fax +45 8716 7215Email ve@clin.au.dkJournal name: Clinical Epidemiology Article Designation: PERSPECTIVESY ear: 2017V olume: 9Running head verso: Ehrenstein et alRunning head recto: Big data in clinical epidemiologyDOI: http://dx.doi.org/10.2147/CLEP .S129779",Non-OADS,/arxiv_data1/oa_pdf/50/1b/clep-9-245.PMC5413488.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/50/1b/clep-9-245.PMC5413488.pdf
Available from: http://nowbase.org/Publikationer/~ /media/Projekt%20sites/Nowbase/Publikationer/NCSP/ NCSP%201_14.ashx.,OADS,/arxiv_data1/oa_pdf/50/1b/clep-9-245.PMC5413488.pdf
Available from: http://www.nordclass.se/ncsp_e.htm.,Non-OADS,/arxiv_data1/oa_pdf/50/1b/clep-9-245.PMC5413488.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/copd-12-1287.PMC5413534.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1287–1293International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1287OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13499 8 Correlation between fractional exhaled nitric  oxide and sputum eosinophilia in exacerbations  of COPD Jie gao1 Min Zhang2 liqin Zhou1 Xing Yang1 haigui Wu1 Jianfang Zhang1 Feng Wu1 1Department of respiratory Medicine,   2Internal Medicine-Cardiovascular  Department, The Third People’s  hospital, guangzhou Medical College,   huizhou, People’s republic of ChinaIntroduction:  Measurements of eosinophils in induced sputum and fractional exhaled nitric  oxide (FeNO) are noninvasive biomarkers for assessing airway inflammation phenotypes in  chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/copd-12-1287.PMC5413534.pdf
"Both of them are considered as chronic  airway inflammatory diseases, typically associated with Th2-mediated immune Correspondence: Feng Wu Department of respiratory Medicine,   The Third People’s hospital, guangzhou   Medical College 1# Xuebei ave,  huizhou 516002, guangdong,  People’s republic of China Tel +86 135 0243 6132 Fax +86 752 235 9045 email huizhouwufeng@126.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Gao et al Running head recto: Correlation between fractional exhaled nitric oxide and sputum eosinophilia DOI: http://dx.doi.org/10.2147/COPD.S134998",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/copd-12-1287.PMC5413534.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/8d/7f/copd-12-1287.PMC5413534.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/7f/copd-12-1287.PMC5413534.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/40/89/ijn-12-3357.PMC5413537.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3357–3364International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3357OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13470 8 Mechanism of transdermal permeation promotion  of lipophilic drugs by ethosomes li Yang1,* lifang Wu1,* Dongze Wu2 Deshun shi3 Tai Wang4 Xiaoliang Zhu4 1Department of Dermatology,   Nanfang hospital, southern Medical  University, guangzhou, 2Department  of Medicine and Therapeutics, The  Prince of Wales hospital, The chinese  University of hong Kong, hong Kong,   3Department of Dermatology, The  First People’s hospital of Foshan,   Foshan, 4Department of Dermatology,   Nanfang hospital, southern Medical  University, guangzhou, People’s  republic of china *These authors contributed equally  to this workAbstract:  Ethosomes can promote the penetration of lipophilic drugs into the skin, but the  underlying mechanism is still unknown.",Non-OADS,/arxiv_data1/oa_pdf/40/89/ijn-12-3357.PMC5413537.pdf
"Such approaches include the use of iontophoresis,6 electroporation,7 microneedles,8  sonophoresis,9 surfactants,10 and liposomal-based nanoparticles;11 however, the defi - ciencies associated with these methods, such as complicated processing, skin injury,  patient compliance, poor stability, and high cost, have significantly limited their  widespread applications in clinical practice.correspondence: Xiaoliang Zhu Department of Dermatology, Nanfang  hospital, southern Medical University,  1838 North guangzhou avenue,  guangzhou, guangdong 510515, People’s  republic of china Tel +86 20 6278 6258 Fax +86 20 6164 1049 email nfnpfk@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Y ang et al Running head recto: Mechanism of drug permeation by ethosomes DOI: http://dx.doi.org/10.2147/IJN.S134708",Non-OADS,/arxiv_data1/oa_pdf/40/89/ijn-12-3357.PMC5413537.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/40/89/ijn-12-3357.PMC5413537.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/89/ijn-12-3357.PMC5413537.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b8/42/ijn-12-3315.PMC5413538.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3315–3330International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3315OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13085 9 Tailoring stimuli-responsive delivery system driven  by metal–ligand coordination bonding hongshan liang1–3 Bin Zhou4 Yun he1–3 Yaqiong Pei1–3 Bin li1–3 Jing li1–3 1college of Food science and  T echnology, huazhong agricultural  University, 2Key laboratory of  environment correlative Dietology,   huazhong agricultural University,   Ministry of education, 3Functional  Food engineering & Technology  research center of hubei Province,   Wuhan, hubei, 4college of Food  science and Technology, shanghai  Ocean University, lingang New city,   shanghai, People’s republic of chinaAbstract:  In this study, a novel coordination bonding system based on metal–tannic acid (TA)  architecture on zein/carboxymethyl chitosan (CMCS) nanoparticles (NPs) was investigated  for the pH-responsive drug delivery.",Non-OADS,/arxiv_data1/oa_pdf/b8/42/ijn-12-3315.PMC5413538.pdf
"The formation and breakage of coordination bonds  are achieved by pH changes, which gives the possibility to use metal–organic coordination  materials for constructing an advanced pH-responsive drug delivery system.23correspondence: Jing li college of Food science and Technology,  huazhong agricultural University,  Wuhan, hubei 430070, People’s  republic of china Tel +86 27 6373 0040 Fax +86 27 8728 8636 email lijingfood@mail.hzau.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Liang et al Running head recto: Tailoring stimuli-responsive delivery system DOI: http://dx.doi.org/10.2147/IJN.S130859",Non-OADS,/arxiv_data1/oa_pdf/b8/42/ijn-12-3315.PMC5413538.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b8/42/ijn-12-3315.PMC5413538.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/42/ijn-12-3315.PMC5413538.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/30/ijn-12-3347.PMC5413539.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3347–3356International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3347OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S13324 7 Quantitative and multiplexed detection for blood  typing based on quantum dot–magnetic bead assay Ting Xu Qiang Zhang Ya-han Fan ru-qing li hua lu shu-ming Zhao Tian-lun Jiang Department of Transfusion Medicine,   southwest hospital, Third Military  Medical University, chongqing,   People’s republic of chinaBackground:  Accurate and reliable blood grouping is essential for safe blood transfusion.",Non-OADS,/arxiv_data1/oa_pdf/74/30/ijn-12-3347.PMC5413539.pdf
"Column/gel  filtration and microplate analysis are relatively modern methods based on the same correspondence: Tian-lun Jiang Department of Transfusion Medicine,  southwest hospital, Third Military  Medical University, 30 gaotanyan street,  shapingba District, chongqing 400038,  People’s republic of china Tel +86 23 6876 5475 Fax +86 23 6875 4166 email jtl@tmmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Xu et al Running head recto: Blood typing based on quantum dot–magnetic bead assay DOI: http://dx.doi.org/10.2147/IJN.S133247",Non-OADS,/arxiv_data1/oa_pdf/74/30/ijn-12-3347.PMC5413539.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/74/30/ijn-12-3347.PMC5413539.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/30/ijn-12-3347.PMC5413539.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8b/04/copd-12-1279.PMC5413540.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1279–1286International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1279OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12754 0 home noninvasive positive pressure ventilation  with built-in software in stable hypercapnic  COPD: a short-term prospective, multicenter,  randomized, controlled trial luqian Zhou,1,* Xiaoying  li,1,* lili guan,1,* Jianhua  Chen,1 Bingpeng guo,1  Weiliang Wu,1 Yating huo,1  Ziqing Zhou,1 Zhenyu  liang,1 Yuqi Zhou,2 Jie Tan,3  Xin Chen,4 Yuanlin song,5  rongchang Chen1 1Department of respiratory Medicine,   state Key laboratory of respiratory  Disease, guangzhou Institute of  respiratory Disease, The First  affiliated hospital of guangzhou  Medical University, 2Department  of respiratory Medicine, The  Third affiliated hospital of sun- Yat sen University, 3Department  of respiratory Medicine, The  First affiliated hospital, school of  Clinical Medicine of guangzhou  Pharmaceutical University,   4Department of respiratory Medicine,   Zhujiang hospital of southern Medical  University, guangzhou, 5Department  of Pulmonary Medicine, Zhongshan  hospital, Fudan University, shanghai,   People’s republic of China *These authors contributed equally  to this workBackground:  The benefits of noninvasive positive pressure ventilation (NPPV) in patients with  hypercapnic COPD are controversial.",Non-OADS,/arxiv_data1/oa_pdf/8b/04/copd-12-1279.PMC5413540.pdf
"The mechanisms related Correspondence: rongchang Chen state Key laboratory of respiratory  Disease, guangzhou Institute of  respiratory Disease, The First  Affiliated Hospital of Guangzhou  Medical University, 151 Yanjiang  road, guangzhou 510120, People’s  republic of China Tel/fax +86 20 8306 2882 email chenrc@vip.163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhou et al Running head recto: NPPV in stable hypercapnic COPD DOI: http://dx.doi.org/10.2147/COPD.S127540",Non-OADS,/arxiv_data1/oa_pdf/8b/04/copd-12-1279.PMC5413540.pdf
Available from: http://goldcopd.org.,Non-OADS,/arxiv_data1/oa_pdf/8b/04/copd-12-1279.PMC5413540.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/8b/04/copd-12-1279.PMC5413540.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/04/copd-12-1279.PMC5413540.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/70/e0/ijn-12-3375.PMC5413542.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3375–3393International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3375OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12631 0 low-density lipoprotein-coupled micelles  with reduction and ph dual sensitivity for  intelligent co-delivery of paclitaxel and sirNa  to breast tumor Wen-jing Zhu1,* shu-di Yang1,* chen-xi Qu1 Qiao-ling Zhu1,2 Wei-liang chen1 Fang li1 Zhi-qiang Yuan1 Yang liu1 Ben-gang Y ou1 Xue-nong Zhang1 1Department of Pharmaceutics,   college of Pharmaceutical sciences,   soochow University, suzhou,   2Department of clinical Medicine,   Nanjing gulou hospital, Nanjing,   People’s republic of china *These authors contributed equally  to this workAbstract:  Multidrug resistance (MDR) is a major obstacle for the clinical therapy of malignant  human cancers.",Non-OADS,/arxiv_data1/oa_pdf/70/e0/ijn-12-3375.PMC5413542.pdf
"Polyspecific ABC transporters, including P-glycoprotein (ABCB1),  MRP1 (ABCC1), and breast cancer resistance protein (BCRP; ABCG2), are associ - ated with MDR.4,5 ABCG2 was discovered in the multidrug-resistant breast cancer cell  line MCF-7/AdrVp.6,7 This protein is expressed in various organs with barrier func - tions and numerous types of cancer.8 ABCG2 induces MDR via the transportation of  diverse molecules with amphipathic characteristics, and the diversity of its substrates  ranges from anticancer drugs to fluorescence dyes.9,10 Thus, the exploration of potent, correspondence: Xue-nong Zhang Department of Pharmaceutics, college  of Pharmaceuticals science, soochow  University, Dushuhu high education  Zone, suzhou, Jiang su 215123, People’s  republic of china Tel/fax +86 512 6588 2087 email zhangxuenong@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhu et al Running head recto: LDL-coupled micelles co-delivering siRNA and paclitaxel DOI: http://dx.doi.org/10.2147/IJN.S126310",Non-OADS,/arxiv_data1/oa_pdf/70/e0/ijn-12-3375.PMC5413542.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/70/e0/ijn-12-3375.PMC5413542.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/e0/ijn-12-3375.PMC5413542.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/24/9b/dddt-11-1315.PMC5413543.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1315–1334Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1315Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12727 0 Development and evaluation of a new modular  nanotransporter for drug delivery into nuclei of  pathological cells expressing folate receptors Tatiana a slastnikova1 andrey a rosenkranz1,2 Yuri V Khramtsov1 Tatiana s Karyagina1 sergey a Ovechko2 alexander s sobolev1,2 1laboratory of Molecular genetics  of intracellular Transport, institute  of gene Biology, russian academy of  sciences, 2Department of Biophysics,   Faculty of Biology, lomonosov  Moscow state University,   Moscow, russiaPurpose:  Modular nanotransporters (MNTs) are artificial multifunctional systems designed to  facilitate receptor-specific transport from the cell surface into the cell nucleus through inclusion of  polypeptide domains for accomplishing receptor binding and internalization, as well as sequential  endosomal escape and nuclear translocation.",Non-OADS,/arxiv_data1/oa_pdf/24/9b/dddt-11-1315.PMC5413543.pdf
"One promising approach to provide this is  the use of lesion-specific surface cell receptors or antigens as a target for therapeutics.1  Folate receptors (FRs), which are frequently overexpressed and accessible to blood- circulating agents either upon malignant transformation of the cell or upon activation  of macrophages in contrast to their negligible exposure to the blood pool in normal  tissues and non-activated macrophages, are among the best known and recognized  types of these target antigens;1–4 FRs are prospective surface receptors for targeting correspondence: alexander s sobolev laboratory of Molecular genetics of  intracellular Transport, institute of  gene Biology, 34/5 Vavilov st, 119334,  Moscow, russia Tel +7499 135 3100 Fax +7499 135 4105 email alsobolev@yandex.r u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Slastnikova et al Running head recto: New folate receptor-targeted modular nanotransporter DOI: http://dx.doi.org/10.2147/DDDT.S127270",Non-OADS,/arxiv_data1/oa_pdf/24/9b/dddt-11-1315.PMC5413543.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/24/9b/dddt-11-1315.PMC5413543.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/9b/dddt-11-1315.PMC5413543.pdf
"© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0144; February 2017 DOI: 10.1530/EDM-16-0144Cushing’s syndrome and risk of  thromboembolismS Takayasu and others Acute mesenteric ischemia and hepatic  infarction after treatment of ectopic Cushing’s  syndrome Shinobu Takayasu1, Shingo Murasawa1, Satoshi Yamagata1, Kazunori Kageyama1,  Takeshi Nigawara1, Yutaka Watanuki1, Daisuke Kimura2, Takao Tsushima2,   Yoshiyuki Sakamoto3, Kenichi Hakamada3, Ken Terui1 and Makoto Daimon1 Departments of 1Endocrinology and Metabolism, 2Thoracic and Cardiovascular Surgery, and 3Gastroenterological  Surgery, Hirosaki University Graduate School of Medicine and Hospital, Hirosaki, Aomori, Japan Summary Patients with Cushing’s syndrome and excess exogenous glucocorticoids have an increased risk for venous  thromboembolism, as well as arterial thrombi.",Non-OADS,/arxiv_data1/oa_pdf/fd/11/edmcr-2017-160144.PMC5413775.pdf
S Takayasu and others Cushing’s syndrome and risk of  thromboembolismID: 16-0144; February 2017 DOI: 10.1530/EDM-16-0144 http://www.edmcasereports.com  2of thrombosis in such patients have not been described.,Non-OADS,/arxiv_data1/oa_pdf/fd/11/edmcr-2017-160144.PMC5413775.pdf
"S Takayasu and othersID: 16-0144; February 2017 DOI: 10.1530/EDM-16-0144 Cushing’s syndrome and risk of  thromboembolism http://www.edmcasereports.com  3thromboplastin time of 45.6 s (range, 26–36).",OADS,/arxiv_data1/oa_pdf/fd/11/edmcr-2017-160144.PMC5413775.pdf
"S Takayasu and others Cushing’s syndrome and risk of  thromboembolismID: 16-0144; February 2017 DOI: 10.1530/EDM-16-0144 http://www.edmcasereports.com  4Discussion The etiology of mesenteric ischemia represents a complex  of diseases, including acute arterial mesenteric ischemia,  acute venous mesenteric ischemia, non-occlusive  mesenteric ischemia and ischemia/reperfusion injury.",Non-OADS,/arxiv_data1/oa_pdf/fd/11/edmcr-2017-160144.PMC5413775.pdf
"S Takayasu and othersID: 16-0144; February 2017 DOI: 10.1530/EDM-16-0144 Cushing’s syndrome and risk of  thromboembolism http://www.edmcasereports.com  5 8 van der Pas R, Leebeek FW, Hofland LJ, de Herder WW & Feelders RA   2013 Hypercoagulability in Cushing’s syndrome: prevalence,  pathogenesis and treatment.",Non-OADS,/arxiv_data1/oa_pdf/fd/11/edmcr-2017-160144.PMC5413775.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dinesh Vyas, MD, FACS, Associate  Dean of Surgery Research,  Department of Surgery, Texas Tech  University, 701 West 5th Street, Suite 2263 Odessa, TX 79763,  United States.",Non-OADS,/arxiv_data1/oa_pdf/e9/17/WJG-23-2819.PMC5413777.pdf
"World J Gastroenterol  2017; 23(16): 2819-2825  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i16/2819.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i16.2819 INTRODUCTION   RNA Sequencing Basics: RNA sequencing is the  use of high throughput next generation sequencing EDITORIALSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2819 2819 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2819-2825  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/e9/17/WJG-23-2819.PMC5413777.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/e9/17/WJG-23-2819.PMC5413777.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Atsushi Masamune, MD, PhD, Associate  Professor,  Division of Gastroenterology, Tohoku University  Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai  980-8574, Japan.",Non-OADS,/arxiv_data1/oa_pdf/21/59/WJG-23-2826.PMC5413778.pdf
"amasamune@med.tohoku.ac.j p Telephone:  +81-22-7177172 Fax:  +81-22-7177177 Received:  January 23, 2017 Peer-review started:  January 27, 2017 First decision:  February 23, 2017 Revised:  February 28, 2017 Accepted:  March 21, 2017    Article in press:  March 21, 2017 Published online: April 28, 2017EDITORIALSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2826 2826 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2826-2831  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/21/59/WJG-23-2826.PMC5413778.pdf
World J Gastroenterol  2017;  23(16): 2826-2831  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/21/59/WJG-23-2826.PMC5413778.pdf
com/1007-9327/full/v23/i16/2826.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/59/WJG-23-2826.PMC5413778.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/21/59/WJG-23-2826.PMC5413778.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Mirella Fraquelli, MD, PhD, Gastro - enterology and Endoscopy Unit, Fondazione IRCCS Ca’ Granda  Ospedale Maggiore Policlinico,  Via F. Sforza 35, 20122 Milan,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/f5/57/WJG-23-2832.PMC5413779.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.DIAGNOSTIC ADVANCESSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2832 2832 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2832-2840  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/f5/57/WJG-23-2832.PMC5413779.pdf
World J Gastroenterol  2017;  23(16): 2832-2840  available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/f5/57/WJG-23-2832.PMC5413779.pdf
com/1007-9327/full/v23/i16/2832.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/57/WJG-23-2832.PMC5413779.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/f5/57/WJG-23-2832.PMC5413779.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Nori Tolosa de Talamoni, Professor,  Laboratorio “Dr.",Non-OADS,/arxiv_data1/oa_pdf/b3/ef/WJG-23-2841.PMC5413780.pdf
"ntolosatalamoni@yahoo.com.a r Telephone:  +54-351-4333024 Received:  January 7, 2017 Peer-review started:  January 9, 2017 First decision:  February 9, 2017 Revised:  March 1, 2017 Accepted:  March 30, 2017   Article in press:  March 30, 2017 Published online: April 28, 2017REVIEWSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2841 2841 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2841-2853  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/b3/ef/WJG-23-2841.PMC5413780.pdf
World J Gastroenterol  2017; 23(16): 2841-2853  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i16/2841.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i16.2841 INTRODUCTION The imbalance between the production of reactive  oxygen (ROS) and nitrogen (RNS) species and  their elimination by protective mechanisms leads  to oxidative stress[1].,Non-OADS,/arxiv_data1/oa_pdf/b3/ef/WJG-23-2841.PMC5413780.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/b3/ef/WJG-23-2841.PMC5413780.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Özlem Yılmaz, PhD, Professor,  Department of Medical Microbiology, Faculty of Medicine,  Dokuz Eylül University, Inciraltı, Izmir 35340,  Turkey.",Non-OADS,/arxiv_data1/oa_pdf/7b/16/WJG-23-2854.PMC5413781.pdf
"REVIEWSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2854 2854 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2854-2869  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/7b/16/WJG-23-2854.PMC5413781.pdf
"World J  Gastroenterol  2017; 23(16): 2854-2869  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i16/2854.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i16.2854 INTRODUCTION Helicobacter pylori  (H. pylori ) is an important gas­ troduodenal pathogen of humans[1,2].",Non-OADS,/arxiv_data1/oa_pdf/7b/16/WJG-23-2854.PMC5413781.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/7b/16/WJG-23-2854.PMC5413781.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Amin Talebi Bezmin Abadi, PhD,  Assistant Professor,  Department of Bacteriology, Faculty of  Medical Sciences, Tarbiat Modares University, Tehran 14115-111,  Iran.",Non-OADS,/arxiv_data1/oa_pdf/38/51/WJG-23-2870.PMC5413782.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.REVIEWSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2870 2870 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2870-2882  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/38/51/WJG-23-2870.PMC5413782.pdf
World J Gastroenterol  2017;  23(16): 2870-2882  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/38/51/WJG-23-2870.PMC5413782.pdf
com/1007-9327/full/v23/i16/2870.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/51/WJG-23-2870.PMC5413782.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/38/51/WJG-23-2870.PMC5413782.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Amit Bhatt, MD,  Department of Gastro - enterology and Hepatology, Digestive Disease Institute, A30,  Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195,  United States.",Non-OADS,/arxiv_data1/oa_pdf/67/dc/WJG-23-2883.PMC5413783.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.MINIREVIEWSSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2883 2883 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2883-2890  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/67/dc/WJG-23-2883.PMC5413783.pdf
World  J Gastroenterol  2017; 23(16): 2883-2890  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i16/2883.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i16.2883 INTRODUCTION Endoscopic submucosal dissection (ESD) is an  advanced endoscopic technique that allows for en-bloc   resection of early gastrointestinal tract cancers[1-3].,Non-OADS,/arxiv_data1/oa_pdf/67/dc/WJG-23-2883.PMC5413783.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/67/dc/WJG-23-2883.PMC5413783.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to: Jean-François Beaulieu, PhD, Professor,  Laboratory of Intestinal Physiopathology, Department of Anatomy  and Cell Biology, Faculty of Medicine and Health Sciences,  Université de Sherbrooke, Sherbrooke, Québec J1H5N4,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/f9/6c/WJG-23-2891.PMC5413784.pdf
"RESULTS We found that the ddPCR and qPCR methods per-Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2891 2891 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2891-2898  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Droplet digital PCR for quantification of ITGA6  in a stool  mRNA assay for the detection of colorectal cancersBasic Study Elizabeth Herring, Shigeru Kanaoka, Éric Tremblay, Jean-François Beaulieu",Non-OADS,/arxiv_data1/oa_pdf/f9/6c/WJG-23-2891.PMC5413784.pdf
World J Gastroenterol  2017;  23(16): 2891-2898  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/f9/6c/WJG-23-2891.PMC5413784.pdf
com/1007-9327/full/v23/i16/2891.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/6c/WJG-23-2891.PMC5413784.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/f9/6c/WJG-23-2891.PMC5413784.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Markus Brückner, MD,  Department of  Medicine B, University Hospital of Münster, Albert-Schweitzer- Campus 1, D-48149 Münster,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/bc/a2/WJG-23-2899.PMC5413785.pdf
"markus.brueckner@ukmuenster.d e Telephone:  +49-251-8347661 Fax:  +49-251-8347570 Received:  December 29, 2016 Peer-review started:  December 30, 2016 First decision:  February 23, 2017 Revised:  March 14, 2017 Accepted:  March 30, 2017   Article in press:  March 30, 2017 Published online: April 28, 2017Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2899 2899 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2899-2911  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Detection and characterization of murine colitis and  carcinogenesis by molecularly targeted contrast-enhanced  ultrasoundBasic Study Markus Brückner, Jan Heidemann, Tobias M Nowacki, Friederike Cordes, Jörg Stypmann, Philipp Lenz,  Faekah Gohar, Andreas Lügering, Dominik Bettenworth",Non-OADS,/arxiv_data1/oa_pdf/bc/a2/WJG-23-2899.PMC5413785.pdf
"World J  Gastroenterol  2017; 23(16): 2899-2911  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i16/2899.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i16.2899 INTRODUCTION Inflammatory bowel diseases (IBD) such as Crohn’s  disease (CD) and ulcerative colitis (UC) are chronic  relapsing and remitting inflammatory disorders of the  gastrointestinal tract often resulting in challenging  clinical diagnostic and therapeutic scenarios[1,2].",Non-OADS,/arxiv_data1/oa_pdf/bc/a2/WJG-23-2899.PMC5413785.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/bc/a2/WJG-23-2899.PMC5413785.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Yang Xu, PhD, Professor,  Institute of  Medicinal Plant Development, Chinese Academy of Medical  Sciences and Peking Union Medical College, 151 Malianwa  North Road, Beijing 100193, China.",Non-OADS,/arxiv_data1/oa_pdf/81/15/WJG-23-2912.PMC5413786.pdf
"The in  vivo hepatoprotective  and antioxidant effects of CDAE Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2912 2912 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2912-2927  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE In vitro  and in vivo  antioxidative and hepatoprotective  activity of aqueous extract of Cortex DictamniBasic Study Lin Li, Yun-Feng Zhou, Yan-Lin Li, Li-Li Wang, Hiderori Arai, Yang Xu",Non-OADS,/arxiv_data1/oa_pdf/81/15/WJG-23-2912.PMC5413786.pdf
World J Gastroenterol  2017;  23(16): 2912-2927  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/81/15/WJG-23-2912.PMC5413786.pdf
com/1007-9327/full/v23/i16/2912.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/15/WJG-23-2912.PMC5413786.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/81/15/WJG-23-2912.PMC5413786.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Yin Shi, PhD,  Shanghai Institute of  Acupuncture-Moxibustion and Meridian, No.",Non-OADS,/arxiv_data1/oa_pdf/87/5a/WJG-23-2928.PMC5413787.pdf
"Mast cells (MC) activity in the colons of  rats were assessed, and 5-hydro xytryptamine (5-HT),  5-hydroxytryptamine 3 receptor (5-HT3R) and 5-HT4R Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2928 2928 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2928-2939  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Comparison of the analgesic effects between  electro-acupuncture and moxibustion with visceral  hypersensitivity rats in irritable bowel syndromeBasic Study Ji-Meng Zhao, Liang Li, Liu Chen, Yin Shi, Yu-Wei Li, Hai-Xia Shang, Lu-Yi Wu, Zhi-Jun Weng, Chun-Hui Bao,  Huan-Gan Wu",Non-OADS,/arxiv_data1/oa_pdf/87/5a/WJG-23-2928.PMC5413787.pdf
World J  Gastroenterol  2017; 23(16): 2928-2939  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i16/2928.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i16.2928 INTRODUCTION Irritable  bowel  syndrome  (IBS) is a common  functional   gastrointestinal  disorder  characterized  by abdominal   discomfort  or pain associated  with abnormal  bowel   movements.,Non-OADS,/arxiv_data1/oa_pdf/87/5a/WJG-23-2928.PMC5413787.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/87/5a/WJG-23-2928.PMC5413787.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript   Correspondence to: Dr. Guo-Tao Yang,  Department of Third Neurology, Cangzhou Central Hospital, Cangzhou Clinical  Medical School of Hebei Medical University, Cangzhou 061001,  Hebei Province, China.",Non-OADS,/arxiv_data1/oa_pdf/82/74/WJG-23-2940.PMC5413788.pdf
"This Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2940 2940 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2940-2947  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Study of the effects of nesfatin-1 on gastric function in  obese ratsBasic Study Guo-Tao Yang, Hong-Ying Zhao, Yu Kong, Ning-Ning Sun, Ai-Qin Dong",Non-OADS,/arxiv_data1/oa_pdf/82/74/WJG-23-2940.PMC5413788.pdf
World J  Gastroenterol  2017; 23(16): 2940-2947  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i16/2940.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i16.2940 INTRODUCTION Obesity is a global public health priority.,Non-OADS,/arxiv_data1/oa_pdf/82/74/WJG-23-2940.PMC5413788.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/82/74/WJG-23-2940.PMC5413788.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Solomon Chih-Cheng Chen, MD, MS,  PhD,  Heng Chun Christian Hospital,  No.",Non-OADS,/arxiv_data1/oa_pdf/90/15/WJG-23-2948.PMC5413789.pdf
"solomon.ccc@gmail.co m Telephone:  +886-928901217 Fax:  +886-88880111 Received:  January 5, 2017 Peer-review started:  January 8, 2017 First decision:  January 19, 2017 Revised:  February 1, 2017 Accepted:  March 30, 2017 Article in press:  March 30, 2017 Published online: April 28, 2017 Abstract AIM To investigate the association between a recent  gastrointestinal (GI) endoscopy and the subsequent  risk of pyogenic liver abscess (PLA).Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2948 2948 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2948-2956  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Recent upper gastrointestinal panendoscopy increases the  risk of pyogenic liver abscessCase Control Study Ming-Jen Tsai, Chin-Li Lu, Ying C Huang, Chung Hsien Liu, Wan-Ting Huang, Kai-Yuan Cheng,  Solomon Chih-Cheng Chen",Non-OADS,/arxiv_data1/oa_pdf/90/15/WJG-23-2948.PMC5413789.pdf
World J Gastroenterol  2017;  23(16): 2948-2956  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/90/15/WJG-23-2948.PMC5413789.pdf
com/1007-9327/full/v23/i16/2948.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/15/WJG-23-2948.PMC5413789.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/90/15/WJG-23-2948.PMC5413789.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to: Xiao-Yu Hu, Professor,  Department of  Infectious Diseases, Teaching Hospital of Chengdu University of  Traditional Chinese Medicine , No.",Non-OADS,/arxiv_data1/oa_pdf/95/b6/WJG-23-2957.PMC5413790.pdf
"A retrospective  analysis was performed by comparing age, alcohol  intake, and clinical parameters of liver injury before Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2957 2957 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2957-2963  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Gutuo Jiejiu decoction improves survival of patients with  severe alcoholic hepatitis: A retrospective cohort studyRetrospective Cohort Study Hong-Yuan Mou, Hong-Ming Nie, Xiao-Yu Hu",Non-OADS,/arxiv_data1/oa_pdf/95/b6/WJG-23-2957.PMC5413790.pdf
World J Gastroenterol  2017; 23(16): 2957-2963   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i16/2957.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/95/b6/WJG-23-2957.PMC5413790.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/95/b6/WJG-23-2957.PMC5413790.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Otto S Lin, MD,  Digestive Disease  Institute, Virginia Mason Medical Center, 1100 Ninth Avenue,  Seattle, WA 98101, United States.",Non-OADS,/arxiv_data1/oa_pdf/0a/a4/WJG-23-2964.PMC5413791.pdf
"Procedural success rates, polyp detection rates,  procedure times and recovery times were recorded and  compared against corresponding historical measures  2964 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comORIGINAL ARTICLE One year experience with computer-assisted propofol  sedation for colonoscopyRetrospective Study Otto S Lin, Danielle La Selva, Richard A Kozarek, Deborah Tombs, Wade Weigel, Ryan Beecher,  Johannes Koch, Susan McCormick, Michael Chiorean, Fred Drennan, Michael Gluck, Nanda Venu,  Michael Larsen, Andrew RossSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2964World J Gastroenterol   2017 April 28; 23(16): 2964-2971  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/0a/a4/WJG-23-2964.PMC5413791.pdf
World J Gastroenterol  2017; 23(16): 2964-2971  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/0a/a4/WJG-23-2964.PMC5413791.pdf
com/1007-9327/full/v23/i16/2964.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/a4/WJG-23-2964.PMC5413791.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/0a/a4/WJG-23-2964.PMC5413791.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Alba Manuel-Vázquez, MD,  Department of General and Digestive Surgery, University Hospital of  Guadalajara, Calle Donante de sangre s/n, 19002 Guadalajara,  Spain.",Non-OADS,/arxiv_data1/oa_pdf/76/de/WJG-23-2972.PMC5413792.pdf
"There were 71 readmissions  in the 90 d aft er discharge, with a readmission rate of Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2972 2972 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2972-2977  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Ninety-day readmissions after inpatient cholecystectomy: A  5-year analysisRetrospective Study Alba Manuel-Vázquez, Raquel Latorre-Fragua, Carmen Ramiro-Pérez, Aylhin López-Marcano, Farah Al-Shwely,  Roberto De la Plaza-Llamas, José Manuel Ramia",Non-OADS,/arxiv_data1/oa_pdf/76/de/WJG-23-2972.PMC5413792.pdf
World J Gastroenterol  2017; 23(16): 2972-2977   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i16/2972.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/76/de/WJG-23-2972.PMC5413792.pdf
"Available from:  URL: http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH062884;2005e06 6 Havens JM , Olufajo OA, Cooper ZR, Haider AH, Shah AA, Salim  A.",Non-OADS,/arxiv_data1/oa_pdf/76/de/WJG-23-2972.PMC5413792.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/76/de/WJG-23-2972.PMC5413792.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscriptSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2978 2978 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2978-2986  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Early hepatitis B viral DNA clearance predicts treatment  response at week 96Clinical Trials Study Xiao-Yu Fu, De-Ming Tan, Cui-Mei Liu, Bin Gu, Li-Hua Hu, Zhong-Tian Peng, Bin Chen, Yuan-Lin Xie,  Huan-Yu Gong, Xiao-Xuan Hu, Lian-Hui Yao, Xiao-Ping Xu, Zheng-Yuan Fu, Lang-Qiu He, Si-Hai Li,  Yun-Zhu Long, De-Hui Li, Ji-Long Gu, Shi-Fang Peng",Non-OADS,/arxiv_data1/oa_pdf/55/93/WJG-23-2978.PMC5413793.pdf
World J  Gastroenterol  2017; 23(16): 2978-2986  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i16/2978.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i16.2978 INTRODUCTION Hepatitis B virus (HBV) infection is a pandemic disease.,Non-OADS,/arxiv_data1/oa_pdf/55/93/WJG-23-2978.PMC5413793.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/55/93/WJG-23-2978.PMC5413793.pdf
Data sharing statement:  We share the statistical results at  http://www.chictr.org.cn/searchproj.aspx.Open-Access:  This article is an open-access article which was  selected by an in-house editor and fully peer-reviewed by external  reviewers.,Non-OADS,/arxiv_data1/oa_pdf/84/9c/WJG-23-2987.PMC5413794.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Zhi-Qiang Chen,  Second Affiliated  Hospital of Guangzhou University of Chinese Medicine,  Guangzhou 510120, Guangdong Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/84/9c/WJG-23-2987.PMC5413794.pdf
"Antroduodenojejunal  manometry was used to monitor gastrointestinal Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2987 2987 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2987-2994  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Effects of Chinese herbal medicine Xiangbin prescription on  gastrointestinal motilityClinical Trials Study Zhi Jiang, Li-Xing Cao, Bo Liu, Qi-Cheng Chen, Wen-Fan Shang, Lu Zhou, Dan-Yan Li, De-An Guo,  Zhi-Qiang Chen",Non-OADS,/arxiv_data1/oa_pdf/84/9c/WJG-23-2987.PMC5413794.pdf
World J Gastroenterol   2017; 23(16): 2987-2994  Available from: URL: http://www.wjgnet.com/1007-9327/full/v23/i16/2987.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/9c/WJG-23-2987.PMC5413794.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/84/9c/WJG-23-2987.PMC5413794.pdf
"Conflict-of-interest statement:  Ben­Horin S has received  consultancy and/or advisory board fees from Schering ­Plough, Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.2995 2995 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 2995-3002  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Combination of corticosteroids and 5-aminosalicylates or  corticosteroids alone for patients with moderate-severe  active ulcerative colitis: A global survey of physicians'  practiceObservational Study Shomron Ben-Horin, Jane M Andrews, Konstantinos H Katsanos, Florian Rieder, Flavio Steinwurz,  Konstantinos Karmiris, Jae Hee Cheon, Gordon William Moran, Monica Cesarini, Christian D Stone,  Doron Schwartz, Marijana Protic, Xavier Roblin, Giulia Roda, Min-Hu Chen, Ofir Har-Noy, Charles N Bernstein",Non-OADS,/arxiv_data1/oa_pdf/8f/8f/WJG-23-2995.PMC5413795.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Shomron Ben-Horin, MD, Department  of Gastroenterology, Sheba Medical Center, Sackler School of Medicine, Tel Hashomer, Ramat ­Gan 52621,  Israel.",Non-OADS,/arxiv_data1/oa_pdf/8f/8f/WJG-23-2995.PMC5413795.pdf
World J Gastroenterol  2017; 23(16):  2995 ­3002  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/8f/8f/WJG-23-2995.PMC5413795.pdf
com/1007 ­9327/full/v23/i16/2995.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/8f/WJG-23-2995.PMC5413795.pdf
Available from: URL: http://www.ClinicalTrials.,Non-OADS,/arxiv_data1/oa_pdf/8f/8f/WJG-23-2995.PMC5413795.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/8f/8f/WJG-23-2995.PMC5413795.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript   Correspondence to: Wolfgang Kreisel, MD, Professor,  Department of Medicine II, Gastroenterology, Hepatology,  Endocrinology and Infectious Diseases, Medical Center, University  of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter  Str.",Non-OADS,/arxiv_data1/oa_pdf/33/a7/WJG-23-3003.PMC5413796.pdf
"Endoscopy and CASE REPORTSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i16.3003 3003 April 28, 2017 |Volume 23 |Issue 16 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 April 28; 23(16): 3003-3010  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/33/a7/WJG-23-3003.PMC5413796.pdf
World J Gastroenterol  2017; 23(16): 3003-3010  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i16/3003.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i16.3003 INTRODUCTION Protein-losing enteropathy (PLE) is a rare condition of  excessive serum protein losses into the gastrointestinal  tract.,Non-OADS,/arxiv_data1/oa_pdf/33/a7/WJG-23-3003.PMC5413796.pdf
"Available from: URL: https://www.uptodate.com/ contents/protein-losing-gastroenteropathy 4 Aslam N , Wright R. Protein-Losing Enteropathy: Background,  Pathophysiology, Etiology.",Non-OADS,/arxiv_data1/oa_pdf/33/a7/WJG-23-3003.PMC5413796.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  6",Non-OADS,/arxiv_data1/oa_pdf/33/a7/WJG-23-3003.PMC5413796.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/8a/vex010.PMC5413804.pdf
"Pan American Health Organization (2014a), Number of reported cases of Chikungunya fever in the Americas—EW 52(December 29, 2014) http://www2.paho.org/hq/index.php?option=com_topics&view=readall&cid=5927&Itemid=40931&lang=en.—— (2014b), Number of reported cases of Chikungunya fever in the Americas—EW 09 (February 28, 2014) http://www2.pa- ho.org/hq/index.php?option=com_topics&view=readall&cid= 5927&Itemid= 40931&lang=en.",Non-OADS,/arxiv_data1/oa_pdf/42/8a/vex010.PMC5413804.pdf
Available at: http://www.niaaa.nih.gov/sites/default/files/newsletters/Newsletter_Number3.,Non-OADS,/arxiv_data1/oa_pdf/5b/8d/APT-45-1319.PMC5413805.pdf
https://doi.org/10.1002/ajmg.a.38143ZWEIER ET AL.,OADS,/arxiv_data1/oa_pdf/81/6a/AJMG-173-1440.PMC5413807.pdf
"Chung Received 14 October 2016; Revision received 25 January 2017; Accepted 7 February2017Accepted manuscript online 10 February 2017; Article ﬁrst published online 6 March 2017 in Wiley Online Library (http://onlinelibrary.wiley.com/doi/10.1002/bit.26265/abstract).DOI 10.1002/bit.26265ARTICLE 1264 Biotechnology and Bioengineering, V ol.",Non-OADS,/arxiv_data1/oa_pdf/20/11/BIT-114-1264.PMC5413809.pdf
"Among these, two nonsense mutations (c.1021C >T, p.Q341X; c.3046C >T, p. R1016X) had been reported in MVID patients without cholestasis,(27,36)and one missense mutation (c.1604G >A, p.S535N) has a reported fre- quency of 0.001 in East Asian populations in the ExAC database ( http://exac.broadinstitute.org/variant/ 18-47480747-C-T ), but is predicted to be disease causing (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
(38)Protein data are deduced from UniProt ( http://www.uniprot.org/uniprot/Q9ULV0 ).,OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://www.genecards.org/ Orphanet.,Non-OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://www.orpha.net/consor/cgi-bin/index.,OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://www.drwang.top/ ClinVar.,Non-OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://www.clinvar.com OMIM.,Non-OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://www.omim.org PubMed.,Non-OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://www.pubmed.org/ HGMD.,Non-OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://www.hgmd.cf.a c.uk/ac/index.php db SNP.,OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://gvs-1.gs.,Non-OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
washington.edu/EVS/ 1000 Genomes http://www.1000genomes.org/ ExAC Browser.,OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://exac.broadinstitute.org/ These tools were applied in filtering common variants.,OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://genetics.bwh.harvard.edu/pph2/ SIFT.,Non-OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
http://sift.jcvi.org MutationTaster.,Non-OADS,/arxiv_data1/oa_pdf/35/e0/HEP-65-1655.PMC5413810.pdf
Availableat: http://bura.brunel.ac.uk/handle/ 2438/6497.,Non-OADS,/arxiv_data1/oa_pdf/ca/56/JOCN-26-1217.PMC5413812.pdf
Avail- able at: http://www.dh.gov.uk/prod_- consum_dh/groups/dh_digitalassets/@d h/@en/@ps/documents/digitalasset/dh_117794.pdf (accessed 2 July 2012).,OADS,/arxiv_data1/oa_pdf/ca/56/JOCN-26-1217.PMC5413812.pdf
Available at: http://webarchi- ve.nationalarchives.gov.uk/20130107 105354/http://www.dh.gov.uk/health/ ﬁles/2012/02/C1-Improving-quality-of-care.pdf (accessed 3 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/ca/56/JOCN-26-1217.PMC5413812.pdf
Available at: http://data.par- liament.uk/DepositedPapers/Files/DEP 2012-0834/LiberatingtheNHS-Nodeci-sionaboutmewithoutme.pdf (accessed5 July 2012).,Non-OADS,/arxiv_data1/oa_pdf/ca/56/JOCN-26-1217.PMC5413812.pdf
"Department of Health, https://www.gov.uk/government/uploads/system/uploads/attachment_data/ﬁle/22 6703/Berwick_Report.pdf (Accessed 3 June 2016).",Non-OADS,/arxiv_data1/oa_pdf/ca/56/JOCN-26-1217.PMC5413812.pdf
Avail- able at: http://www.ncbi.nlm.nih.gov/pubmed/24019507 (accessed 3 June2016).,Non-OADS,/arxiv_data1/oa_pdf/ca/56/JOCN-26-1217.PMC5413812.pdf
Available at: http://qhr.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/ca/56/JOCN-26-1217.PMC5413812.pdf
Available at: http://www.the- creativeindustries.co.uk/uk-creative-over view/news-and-views/view-what-is-design- and-why-it-matters (accessed 3 June2016).,Non-OADS,/arxiv_data1/oa_pdf/ca/56/JOCN-26-1217.PMC5413812.pdf
Avail- able at: http://www.socresonline.org.,Non-OADS,/arxiv_data1/oa_pdf/ca/56/JOCN-26-1217.PMC5413812.pdf
"Dr.T.Tanaka, Prof. Dr.S.Sakaki, Prof. Dr.M.Ehara Elemen tsStrategy Initiati veforCatalysts and Batteries (ESIC B) Kyoto Unive rsity Kyoto 615–8 510 (Japan) Supp orting informa tionandtheORCIDidentification numb er(s) forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / cctc.20 160171 3.",Non-OADS,/arxiv_data1/oa_pdf/aa/81/CCTC-9-1222.PMC5413816.pdf
"See, for example, http://medical-dictionary.thefreedictionary.com/psychological+tests.",Non-OADS,/arxiv_data1/oa_pdf/12/2a/JHBS-53-176.PMC5413820.pdf
"Retrieved through the follow- ing link: http://galton.org/essays/1870-1879/galton-1879-brain-psychometric-experiments/galton-1879-brain- psychometric-experiments.pdf Galton, F .",Non-OADS,/arxiv_data1/oa_pdf/12/2a/JHBS-53-176.PMC5413820.pdf
The	diagram	was	constructed	using	the	program	 VENN	(http://bioinformatics.psb.ugent.be/webtools/Vennwileyonlinelibrary.com]).,OADS,/arxiv_data1/oa_pdf/b6/35/GBI-15-453.PMC5413822.pdf
https://doi.org/10.1111/gbi.12231,Non-OADS,/arxiv_data1/oa_pdf/b6/35/GBI-15-453.PMC5413822.pdf
"Available online at: http://www.who.int/maternal_child_adolescent/epidemiology/stillbirth/en/ (accessedJanuary 03, 2016).",Non-OADS,/arxiv_data1/oa_pdf/07/99/AOGS-96-519.PMC5413831.pdf
"Available online at: http://www.who.int/maternal_child_adolescent/documents/9241591838/en/ (accessed December 03, 2015).",Non-OADS,/arxiv_data1/oa_pdf/07/99/AOGS-96-519.PMC5413831.pdf
"Available online at: http://www.stillbirthalliance.org.au/doc/Section_7_Version_2.2_April_2009.pdf (accessedAugust 30, 2013).",Non-OADS,/arxiv_data1/oa_pdf/07/99/AOGS-96-519.PMC5413831.pdf
"Available online at: http://www.who.int/reproductivehealth/projects/02-ICD-PM.pdf(accessed August 16, 2016).",Non-OADS,/arxiv_data1/oa_pdf/07/99/AOGS-96-519.PMC5413831.pdf
"Available online at: http://www.who.int/reproductivehealth/publications/monitoring/9789241548458/en/ (accessed September 02, 2015).",Non-OADS,/arxiv_data1/oa_pdf/07/99/AOGS-96-519.PMC5413831.pdf
https://doi.org/10.1002/jlcr.3489KRZYCZMONIK ET AL .,OADS,/arxiv_data1/oa_pdf/79/39/JLCR-60-186.PMC5413832.pdf
"Accessed August 30, 2016. http://www.who.int/gho/ncd/risk_ factors/obesity_text/en/.",Non-OADS,/arxiv_data1/oa_pdf/40/be/NYAS-1392-43.PMC5413842.pdf
"Accessed August 30, 2016. http://www.pulsecanada.com/ environment/sustainability.",Non-OADS,/arxiv_data1/oa_pdf/40/be/NYAS-1392-43.PMC5413842.pdf
"Acessed December 13, 2016. http://www.hc-sc.gc.ca/ fn-an/food-guide-aliment/index-eng.php.",Non-OADS,/arxiv_data1/oa_pdf/40/be/NYAS-1392-43.PMC5413842.pdf
"Accessed August 30, 2016. http://www.fda.gov/ downloads/Drugs/.../Guidances/ucm071624.pdf.55.",Non-OADS,/arxiv_data1/oa_pdf/40/be/NYAS-1392-43.PMC5413842.pdf
This novel variant was not present in the Human Gene Mutation Database (HGMD Version 2014.2) nor in the ExAC database (http://exac.broadinstitute.org).,Non-OADS,/arxiv_data1/oa_pdf/a3/22/AJMG-173-1383.PMC5413846.pdf
WEB RESOURCES UCSC Genome Browser http://genome.ucsc.edu/ OMIM http://www.ncbi.nlm.nih.gov/ ExAC database (http://exac.broadinstitute.org) CONFLICT OF INTEREST None.,Non-OADS,/arxiv_data1/oa_pdf/a3/22/AJMG-173-1383.PMC5413846.pdf
https://doi.org/10.1002/ajmg.a.38179BOUMAN ET AL.,OADS,/arxiv_data1/oa_pdf/a3/22/AJMG-173-1383.PMC5413846.pdf
"census throughNHGIShttps://www.nhgis.org Percentage of population who indicated their race as white 2006-2010Census tractACS through NHGIShttps://www.nhgis.org Median household income 2006-2010 Census tractACS through NHGIShttps://www.nhgis.org Percentage of persons (aged ≥25 years) with educational attainment less than some college 2006-2010Census tractACS through NHGIShttps://www.nhgis.org Annual household income inequality (Gini coefficient) 2002- 2008State U.S. census http://factfinder2.census.gov/faces/nav/jsf/pages/ searchresults.xhtml?refresh = t#none Annual rate of unemployment 2002-2008 State U.S. BLS http://www.bls.gov/lau/#data Annual rate of disabled workers receiving SSDI 2002-2008 State U.S. SSA http://www.ssa.gov/policy/docs/statcomps/di_asr/ 2008/index.html Percentage of population below 100% poverty 2002-2008 State U.S. census http://www.census.gov/hhes/www/poverty/data/ incpovhlth/index.html ACS, American Community Survey (published every 5 years during study period); BLS, U.S. Bureau of Labor Statistics; NHGIS, The National Historical Geographic Information System, University of Minnesota; SSA, Social Security Administration; SSDI, Social Security Disability Insurance.TABLE 1 (Continued) Variable Number Percentage Grand mean (minimum, maximum) SDa Allowed once 14 241 24.0 Not Allowed 36 837 62.1 Annual population below 100% poverty (%) 12.3 (5.4, 22.6) 2.7Annual unemployment rate 5.3 (2.5, 8.3) 1.0 Annual Gini coefficient 45.4 (38.0, 54.0) 2.2 Annual rate of disabled workers receiving SSDI d3.4 (1.7, 7.8) 0.9 aStandard deviation.",Non-OADS,/arxiv_data1/oa_pdf/25/5b/AJIM-60-472.PMC5413850.pdf
Available at: http://www.joepaduda.com/2013/06/workers-comp- rates-up-still-profit/.,Non-OADS,/arxiv_data1/oa_pdf/25/5b/AJIM-60-472.PMC5413850.pdf
Available at: http://www.bls.gov/cpi/cpifact4.htm.,Non-OADS,/arxiv_data1/oa_pdf/25/5b/AJIM-60-472.PMC5413850.pdf
Available at: http://www2.census.gov/geo/pdfs/ reference/GARM/Ch10GARM.pdf.,OADS,/arxiv_data1/oa_pdf/25/5b/AJIM-60-472.PMC5413850.pdf
Available at: https://www.ncci.com/Articles/Documents/II_TTD_Duration_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/5b/AJIM-60-472.PMC5413850.pdf
Available at:http://www.bls.gov/news.release/pdf/osh2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/5b/AJIM-60-472.PMC5413850.pdf
"[a]Dr.U.Prad/C155re,F.Halloy ,Prof.Dr.J.Hall Institute ofPharma ceuti calSciences, Depar tment ofChem istry and Appli edBiosc iences, ETH Z/C252rich,8093Z/C252rich (Switzerland ) E-mail :jonath an.hall@ pharma.eth z.ch Supportin ginformat ionforthisarticle canbefound under : http://dx.doi.or g/10.10 02/chem.20 1700514.",Non-OADS,/arxiv_data1/oa_pdf/7a/e2/CHEM-23-5210.PMC5413853.pdf
Supp orting informa tionandtheORCIDidentification numb er(s) forthe autho r(s)ofthis article canbefoundunde rhttp://dx.doi.org/ 10.1002 / cctc.20 160156 8.,Non-OADS,/arxiv_data1/oa_pdf/88/b5/CCTC-9-1413.PMC5413858.pdf
2017;98:   508-516. https://doi.org/10.1111/ejh.12864,Non-OADS,/arxiv_data1/oa_pdf/c3/84/EJH-98-508.PMC5413861.pdf
"Werner, P. J. Knowles, G. Knizia, F. R. Manby, M. Sch ¨utz and others, MOLPRO, version 2015.1 ,a package of ab initio programs , see http://www.molpro.net.",Non-OADS,/arxiv_data1/oa_pdf/26/d9/SC-008-C7SC00033B.PMC5413972.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/86/ofw261.PMC5413986.pdf
Available at: https://www.imbruvicahcp.com/ docs/librariesprovider2/pdf-downloads/prescribing_information.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/86/ofw261.PMC5413986.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/0 21721s020_020635s57_020634s52_lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/86/ofw261.PMC5413986.pdf
Available at: https://www.astellas.us/docs/ambisome.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/86/ofw261.PMC5413986.pdf
Available at: http://www.valeant.com/Portals/25/Pdf/PI/ FPO_LB0096-00-nov13.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/86/ofw261.PMC5413986.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019949s051lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/86/ofw261.PMC5413986.pdf
Available at: http://www.immy.com/bluejuice/wp-content/ uploads/2016/09/CR2003-CrAg-LFA-PI-US-1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/68/86/ofw261.PMC5413986.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/72/ofw248.PMC5413988.pdf
Available at: http://www.unaids.org/en/ regionscountries/countries/southafrica/.,Non-OADS,/arxiv_data1/oa_pdf/4c/72/ofw248.PMC5413988.pdf
"Geneva,  Switzerland: World Health Organization; Available at: http://www.who.int/tb/ publications/global_report/en/.",Non-OADS,/arxiv_data1/oa_pdf/4c/72/ofw248.PMC5413988.pdf
Available at: http://www.who.int/hiv/pub/guidelines/earlyre- lease-arv/en/.,Non-OADS,/arxiv_data1/oa_pdf/4c/72/ofw248.PMC5413988.pdf
Available at: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/4c/72/ofw248.PMC5413988.pdf
Available at: http://www.hst.org.za/publica- tions/district-health-barometer-201415-1.,Non-OADS,/arxiv_data1/oa_pdf/4c/72/ofw248.PMC5413988.pdf
Available at: http://www.hst.org.za/publica- tions/district-health-barometer-201213.,Non-OADS,/arxiv_data1/oa_pdf/4c/72/ofw248.PMC5413988.pdf
Available at: http://www.who.int/hiv/pub/guidelines/south_africa_hiv_tb.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4c/72/ofw248.PMC5413988.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/  by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/8a/ofw255.PMC5413991.pdf
Available at: http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/ documents/document/ucm071185.pdf .,Non-OADS,/arxiv_data1/oa_pdf/89/8a/ofw255.PMC5413991.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/05/ofw265.PMC5413992.pdf
Available at: http://resistancemap.cddep.,OADS,/arxiv_data1/oa_pdf/38/05/ofw265.PMC5413992.pdf
"This ST is novel, and no other isolate with this ST has been recorded so far in the MLST database (http://pubmlst.org/cdiphtheriae/).",OADS,/arxiv_data1/oa_pdf/92/5e/ofw271.PMC5413993.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/5e/ofw271.PMC5413993.pdf
Available at:  http://www.hcsp.fr/Explore.cgi/Telecharger?NomFichier=hcspr20110304_con-duitediphterie.pdf.,Non-OADS,/arxiv_data1/oa_pdf/92/5e/ofw271.PMC5413993.pdf
b ahttp://www.samhsa.gov/medication-assisted-treatment/training-resources/ buprenorphinephysician-trainin.,Non-OADS,/arxiv_data1/oa_pdf/46/12/ofw251.PMC5413994.pdf
bhttp://www.samhsa.gov/medication-assisted-treatment/buprenor phinewaiver-management/ apply-for-physician-waiver .,Non-OADS,/arxiv_data1/oa_pdf/46/12/ofw251.PMC5413994.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/5e/ofx015.PMC5413995.pdf
Available at:  https://www.healthypeople.gov/2020/topics-objectives/topic/diabetes/objectives.,Non-OADS,/arxiv_data1/oa_pdf/a2/5e/ofx015.PMC5413995.pdf
Available at: http://www.dartmouthatlas.org/tools.,Non-OADS,/arxiv_data1/oa_pdf/a2/5e/ofx015.PMC5413995.pdf
Available at http://www.ers.usda.gov/topics/rural-economy-population/rural-classifications.aspx.,Non-OADS,/arxiv_data1/oa_pdf/a2/5e/ofx015.PMC5413995.pdf
Available at: http://www.idsociety.org/Workforce_Policy/.,Non-OADS,/arxiv_data1/oa_pdf/a2/5e/ofx015.PMC5413995.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/02/ofw264.PMC5413996.pdf
2013; Available at: http://www.fda.gov/ Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ ucm370170.htm.,Non-OADS,/arxiv_data1/oa_pdf/5d/02/ofw264.PMC5413996.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/8a/ofw259.PMC5413998.pdf
"Based  on the top BLASTN hit (http://blast.ncbi.nlm.nih.gov), the par - tial hexon sequence of this adenovirus-positive specimen was  most similar (100% nucleotide identity) to human adenovirus 3 isolate GZ_31_2011 (accession no.",Non-OADS,/arxiv_data1/oa_pdf/3d/8a/ofw259.PMC5413998.pdf
Available at: https://ep70.eventpilotadmin.com/web/page.,Non-OADS,/arxiv_data1/oa_pdf/3d/8a/ofw259.PMC5413998.pdf
Available at: https://ep70.eventpilotadmin.com/web/page.php?page=Inthtm- l&project=ISIRV16&id=8091.,Non-OADS,/arxiv_data1/oa_pdf/3d/8a/ofw259.PMC5413998.pdf
Available at: https://ep70.eventpilotad- min.com/web/page.php?page=Inthtml&project=ISIRV16&id=8099.,OADS,/arxiv_data1/oa_pdf/3d/8a/ofw259.PMC5413998.pdf
Available at: https://ep70.eventpilotadmin.,Non-OADS,/arxiv_data1/oa_pdf/3d/8a/ofw259.PMC5413998.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/ac/ofx004.PMC5414000.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/38/ofx026.PMC5414001.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.,Non-OADS,/arxiv_data1/oa_pdf/2a/38/ofx026.PMC5414001.pdf
Available from:  http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_ phase6_20090611/en/.,Non-OADS,/arxiv_data1/oa_pdf/2a/38/ofx026.PMC5414001.pdf
Available from: http://www.abcombibio.com/pneumococcal.,Non-OADS,/arxiv_data1/oa_pdf/2a/38/ofx026.PMC5414001.pdf
Available from: http://www.gavi.org/sup- port/nvs/pneumococcal/.,Non-OADS,/arxiv_data1/oa_pdf/2a/38/ofx026.PMC5414001.pdf
Available from: http://www.who.int/childgrowth/standards/weight_for_length_height/en/.,Non-OADS,/arxiv_data1/oa_pdf/2a/38/ofx026.PMC5414001.pdf
Available from: http://www.who.int/influenza/vaccines/virus/recommendations/en/.,Non-OADS,/arxiv_data1/oa_pdf/2a/38/ofx026.PMC5414001.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
Available at: http://www.health.gov.on.ca/en/pro/programs/publiche- alth/oph_standards/docs/gas_cd.pdf .,Non-OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
Available at: http://dsol-smed.phac-aspc.gc.ca/dsol- smed/ndis/charts.php?c=pl .,OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
Available at: http://www.ahf.ca/down- loads/addictive-behaviours.pdf .,Non-OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
Available at: http://www.phac-aspc.gc.ca/cd-mc/diabetes-diabete/index-eng.php .,Non-OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
"Ottawa, ON: FNIGC; Available at: http://fnigc.ca/sites/default/files/First_Nations_Regional_Health_Survey_2008-10_National_ Report.pdf .",Non-OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
"Ottawa, ON: Statistics  Canada; Available at: http://www12.statcan.ca/census-recensement/2006/ as-sa/97-558/pdf/97-558-XIE2006001.pdf .",OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
"Toronto, ON: Chiefs of Ontario; Available at: http://fnigc.ca/sites/default/files/",Non-OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
Available at: http://www.afn.ca/uploads/files/housing/factsheet-housing.,Non-OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
Available at: https://idsa.confex.com/idsa/2015/webprogram/Paper51217.html .,Non-OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
Available at: http://www.bccdc.ca/resource-gal- lery/Documents/Statistics%20and%20Research/Statistics%20and%20Reports/Epid/ AntimicrobialResistanceTrendsinBC_2011.pdf .,OADS,/arxiv_data1/oa_pdf/96/7d/ofw243.PMC5414009.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/d4/ofx002.PMC5414011.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/ofx020.PMC5414013.pdf
Available at: http://www.who.int/maternal_child_adolescent/documents/levels_ trends_child_mortality_2013/en/.,Non-OADS,/arxiv_data1/oa_pdf/e7/67/ofx020.PMC5414013.pdf
Available at: https://www.usaid.gov/sites/default/files/docu- ments/1862/Guatemala-HSA%20_ENG-FULL-REPORT-FINAL-APRIL-2016.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e7/67/ofx020.PMC5414013.pdf
Available at: http://www.r-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/e7/67/ofx020.PMC5414013.pdf
Available at:  http://biblioteca.usac.edu.gt/tesis/06/06_3368.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e7/67/ofx020.PMC5414013.pdf
Available at: http://biblioteca.usac.edu.gt/tesis/06/06_2186.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e7/67/ofx020.PMC5414013.pdf
Available at: http://www.thecie.com.au/wp-content/uploads/2014/08/CIE-Final-Report_-Economic-analysis-of-Group-B-streptococcus-screening.,Non-OADS,/arxiv_data1/oa_pdf/e7/67/ofx020.PMC5414013.pdf
Available at: http://www.segeplan.gob.gt/2.0/images/pdf/informe%20odm.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e7/67/ofx020.PMC5414013.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/67/ofw272.PMC5414014.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/85/ofw260.PMC5414016.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/ec/ofw262.PMC5414019.pdf
Available at: http://www.actuarialsociety.org.za/Societyactivities/CommitteeActivities/ DemographyEpidemiologyCommittee/Models.aspx.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/ofw262.PMC5414019.pdf
Available at: http://www.hsrc.ac.za/uploads/pageNews/72/SANHANES- launch%20edition%20(online%20version).pdf .,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/ofw262.PMC5414019.pdf
Available at: http://www.statssa.gov.,OADS,/arxiv_data1/oa_pdf/d6/ec/ofw262.PMC5414019.pdf
Available at: http://www.who.int/ influenza/resources/documents/influenza_surveillance_manual/en/.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/ofw262.PMC5414019.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/e8/ofx021.PMC5414020.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/a9/ofw239.PMC5414023.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/35/ofx008.PMC5414024.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/a5/ofx017.PMC5414025.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/da/ofx011.PMC5414026.pdf
2016; Available at: https://www.cms.gov/medicare-coverage-database .,OADS,/arxiv_data1/oa_pdf/d5/da/ofx011.PMC5414026.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/03/ofx009.PMC5414027.pdf
Available at: http://www.alinia.com/images/Alinia-Prescribing-Information.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fa/03/ofx009.PMC5414027.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/9c/ofw278.PMC5414028.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licens- es/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in  any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/21/ofw275.PMC5414029.pdf
Available at: http://www.fda.gov/down- loads/Drugs/.../Guidances/UCM174090.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8b/21/ofw275.PMC5414029.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/  by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/d7/ofw257.PMC5414031.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/28/ofw281.PMC5414046.pdf
Available at: https://fred.stlouisfed.org/series/ CPIMEDSL.,Non-OADS,/arxiv_data1/oa_pdf/c3/28/ofw281.PMC5414046.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/ef/ofw274.PMC5414048.pdf
"All participants provided written informed consent (Trial Registration: https://clinicaltrials.gov/ct2/show/ NCT01252719?term=oritavancin&rank=6, https://clinicaltri- als.gov/ct2/show/NCT01252732?term=oritavancin&rank=7).",Non-OADS,/arxiv_data1/oa_pdf/66/ef/ofw274.PMC5414048.pdf
Available at: http://hcupnet.ahrq.gov/HCUPnet.jsp?Parms=H4sIAAAA AA  AAAEuxTPNzdQk2NEzNyzZMS0sMTkpNynGJCAhKA4PUzLTEQleX   sKTMpGIgLgGJAQAP0Gj9MwAAAAF9F36C42E3DB7294FD516624A   A628A24D0ABF881&JS=Y .,Non-OADS,/arxiv_data1/oa_pdf/66/ef/ofw274.PMC5414048.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/ofx018.PMC5414050.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/ea/ofx028.PMC5414056.pdf
FDA Drug Safety Communication: FDA warns about the risk of hepatitis B reactivating in some patients treated with  direct-acting antivirals for hepatitis C. Available at: http://www.fda.gov/Drugs/ DrugSafety/ucm522932.htm.,Non-OADS,/arxiv_data1/oa_pdf/df/ea/ofx028.PMC5414056.pdf
"HCV Guidance: recommendations for testing, managing, and treating hepatitis C. Available at: http://www.hcvguidelines.org .",Non-OADS,/arxiv_data1/oa_pdf/df/ea/ofx028.PMC5414056.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/eb/ofw263.PMC5414059.pdf
Available at: http://promedmail.org/direct.php?id=20160422.4174904.,Non-OADS,/arxiv_data1/oa_pdf/38/eb/ofw263.PMC5414059.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/93/ofw280.PMC5414060.pdf
"Geocoding the latitude and longitude of case addresses and  homeless shelter locations extracted from the Homeless Shelter Directory (http://www.homelessshelterdirectory.org/cgi-bin/id/city.cgi?city=Atlanta&state=GA) was performed using ArcGIS 10.2.2 (ESRI, Redlands, CA) using reference data from Topologically Integrated Geographic Encoding and Referencing (TIGER)/Line shapefiles (www.census.gov).",OADS,/arxiv_data1/oa_pdf/13/93/ofw280.PMC5414060.pdf
Available at: https://www.cdc.gov/tb/statistics/reports/2013/default.,OADS,/arxiv_data1/oa_pdf/13/93/ofw280.PMC5414060.pdf
"2 The primary source of information on the Icelandic LC cases is the Icelandic Cancer Registry, which covers the entire population ofIceland (http://www.cancerregistry.is).",Non-OADS,/arxiv_data1/oa_pdf/ae/26/mp201613a.PMC5414061.pdf
"Available at: http://www.who.int/tobacco/mpower/mpower_report_full_2008.pdf Accessed February 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ae/26/mp201613a.PMC5414061.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Missense mutation in CHRNA4 TE Thorgeirsson et al 600 Molecular Psychiatry (2016), 594 –600 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/ae/26/mp201613a.PMC5414061.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Age of onset modi ﬁer mutations in PSEN1 E280A Alzheimer ’s disease JI Vélez et al 924 Molecular Psychiatry (2016), 916 –924 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/a8/f8/mp2015177a.PMC5414071.pdf
Available at http://cran.r-project.org/web/packages/gamm4/index.,Non-OADS,/arxiv_data1/oa_pdf/a2/7a/mp201570a.PMC5414073.pdf
Available at http://www.R-project.org (accessed 10 November 2011).,Non-OADS,/arxiv_data1/oa_pdf/a2/7a/mp201570a.PMC5414073.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Autism risk associated with parental age S Sandin et al 700 Molecular Psychiatry (2016), 693 –700 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/a2/7a/mp201570a.PMC5414073.pdf
"Generated sequence data (fastq ﬁles) were processed by using the pipeline with BWA-MEM 30(version 0.7.5a), SAMtools,31 Picard (version 1.92, http://picard.sourceforge.net/) and GATK32 (version 2.6 –4).",OADS,/arxiv_data1/oa_pdf/27/98/mp201669a.PMC5414074.pdf
"This was because, Total coding length of the first quartile of intolerant genes Total coding length of all genes¼0:38 : We obtained the data of coding length for each gene assigned for RVIS using UCSC Table Browser (https://genome.ucsc.edu/cgi-bin/ hgTables) and calculated that Total coding length of the first percentile of intolerant genes Total coding length of all genes¼0:04 : Therefore if a mutation is randomly generated, the probabilities to hit the ﬁrst percentile and the ﬁrst quartile of the intolerant genes are 4% and 38%, respectively.",OADS,/arxiv_data1/oa_pdf/27/98/mp201669a.PMC5414074.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Exome sequencing points to de novo mutations in BD M Kataoka et al 893 © 2016 Macmillan Publishers Limited Molecular Psychiatry (2016), 885 –893",Non-OADS,/arxiv_data1/oa_pdf/27/98/mp201669a.PMC5414074.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Depressive episodes in mice with mtDNA deletions in PVT T Kasahara et al 48 Molecular Psychiatry (2016), 39 –48 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/2b/60/mp2015156a.PMC5414076.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/9a/ofw047.PMC5414081.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/1f/9a/ofw047.PMC5414081.pdf
In program and abstracts ofthe 2015 AASLD Liver Meeting (San Francisco) Hepatology 2015: 1390A-1391A.Available at: https://www.aasld.org/sites/default/ ﬁles/TLM-2015-LateBreaking Abstracts.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1f/9a/ofw047.PMC5414081.pdf
Available at: http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1f/9a/ofw047.PMC5414081.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017Role of MiR-137 in brain function E Mahmoudi and MJ Cairns 55 Molecular Psychiatry (2017), 44 –55",Non-OADS,/arxiv_data1/oa_pdf/83/82/mp2016150a.PMC5414082.pdf
Available at http://homepages.unituebingen.de/ ﬂorian.,Non-OADS,/arxiv_data1/oa_pdf/e1/06/mp2015169a.PMC5414084.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Alternating patterns of limbic activity in PTSD G Ritov et al 641 © 2016 Macmillan Publishers Limited Molecular Psychiatry (2016), 630 –641",Non-OADS,/arxiv_data1/oa_pdf/e1/06/mp2015169a.PMC5414084.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/a3/ofx006.PMC5414085.pdf
Available at: https://www.cdc.gov/flu/professionals/ infectioncontrol/healthcaresettings.htm.,Non-OADS,/arxiv_data1/oa_pdf/b7/a3/ofx006.PMC5414085.pdf
"Clinical characteristics,neuropsychological assessment, behavioral and functional scales, andprogression to AD dementia rates for each MCI data set are shown inTable 1, Supplementary Table 1 and at http://detritus.fundacioace.com/pgs.",Non-OADS,/arxiv_data1/oa_pdf/a6/5d/mp201618a.PMC5414086.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Clusterin, polygenic scores and Alzheimer ’s A Lacour et al 160 Molecular Psychiatry (2017), 153 –160",Non-OADS,/arxiv_data1/oa_pdf/a6/5d/mp201618a.PMC5414086.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licens - es/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/98/ofw219.PMC5414088.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/df/ofx013.PMC5414090.pdf
A full list of contributing groups can befound at http://exac.broadinstitute.org/about.,Non-OADS,/arxiv_data1/oa_pdf/9a/7f/mp2014193a.PMC5414091.pdf
"Web Resources1000 Genomes Project Consortium, http://www.1000genomes.org/data.",OADS,/arxiv_data1/oa_pdf/9a/7f/mp2014193a.PMC5414091.pdf
"SplazerS, http://www.seqan.de/projects/splazers.html.",Non-OADS,/arxiv_data1/oa_pdf/9a/7f/mp2014193a.PMC5414091.pdf
"SnpStore, http://www.seqan.de/projects/snpstore.html.Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/omim.PolyPhen2, http://genetics.bwh.harvard.edu/pph2/.SIFT, http://sift.jcvi.org/.NHLBI Exome Variant Server (ESP6500), http://evs.gs.washington.edu/EVS/.dbSNP135, dbSNP138, http://www.ncbi.nlm.nih.gov/snp.",Non-OADS,/arxiv_data1/oa_pdf/9a/7f/mp2014193a.PMC5414091.pdf
"Ingenuity tool, http://www.ingenuity.com.",Non-OADS,/arxiv_data1/oa_pdf/9a/7f/mp2014193a.PMC5414091.pdf
"HOPE server, http://www.cmbi.ru.nl/hope/home.shRNA designer tools, http://france.promega.com/resources/tools/.Decipher, http://decipher.sanger.ac.uk/.",Non-OADS,/arxiv_data1/oa_pdf/9a/7f/mp2014193a.PMC5414091.pdf
"RNAi Consortium (TCR) shRNA Library, http://www.broadinstitute.org/rnai/trc/lib.MutationTaster, http://www.mutationtaster.org/.The Human Gene Mutation Database, http://www.hgmd.org/.",OADS,/arxiv_data1/oa_pdf/9a/7f/mp2014193a.PMC5414091.pdf
"Exome Aggregation Consortium (ExAC), Cambridge, MA, http://exac.broadinstitute.org/.",OADS,/arxiv_data1/oa_pdf/9a/7f/mp2014193a.PMC5414091.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Novel X-linked intellectual disability genes HH u et al 148 Molecular Psychiatry (2016), 133 –148 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/9a/7f/mp2014193a.PMC5414091.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licens- es/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in  any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/f2/ofw216.PMC5414092.pdf
(http://www.mix-for- meta-analysis.info).,OADS,/arxiv_data1/oa_pdf/67/ae/mp201674a.PMC5414093.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Review and meta-analyses in adults with ADHD C Bonvicini et al 884 Molecular Psychiatry (2016), 872 –884",Non-OADS,/arxiv_data1/oa_pdf/67/ae/mp201674a.PMC5414093.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/29/ofw273.PMC5414095.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/c2/ofx022.PMC5414097.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/  by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/93/ofw236.PMC5414098.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/89/ofw215.PMC5414099.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/cb/ofx007.PMC5414100.pdf
Available at: http://www.pref.miyazaki.lg.jp/contents/org/honbu/ toukei/jinko-setai/kako2.html .Accessed 8 March 2016.,Non-OADS,/arxiv_data1/oa_pdf/98/cb/ofx007.PMC5414100.pdf
Available at: http://api-net.jfap.or.jp/status/2010/10nenpo/nenpo_menu.htm.,OADS,/arxiv_data1/oa_pdf/98/cb/ofx007.PMC5414100.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licens - es/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/3b/ofw238.PMC5414101.pdf
Available at: https://www.cdc.gov/nchs/data/nhds/2aver - age/2010ave2_firstlist.pdf .,OADS,/arxiv_data1/oa_pdf/93/3b/ofw238.PMC5414101.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/b3/ofw246.PMC5414102.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/54/ofw250.PMC5414105.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/2d/ofx027.PMC5414106.pdf
Available at: http://www.cdc.gov/tularemia/publiche- althofficials/index.html .,Non-OADS,/arxiv_data1/oa_pdf/68/2d/ofx027.PMC5414106.pdf
Available at: http://wwwn.cdc.gov/NNDSS/script/casedef.,OADS,/arxiv_data1/oa_pdf/68/2d/ofx027.PMC5414106.pdf
Available at: http://www.arupconsult.com/ Topics/Tularemia.html?client_ID=LTD .,Non-OADS,/arxiv_data1/oa_pdf/68/2d/ofx027.PMC5414106.pdf
Available at: http://ltd.aruplab.com/tests/pub/2005350.,Non-OADS,/arxiv_data1/oa_pdf/68/2d/ofx027.PMC5414106.pdf
Available at: http://www.mayomedicallaboratories.com/test-catalog/ Overview/91552.,Non-OADS,/arxiv_data1/oa_pdf/68/2d/ofx027.PMC5414106.pdf
Available at: https://www.cdc.gov/tularemia/statistics/state.,Non-OADS,/arxiv_data1/oa_pdf/68/2d/ofx027.PMC5414106.pdf
Available at: https://www.cdc.gov/rmsf/ stats/index.html .,OADS,/arxiv_data1/oa_pdf/68/2d/ofx027.PMC5414106.pdf
Available at: https://www.cdc.gov/ehrlichiosis/stats/index.html .,Non-OADS,/arxiv_data1/oa_pdf/68/2d/ofx027.PMC5414106.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/0e/ofx016.PMC5414107.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/f9/ofw266.PMC5414108.pdf
Avalable at: http://www.micro- medexsolutions.com.,Non-OADS,/arxiv_data1/oa_pdf/46/f9/ofw266.PMC5414108.pdf
Available at: http://www.health.ny.gov/health_care/medicaid/program/dur/meetings/2015/02/sum_0226_15_durbs.,Non-OADS,/arxiv_data1/oa_pdf/46/f9/ofw266.PMC5414108.pdf
Available at: http://meps.ahrq.gov/mepsweb/.,OADS,/arxiv_data1/oa_pdf/46/f9/ofw266.PMC5414108.pdf
Available at: http://oig.hhs.gov/oei/reports/oei-05-05- 00240.pdf .,Non-OADS,/arxiv_data1/oa_pdf/46/f9/ofw266.PMC5414108.pdf
Available at: http://www.fda.gov/Drugs/DrugSafety/ucm468634.htm.,Non-OADS,/arxiv_data1/oa_pdf/46/f9/ofw266.PMC5414108.pdf
Available at: http://www.chlpi.org/wp-content/uploads/2013/12/HCV-Report-Card-National-Summary_FINAL.,Non-OADS,/arxiv_data1/oa_pdf/46/f9/ofw266.PMC5414108.pdf
Available at: http://www.dailybusinessreview.com/id=1202767146286/ Insurer-Expands-Hepatitis-Cure-Coverage-to-Settle-Nationwide-Class-Action?slreturn=20160821164916.,Non-OADS,/arxiv_data1/oa_pdf/46/f9/ofw266.PMC5414108.pdf
Availble at: http://www.gilead.com/~/media/Files/pdfs/medicines/liver-disease/harvoni/harvoni_pi.pdf .,Non-OADS,/arxiv_data1/oa_pdf/46/f9/ofw266.PMC5414108.pdf
Available at: http://www.cms.gov/Medicare/ Medicare-Fee-for-Service-Payment/PhysicianFeeSched/index.html?redirect=/PhysicianFeeSched .,Non-OADS,/arxiv_data1/oa_pdf/46/f9/ofw266.PMC5414108.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/11/ofw279.PMC5414109.pdf
An alternative test algorithm for poliovirus isolation and characterization  Available at: http://www.who.int/immunization_monitoring/Supplement_polio_ lab_manual.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/11/ofw279.PMC5414109.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/  by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/95/ofw277.PMC5414110.pdf
"The Sequencher program (Gene Codes Corporation, Ann Arbor, MI; http://www.genecodes.com) was used to analyze the  derived sequence data.",OADS,/arxiv_data1/oa_pdf/6e/95/ofw277.PMC5414110.pdf
Sequence data were compared with sequences available in GenBank (http://www.ncbi.nlm.nih.gov)  using the BLASTN program and both the nucleotide collection  (nr/nt) and 16S rRNA sequence databases.,OADS,/arxiv_data1/oa_pdf/6e/95/ofw277.PMC5414110.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/d7/ofw276.PMC5414112.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/8a/ofw225.PMC5414113.pdf
"The curriculum, including learn-ing objectives, learning module, interactive case vignettes, and instructor materials, are freely available for access at the follow- ing site: http://tiny.ucsf.edu/stewardship .",Non-OADS,/arxiv_data1/oa_pdf/93/8a/ofw225.PMC5414113.pdf
Available at: https://ipecollaborative.org/uploads/IPEC-2016-Updated-Core- Competencies-Report__final_release_.PDF .,Non-OADS,/arxiv_data1/oa_pdf/93/8a/ofw225.PMC5414113.pdf
Available at: https://www.acpe-accredit.org/pdf/ Standards2016FINAL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/93/8a/ofw225.PMC5414113.pdf
Available at: http://www.msera.org/ publications-rits.html .,Non-OADS,/arxiv_data1/oa_pdf/93/8a/ofw225.PMC5414113.pdf
Available at:  https://www.whitehouse.gov/sites/default/files/docs/carb_national_strategy.pdf .,Non-OADS,/arxiv_data1/oa_pdf/93/8a/ofw225.PMC5414113.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/30/ofw249.PMC5414114.pdf
Available at: https://clinicaltrials.gov/ct2/show/NCT02130986.,Non-OADS,/arxiv_data1/oa_pdf/1c/30/ofw249.PMC5414114.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/43/ofw235.PMC5414115.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/6f/sjw147.PMC5414208.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/28/omx019.PMC5414390.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/b5/omx018.PMC5414391.pdf
Available from: http://www.krueger.ca/downloads/skincancer.,Non-OADS,/arxiv_data1/oa_pdf/41/07/ABR-6-39.PMC5414406.pdf
Available from: http://www.neopterin.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/AMHSR-6-274.PMC5414438.pdf
Available from: http://www.tibbenabawi.,Non-OADS,/arxiv_data1/oa_pdf/7e/26/PRev-11-13.PMC5414449.pdf
"MeSH Keywords:  Anticonvulsants • Critical Care • Dialysis • Hemofiltration • Pharmacokinetics  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/902709Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Clinical Pharmacy, University of Colorado Skaggs School of  Pharmacy and Pharmaceutical Sciences, Aurora, CO, U.S.A. 2 Department of Neurosurgery, University of Colorado School of Medicine, Aurora,  CO, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 458-462 DOI: 10.12659/AJCR.902709 458 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/c1/cd/amjcaserep-18-458.PMC5414484.pdf
"The evaluation also included the use of the Danish translations of the WHO-QoL BREF ( http://www.cure4you.dk/960/WHOQoL- Bref%20-%20dansk.pdf ;http://depts.washington.edu/seaqol/ docs/WHOQOL-BREF%20with%20scoring%20instructions_ Updated%2001 –10–14.pdf ) and the WHO-5 well-being score ( https://www.psykiatri-regionh.dk/who-5/Documents/ WHO5_Danish.pdf ; Topp et al., 2015).",Non-OADS,/arxiv_data1/oa_pdf/5b/fe/mrr-40-175.PMC5414540.pdf
"2.2 2.1 0.84Overall Quality of Life and General Health –Questions 1,2 b6.8 6.8 1.0 Domain I (physical) Questions 3,4,10,15,16,17,18b25.0 24.3 0.78 Domain II (Psychological) Questions 5,6,7,11,19,26b22.0 23.0 0.68 Domain III (social relationships) Questions 20,21,22b10.5 10.6 0.97 Domain IV (environment) Questions 8,9,12,13,14,23,24,25b29.7 28.0 0.31 WHO-5 well-being score (all questions rated 5 to 0) Over the past 2 weeks I have felt cheerful and in good spirits 3.3 3.3 0.87I have felt calm and relaxed 3.3 3.4 1.0 I have felt active and vigorous 2.4 2.2 0.87 I woke up feeling fresh and rested 2.8 2.3 0.57 My daily life has been filled with things that interest me 3.0 3.1 0.93 Final score c58.0 57.3 0.87 aThe tests are performed with the Mann –Whitney test using http://vassarstats.net/for direct import/entry of data for analyses.",Non-OADS,/arxiv_data1/oa_pdf/5b/fe/mrr-40-175.PMC5414540.pdf
bhttp://depts.washington.edu/seaqol/docs/WHOQOL-BREF%20with%20scoring%20instructions_Updated%2001 –10–14.pdf .,OADS,/arxiv_data1/oa_pdf/5b/fe/mrr-40-175.PMC5414540.pdf
"Heavy popper users and respective control groups had similar time-varying CD4þand CD8þcell counts, CD4þ/CD8þratios, percentage with viral load more than 400 copies/ml (at or above the limit of detection of the available test at some earlier visits), and antiretroviral therapy use (Table 1) and similar mean CD4þcell counts across calendar years 1996–2010 (Supplemental Digital Content 2, http://links.lww.com/ QAD/B60).",Non-OADS,/arxiv_data1/oa_pdf/35/71/aids-31-1169.PMC5414542.pdf
"42 http://www.opensmiles.org.43 G. Landrum, http://www.rdkit.org.44 J. Behler, Phys.",Non-OADS,/arxiv_data1/oa_pdf/21/84/SC-008-C6SC05720A.PMC5414547.pdf
"47 http://developer.nvidia.com/cublas.48 T. Poggio and F. Girosi, Science , 1990, 24–7, 978 –982.",Non-OADS,/arxiv_data1/oa_pdf/21/84/SC-008-C6SC05720A.PMC5414547.pdf
"7 In January 2017, the average prices of Rh, Ir, Pd and Ru were 795, 690, 761, and 42 US$/oz, https://taxfreegold.co.uk,accessed 10/1/2017.",Non-OADS,/arxiv_data1/oa_pdf/36/6c/SC-008-C7SC00156H.PMC5414548.pdf
"This is an Open Access article distrib uted under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/88/evx070.PMC5414570.pdf
"An additional 24 studies were included, resulting in a pooled dataset comprising 30 164 individuals monitored during 1979– 2014 across 25 countries (Table S1, http://links.lww.",OADS,/arxiv_data1/oa_pdf/dd/bb/aids-31-1073.PMC5414573.pdf
"S1, http://links.lww.com/QAD/B52).",Non-OADS,/arxiv_data1/oa_pdf/dd/bb/aids-31-1073.PMC5414573.pdf
URL http://www.R-project.org/) [21].,Non-OADS,/arxiv_data1/oa_pdf/dd/bb/aids-31-1073.PMC5414573.pdf
"Removing observations occurring after a clinical AIDS diagnosis results in qualitatively similar ﬁndings, although survival estimates are shorter by an average of 10 months (Table S3, http://links.lww.com/ QAD/B52).",Non-OADS,/arxiv_data1/oa_pdf/dd/bb/aids-31-1073.PMC5414573.pdf
"Model assessment There is substantial misclassiﬁcation between observed and underlying states in the intermediate stages of disease as expected, given the narrow ranges of these states and the high variability in individual CD4þcell dynamics (Table S4, http://links.lww.com/QAD/B52).",Non-OADS,/arxiv_data1/oa_pdf/dd/bb/aids-31-1073.PMC5414573.pdf
"S2, http://links.lww.com/QAD/B52).Discussion We used the largest database to date of seroconverters infected with HIV-1 to jointly estimate the rates of immune function decline and survival across four continents, thus providing the most comprehensive1078 AIDS 2017, Vol 31 No 8 Table 5.",Non-OADS,/arxiv_data1/oa_pdf/dd/bb/aids-31-1073.PMC5414573.pdf
"S3, http://links.lww.com/QAD/ B52).",Non-OADS,/arxiv_data1/oa_pdf/dd/bb/aids-31-1073.PMC5414573.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/41/78/ijnrd-10-085.PMC5414574.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/41/78/ijnrd-10-085.PMC5414574.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2017:10 85–90International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 85 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S128417 Education and screening for chronic kidney  disease in Indian youth: pilot program results Panduranga S Rao1  Julie A Wright Nunes1  Brenda W Gillespie2  Rachel L Perlman1  Rajan Ravichandran3 1Division of Nephrology, Department  of Internal Medicine, University of  Michigan Health System, 2Department  of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA;  3Department of  Nephrology, Madras Institute of Nephrology, Madras Institute of Orthopedics and Trauma Hospitals,  Chennai, IndiaBackground: There is a paucity of information on kidney education and screening programs  in Indian youth.",Non-OADS,/arxiv_data1/oa_pdf/41/78/ijnrd-10-085.PMC5414574.pdf
"Although some debate exists about how to most effectively identify and educate  persons with CKD in general populations, 4 research shows that early identification Correspondence: Julie A Wright Nunes   Division of Nephrology, Department of  Internal Medicine, University of Michigan Health System, 102 Observatory Road, Simpson Memorial Building, Ann Arbor, MI 48109, USA Tel +1 734 615 3994   Fax +1 734 615 4887   Email juwright@med.umich.eduJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Rao et alRunning head recto: Screening for CKD risk factors in Indian youthDOI: http://dx.doi.org/10.2147/IJNRD.S128417",Non-OADS,/arxiv_data1/oa_pdf/41/78/ijnrd-10-085.PMC5414574.pdf
"International Journal of Nephrology and Renovascular Disease 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/41/78/ijnrd-10-085.PMC5414574.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 90 Rao et al References  1.,Non-OADS,/arxiv_data1/oa_pdf/41/78/ijnrd-10-085.PMC5414574.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/af/e5/cmar-9-149.PMC5414575.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/af/e5/cmar-9-149.PMC5414575.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 149–158Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  149 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S125245Patient and physician preferences for anticancer  drugs for the treatment of metastatic colorectal  cancer: a discrete-choice experiment Juan Marcos González1  Sarika Ogale2  Robert Morlock2  Joshua Posner1  Brett Hauber1  Nicolas Sommer2  Axel Grothey3 1Health Preference Assessment  Department, RTI Health Solutions,   Research Triangle Park, NC,   2Genentech, South San Francisco, CA,   3Division of Medical Oncology, Mayo  Clinic, Rochester, MN, USAObjective: Many publications describe preferences for colorectal cancer (CRC) screening;  however, few studies elicited preferences for anticancer-drug treatment for metastatic CRC  (mCRC).",Non-OADS,/arxiv_data1/oa_pdf/af/e5/cmar-9-149.PMC5414575.pdf
"1 Two groups of targeted  anticancer drugs for metastatic CRC (mCRC), targeting either the vascular endothelial growth factor (VEGF) receptor or the epidermal growth factor receptor (EGFR), have Correspondence: Brett Hauber RTI Health Solutions, 200 Park Office Drive, Research Triangle Park, NC 27709, USATel +1 919 597 5149Fax +1 919 541 7222Email abhauber@rti.orgJournal name: Cancer Management and Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: González et alRunning head recto: Preferences for anticancer drugs for metastatic colorectal cancerDOI: http://dx.doi.org/10.2147/CMAR.S125245",Non-OADS,/arxiv_data1/oa_pdf/af/e5/cmar-9-149.PMC5414575.pdf
Available from: http://www.cancer.org/cancer/colonan-drectumcancer/detailedguide/colorectal-cancer-key-statistics.,Non-OADS,/arxiv_data1/oa_pdf/af/e5/cmar-9-149.PMC5414575.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/af/e5/cmar-9-149.PMC5414575.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 158 González et al 12.,Non-OADS,/arxiv_data1/oa_pdf/af/e5/cmar-9-149.PMC5414575.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c9/d1/jaa-10-141.PMC5414576.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c9/d1/jaa-10-141.PMC5414576.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 141–151Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 141 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S113612Sesame allergy: current perspectives Adil Adatia1  Ann Elaine Clarke2  Yarden Yanishevsky3  Moshe Ben-Shoshan4 1Department of Medicine, University  of Alberta, Edmonton, 2Division  of Rheumatology, Department  of Medicine, Cumming School of Medicine, University of Calgary,  Calgary,  3Section of Allergy and  Clinical Immunology, Department of Pediatrics, University of Alberta,  Edmonton, AB,  4Division of Pediatric  Allergy and Clinical Immunology,  Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Centre, Montreal, QC, CanadaAbstract:  Sesame is an important global allergen affecting ~0.1% of the North American  population.",Non-OADS,/arxiv_data1/oa_pdf/c9/d1/jaa-10-141.PMC5414576.pdf
"8–10 In this systematic review, we assess the literature published in the last 10 years  regarding sesame allergy with a focus on the diagnosis and management of this important global allergen.Correspondence: Moshe Ben-Shoshan Division of Allergy and Clinical Immunology, Department of Pediatrics, Montreal Children’s Hospital,   1001 Decarie, Montreal, QC H4A 3J1, Canada   Tel +1 514 412 4400 ext 24470   Fax +1 514 228 1197 Email moshebenshoshan@gmail.comJournal name: Journal of Asthma and Allergy Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Adatia et alRunning head recto: Sesame allergyDOI: http://dx.doi.org/10.2147/JAA.S113612",Non-OADS,/arxiv_data1/oa_pdf/c9/d1/jaa-10-141.PMC5414576.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/c9/d1/jaa-10-141.PMC5414576.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ab/f0/ijwh-9-265.PMC5414577.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 265–272International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  265RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S12901 7 Reproductive and hormonal risk factors of breast  cancer: a historical perspective Julie Horn1,2 Lars J vatten1 1Department of Public Health  and Nursing, Faculty of Medicine  and Health Sciences, Norwegian  University of Science and T echnology,   Trondheim, Norway; 2Department of  Gynecology and Obstetrics, Levanger  Hospital, Nord-Trøndelag Hospital  Trust, Levanger, NorwayAbstract:  The complexity of breast cancer etiology has puzzled scientists for more than  300 years.",Non-OADS,/arxiv_data1/oa_pdf/ab/f0/ijwh-9-265.PMC5414577.pdf
"One  chapter, entitled “Diseases of wet-nurses,” is devoted to the relationship between the  uterus and the breasts or – to use Ramazzini’s expression: “this marvelous sympathy Correspondence: Julie Horn Department of Public Health and  Nursing, Faculty of Medicine and Health  Sciences, Norwegian University of  Science and Technology, Håkon Jarls gate  11, N-7489 Trondheim, Norway Tel +47 74 07 51 85 email julie.horn@ntnu.n o Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2017 Volume: 9 Running head verso: Horn and Vatten Running head recto: Breast cancer: reproductive and hormonal risk factors DOI: http://dx.doi.org/10.2147/IJWH.S129017",Non-OADS,/arxiv_data1/oa_pdf/ab/f0/ijwh-9-265.PMC5414577.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ab/f0/ijwh-9-265.PMC5414577.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/f0/ijwh-9-265.PMC5414577.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2017:10 135–142Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 135 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S128161Uniform-related infection control practices   of dental students Yazan Aljohani1 Mohammed Almutadares1 Khalid Alfaifi1 Mona El Madhoun1 Maysoon H Albahiti2 Nadia Al-Hazmi3 1Internship Program, Faculty of  dentistry, King Abdulaziz University,   2Department of Endodontics, King  Abdulaziz University, 3Department  of Oral Biology, King Abdulaziz  University,  Faculty of Dentistry,   Jeddah, Saudi ArabiaBackground: Uniform-related infection control practices are sometimes overlooked and  underemphasized.",Non-OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
"Box 80498, Jeddah 21589, Saudi Arabia Tel +966 5 0637 8349Email nalhazmi@kau.edu.saJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Aljohani et alRunning head recto: Infection control and dental uniformsDOI: http://dx.doi.org/10.2147/IDR.S128161",Non-OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
Both documents are available for download on the institute’ s website (http://dentistry.kau.edu.sa/content.aspx?Site_ID=165&lng=AR&cid=43775&URL=www.kau.edu.sa).,Non-OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
"Infection and Drug Resistance  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 142 Aljohani et al Acknowledgments The authors express their gratitude to the students who agreed  to participate in this work by providing their honest answers and time amidst their busy schedules.,Non-OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
Available from: https://www.cdsbc.org/practice-resources/professional-practice/standards-and-guidelines/infection-prevention-and-control-guidelines.,Non-OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
Available from: http://dentistry.kau.edu.sa/content.aspx?Site_ID=165&lng=AR&cid=43775&URL=www.kau.edu.sa.,Non-OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
"Available from: https://www.google.co.nz/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahUKEwinjeKM-ffSAhWLXbwKHRtTAg8QFggYMAA&url=http%3A%2F%2Fwww.ncuh.nhs.uk%2Fabout-us%2Ffreedom-of-information%2Fdisclosure-log%2Frequests%2Finfection-control%2F000771-09.pdf&usg=AFQjCNHMRICS7ial2cqPfR4osM9XS0Z2fg&sig2=vZiovDaW6CkF8BEGefxQFQ&bvm=bv.150729734,d.dGc.",OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
Available from: http://dentistry.kau.edu.sa/content.aspx?Site_ID=165&lng=AR&cid=43775&URL=www.kau.edu.sa.,Non-OADS,/arxiv_data1/oa_pdf/06/4b/idr-10-135.PMC5414578.pdf
"https://doi.org/10.1177/1177932217704667Bioinformatics and Biology Insights Volume 11:  1–17 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177932217704667 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction The transition into lactation is a volatile period in dairy cow  health, largely due to the shifts in energy demands and nutrient partitioning that occur after calving.",Non-OADS,/arxiv_data1/oa_pdf/e0/44/10.1177_1177932217704667.PMC5414586.pdf
"MeSH Keywords:  Carcinoma in Situ • Carcinoma, Non-Small-Cell Lung • Platinum Compounds • Polymorphism, Genetic  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904156Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Thoracic Oncology, Tumor Hospital Affiliated to Xinjiang Medical  University, Urumqi, Xinjiang, P.R.",Non-OADS,/arxiv_data1/oa_pdf/21/db/medscimonit-23-1999.PMC5414593.pdf
"MeSH Keywords:  Heart Diseases • Myocardial Infarction • Phytochemicals  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902196Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Cardiology, The First Peoples Hospital of Tianmen City, Tianmen,  Hubei, P.R.",Non-OADS,/arxiv_data1/oa_pdf/86/c6/medscimonit-23-2007.PMC5414594.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ba/b2/ott-10-2315.PMC5414612.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2315–2321OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2315Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OTT .S13551 4 Identification of potential biomarkers and analysis  of prognostic values in head and neck squamous  cell carcinoma by bioinformatics analysis Bo Yang* Zhifeng Chen* Yu huang guoxu han Weizhong li Department of Oral and Maxillofacial  Surgery, Nanfang Hospital, Southern  Medical University, Guangzhou,   People’s Republic of China *These authors contributed equally  to this workAbstract:  The purpose of this study was to find disease-associated genes and potential  mechanisms in head and neck squamous cell carcinoma (HNSCC) with deoxyribonucleic  acid microarrays.",Non-OADS,/arxiv_data1/oa_pdf/ba/b2/ott-10-2315.PMC5414612.pdf
"Currently, genetic and genomics research is developing rapidly, which helps us  to understand the potential mechanisms of some diseases.4,5 For example, microarray correspondence: Weizhong li Department of Oral and Maxillofacial  Surgery, Nanfang Hospital, Southern  Medical University, 1838 North  guangzhou road, guangzhou 510515,  People’s Republic of China Tel +86 20 6164 2025 Fax +86 20 8728 0183 email gzliwz@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Y ang et al Running head recto: Identification of potential biomarkers and analysis of prognostic values DOI: http://dx.doi.org/10.2147/OTT.S135514",Non-OADS,/arxiv_data1/oa_pdf/ba/b2/ott-10-2315.PMC5414612.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets­and­therapy­journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ba/b2/ott-10-2315.PMC5414612.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/b2/ott-10-2315.PMC5414612.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ef/2f/oarrr-9-081.PMC5414613.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ef/2f/oarrr-9-081.PMC5414613.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2017:9 81–90Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 81 ORiginAl ReseARch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S134780 Determining early referral criteria for patients  with suspected inflammatory arthritis presenting  to primary care physicians: a cross‑sectional study hani Almoallim1–3 nahid Janoudi2 suzan M Attar4 Mohammed garout5 shereen Algohary3 Muhammad irfanullah  siddiqui5 hanan Alosaimi3 Ashraf ibrahim3 Amira Badokhon6 Zaki Algasemi7 1Department of Medicine, Medical  college, Umm Alqura University,   Makkah, 2Department of Medicine,   Dr. soliman Fakeeh hospital,   Jeddah, 3Alzaidi chair of Research  in Rheumatic Diseases, Medical college, Umm Alqura University,  Makkah,  4Department of Medicine,   King Abdulaziz University, Jeddah,   5Department of community Medicine  and Public health, Umm Alqura  University, Makkah, 6Administration  of Public health, Ministry of health,   Jeddah, 7Joint Program of Family and  community Medicine, Ministry of health, Jeddah, Kingdom of saudi  ArabiaObjective: Early diagnosis and initiation of treatment for inflammatory arthritis can greatly  improve patient outcome.",Non-OADS,/arxiv_data1/oa_pdf/ef/2f/oarrr-9-081.PMC5414613.pdf
"6,7 Therefore, there is a need to optimize the process of transition from  the primary care center to the specialist in order to achieve a timely diagnosis.7,8 Whilst  previous studies have outlined potential criteria that could aid a PCP in identifying patients who require early referral to a rheumatology service, these have been based correspondence: hani Almoallim Department of Medicine, Medical college, Umm Alqura University, PO Box 1821, Jeddah 21441, Kingdom of saudi ArabiaTel +966 12 50570 3935Fax +966 12 527 0000 ext 7110email hmmoallim@uqu.edu.saJournal name: Open Access Rheumatology: Research and Reviews Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: Almoallim et alRunning head recto: Early referral criteria for inflammatory arthritisDOI: http://dx.doi.org/10.2147/OARRR.S134780",Non-OADS,/arxiv_data1/oa_pdf/ef/2f/oarrr-9-081.PMC5414613.pdf
Available from: http://www.kck.usm.my/ppsg/statistical_resources/sample-size_forsensitivity_specificitystudiesLinNaing.xls.,OADS,/arxiv_data1/oa_pdf/ef/2f/oarrr-9-081.PMC5414613.pdf
"Open Access Rheumatology: Research and Reviews 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open‑access‑rheumatology‑research‑and‑reviews‑journalOpen Access Rheumatology: Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: Pathology, pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ef/2f/oarrr-9-081.PMC5414613.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 90 Almoallim et al,Non-OADS,/arxiv_data1/oa_pdf/ef/2f/oarrr-9-081.PMC5414613.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 307–315Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 307 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S131043 Assessment of residency program outcomes   via alumni surveys Sonja Lüer   Christoph Aebi Department of Pediatrics, Bern  University Hospital, Inselspital,  University of Bern, Bern, SwitzerlandBackground: One trend in medical education is outcomes-oriented training.",Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
"2 Correspondence: Sonja Lüer Department of Pediatrics, Bern University Hospital, Inselspital,  University of Bern, 3010 Bern, SwitzerlandTel +41 31 632 2111Email Sonja.Lueer@insel.chJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Lüer and AebiRunning head recto: Assessment of residency program outcomes via alumni surveysDOI: http://dx.doi.org/10.2147/AMEP .S131043",Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
"Publicly available statistics software (http://vassarstats.net), Microsoft Word and Excel, Adobe Acrobat and Reader, as well as GraphPad Prism were used for documentation, presentation, and statistical analyses.",OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
Available from: http://www.fmh.ch/bildung-siwf/fachgebiete/facharzttitel-und-schwerpunkte/kinder-und-jugendmedizin.html).,Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
Available from: http://www.siwf-register.ch/.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
Available from: http://www.fmh.ch/bildung-siwf/themen/akkreditierung.html.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
Available from: http://www.bag.admin.ch/themen/berufe/13930/13937/14377/index.html?lang= de.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 315 Assessment of residency program outcomes via alumni surveys  7.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
Available from: http://www.fmh.ch/bildung-siwf/weiterbildung/allge-mein/weiterbildungsqualitaet.html.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
Available from: http://www.fmh.ch/bildung-siwf/weiterbildung/fuer-leiter-wb-staetten/visita-tionen.html.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
"Available from: http://www.bag.admin.ch/themen/berufe/13932/15279/index.html?lang =de&download =NHzLpZeg7t,lnp6I0NTU042l2Z6ln1 acy4Zn4Z2qZpnO2Yuq2Z6gpJCMfHx6e2ym162epYbg2c_JjKbNoK-Sn6A--.",Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
Available from: http://www.fmh.ch/ambulante_tarife/tarmed-tarif.html.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/amep-8-307.PMC5414614.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7e/0c/jep-9-059.PMC5414615.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7e/0c/jep-9-059.PMC5414615.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2017:9 59–66Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  59 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S130491In vivo antiplasmodial activity evaluation of the  leaves of Balanites rotundifolia (Van Tiegh.)",Non-OADS,/arxiv_data1/oa_pdf/7e/0c/jep-9-059.PMC5414615.pdf
"5 Resistance to sulfadoxine–pyrimethamine  is also widespread, and mefloquine and quinine resistance has been reported.6 Recent Correspondence: Seyfe Asrade Department of Pharmacology, College of Medicine and Health Sciences, University of Gondar, PO Box 196, Gondar, EthiopiaTel +251 92 053 4469Fax +251 58 114 1235Email seyepharma@gmail.comJournal name: Journal of Experimental Pharmacology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Asrade et alRunning head recto: Balanites rotundifolia possesses antiplasmodial activityDOI: http://dx.doi.org/10.2147/JEP .S130491",Non-OADS,/arxiv_data1/oa_pdf/7e/0c/jep-9-059.PMC5414615.pdf
Available from: http://delta-intkey.com.,OADS,/arxiv_data1/oa_pdf/7e/0c/jep-9-059.PMC5414615.pdf
"Journal of Experimental Pharmacology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/7e/0c/jep-9-059.PMC5414615.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/0c/jep-9-059.PMC5414615.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/da/c5/jpr-10-973.PMC5414616.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/da/c5/jpr-10-973.PMC5414616.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 973–977Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  973 Case RePo Rt open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S129661Complex management of a patient with  refractory primary erythromelalgia lacking a  SCN9A mutation sarah a Low1 Wendye Robbins2,3 Vivianne L tawfik2 1Department of Internal Medicine,   Banner University Medical Center,   University of arizona College of  Medicine, tucson, aZ, 2Department of  anesthesiology, Perioperative & Pain Medicine, stanford University, Palo  alto,  3Blade therapeutics, south san  Francisco, C a, UsaAbstract: A 41-year-old woman presented with burning and erythema in her extremities  triggered by warmth and activity, which was relieved by applying ice.",Non-OADS,/arxiv_data1/oa_pdf/da/c5/jpr-10-973.PMC5414616.pdf
"Her pain grew more intense Correspondence: Vivianne L Tawfik Department of anesthesiology, Perioperative & Pain Medicine, stanford University, 450 Broadway street, Pavilion a, 1st Floor, Redwood City, Ca 94063, Usatel +1 650 723 6238Fax +1 650 721 3417email vivianne@stanford.eduJournal name: Journal of Pain Research  Article Designation: Case ReportY ear: 2017V olume: 10Running head verso: Low et alRunning head recto: Management of refractory erythromelalgiaDOI: http://dx.doi.org/10.2147/JPR.S129661",Non-OADS,/arxiv_data1/oa_pdf/da/c5/jpr-10-973.PMC5414616.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/da/c5/jpr-10-973.PMC5414616.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 977 Management of refractory erythromelalgia  3.,Non-OADS,/arxiv_data1/oa_pdf/da/c5/jpr-10-973.PMC5414616.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/06/15/nss-9-127.PMC5414617.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/06/15/nss-9-127.PMC5414617.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2017:9 127–133Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  127 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S103462Update on the treatment of narcolepsy: clinical  efficacy of pitolisant Michael W Calik1,2 1Department of Biobehavioral Health  Science, 2Center for Narcolepsy, Sleep  and Health Research, University of  Illinois at Chicago, Chicago, IL, United StatesAbstract:  Narcolepsy is a neurological disease that affects 1 in 2,000 individuals and is char - acterized by excessive daytime sleepiness (EDS).",Non-OADS,/arxiv_data1/oa_pdf/06/15/nss-9-127.PMC5414617.pdf
"Correspondence: Michael W Calik 845 South Damen Avenue (M/C 802), College of Nursing, Room 740, University of Illinois at Chicago, Chicago, IL 60612, USATel +1 312 413 0581Email mcalik@uic.eduJournal name: Nature and Science of Sleep Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: CalikRunning head recto: Clinical efficacy of pitolisant for narcolepsyDOI: http://dx.doi.org/10.2147/NSS.S103462",Non-OADS,/arxiv_data1/oa_pdf/06/15/nss-9-127.PMC5414617.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/06/15/nss-9-127.PMC5414617.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/06/15/nss-9-127.PMC5414617.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1201–1209Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1201OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S13081 8 connectivity to computers and the internet  among patients with schizophrenia spectrum  disorders: a cross-sectional study Maritta Välimäki1–3 lauri Kuosmanen1,4,5 heli hätönen1 Marita Koivunen1,6 anneli Pitkänen7 christina athanasopoulou1 Minna anttila1 1Department of Nursing science,   Faculty of Medicine, University of  T urku, Finland; 2Development Unit,   T urku University hospital, T urku,   Finland; 3school of Nursing, hong  Kong Polytechnic University, Kowloon,   hong Kong, sar, china; 4University  of helsinki and helsinki University  hospital, helsinki, Finland; 5social  and healthcare Department, city of  Vantaa, Vantaa, Finland; 6administrative  centre, research and Development,   satakunta hospital District, Pori,   Finland; 7administration centre,   Pirkanmaa hospital District, Tampere,   FinlandPurpose:  Information and communication technologies have been developed for a variety  of health care applications and user groups in the field of health care.",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"In general, ICTs relate to technologies that facilitate the transfer of information and  various types of electronically mediated communication.5correspondence: Maritta Välimäki Department of Nursing science, 20014  University of Turku, Turku, Finland Tel +358 40 689 0546 email mava@utu.fi  Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Välimäki et al Running head recto: Computer and the Internet use among patients with schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S130818",OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"Available from: http://ec.europa.eu/digital-agenda/en/news/factsheet- 35-i2010-strategy-innovative-and-inclusive-european-information- societ y. Accessed February 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"Available from: http://www.europarl.europa.eu/RegData/etudes/ BRIE/2015/573884/EPRS_BRI(2015)573884_EN.pd f. Accessed  February 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"Available from http://www.attitudeweb.be/doc/resources/studies/ digital_divide_in_europe.pd f. Accessed March 20, 2017.",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"Avail - able from: http://www.citizensonline.org.uk/wp-content/uploads/939_ DigitalEquality1.pd f. Accessed February 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"Available from: http://www.oecd.org/sti/ interneteconomy/46444955.pd f. Accessed February 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"Available  from: http://apps.who.int/classifications/icd10/browse/2010/e n.  Accessed February 14, 2017.",OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"Available from:  http://ec.europa.eu/research/participants/portal/doc/call/h2020/h2020- msca-itn-2015/1620147-h2020_-_guidance_ethics_self_assess_en.pd f.  Accessed February 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"[updated November 29, 2016; cited November 8, 2016]  Available from: http://ec.europa.eu/eurostat/statistics-explained/index.",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"Available from: https://www.eumonitor.nl/9353000/1/ j9vvik7m1c3gyxp/vi7jgstncku q. Accessed February 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/cb/e8/ndt-13-1201.PMC5414618.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1b/81/ott-10-2281.PMC5414625.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2281–2287OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2281Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OTT .S11043 1 Treatment-related severe and fatal adverse events  with molecular targeted agents in the treatment  of advanced gastric cancer: a meta-analysis liang Wang Yagang liu Wenyong Zhou Wei li Department of general surgery,   The central cangzhou hospital,   cangzhou, hebei Province, People’s  republic of chinaAim:  To perform a systematic review and meta-analysis of Phase III randomized controlled  trials (RCTs) to determine the incidence and risk of severe adverse events (AEs) with molecular  targeted agents (MTAs) in advanced/metastatic gastric cancer (GC) patients.",Non-OADS,/arxiv_data1/oa_pdf/1b/81/ott-10-2281.PMC5414625.pdf
"Thus, it is clear that novel treatments are badly needed in  advanced GC patients.correspondence: liang Wang Department of general surgery, The  central cangzhou hospital, cangzhou,  hebei Province 061000, People’s  republic of china Tel +86 0317 207 5646 Fax +86 0317 207 5647 email wangliang201601@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Wang et al Running head recto: AEs with MTAs in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S110431",Non-OADS,/arxiv_data1/oa_pdf/1b/81/ott-10-2281.PMC5414625.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1b/81/ott-10-2281.PMC5414625.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/81/ott-10-2281.PMC5414625.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/25/33/ndt-13-1193.PMC5414626.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1193–1200Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1193OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13131 1 risk of obstructive sleep apnea and excessive  daytime sleepiness in hospitalized psychiatric  patients Farid r Talih1 Jean J ajaltouni1 hani M Tamim2 Firas h Kobeissy3 1Department of Psychiatry,   2Department of internal Medicine,   american University of Beirut Medical  center, Beirut, lebanon; 3Department  of Biochemistry and Molecular  genetics, Faculty of Medicine,   american University of Beirut,   Beirut, lebanonObjectives:  This study evaluated the risk of developing obstructive sleep apnea (OSA)  and excessive daytime sleepiness (EDS) in hospitalized psychiatric patients at the American  University of Beirut Medical Center (AUB-MC).",Non-OADS,/arxiv_data1/oa_pdf/25/33/ndt-13-1193.PMC5414626.pdf
"Keywords:  obstructive sleep apnea, excessive daytime sleepiness, depression, anxiety,  psychiatric patients, inpatient psychiatry Introduction Recent findings indicate a potential bi-directional relationship between psychiatric  disorders and sleep disorders.1–3 Obstructive sleep apnea (OSA), the most common  type of sleep apnea, consists of repetitive episodes of upper airway obstruction  occurring during sleep.4 Upper airway obstruction in OSA is attributed to excess soft  tissue in the oropharynx, pharyngeal muscle dysfunction, or anatomical anomalies.4,5  Excessive body weight and an elevated body mass index (BMI) have been found to be  major predisposing factors for OSA.6 The prevalence of OSA is well documented in  the medical literature ranging from 5% in women to 7% in men.7 There is sparse data correspondence: Farid r Talih american University of Beirut, 3 Dag  hammarskjold Plaza, 8th Floor,  New York, NY 10017-2303, Usa email ft10@aub.edu.l b Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Talih et al Running head recto: Obstructive sleep apnea and psychiatric disorders DOI: http://dx.doi.org/10.2147/NDT.S131311",Non-OADS,/arxiv_data1/oa_pdf/25/33/ndt-13-1193.PMC5414626.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/25/33/ndt-13-1193.PMC5414626.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/33/ndt-13-1193.PMC5414626.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f2/75/mder-10-071.PMC5414627.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f2/75/mder-10-071.PMC5414627.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2017:10 71–80Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 71 PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S135378 Perspective on the Rez ūm® System: a minimally  invasive treatment strategy for benign prostatic  hyperplasia using convective radiofrequency water  vapor thermal therapy Henry H Woo1  Ricardo R Gonzalez2 1Sydney Adventist Hospital Clinical  School, The University of Sydney,   Wahroonga, NSW, Australia; 2Houston  Metro Urology, Houston, TX, USAAbstract: Convective radiofrequency (RF) water vapor thermal therapy is a minimally invasive  office or outpatient procedure for the treatment of bothersome moderate-to-severe lower urinary  tract symptoms associated with benign prostatic hyperplasia (BPH).",Non-OADS,/arxiv_data1/oa_pdf/f2/75/mder-10-071.PMC5414627.pdf
"8 Correspondence: Henry H Woo   Sydney Adventist Hospital Clinical School,  The University of Sydney, PO Box 5017, Wahroonga, NSW 2076, Australia   Tel +61 2 9473 8765   Fax +61 2 9473 8969   Email hwoo@urologist.net.auJournal name: Medical Devices: Evidence and Research Article Designation: PERSPECTIVESY ear: 2017V olume: 10Running head verso: Woo and GonzalezRunning head recto: Convective radiofrequency thermal therapy for BPHDOI: http://dx.doi.org/10.2147/MDER.S135378",Non-OADS,/arxiv_data1/oa_pdf/f2/75/mder-10-071.PMC5414627.pdf
Available from: http://www.auanet.org/common/pdf/education/clinical-guidance/Benign-Prostatic-Hyperplasia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f2/75/mder-10-071.PMC5414627.pdf
"Medical Devices: Evidence and Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/f2/75/mder-10-071.PMC5414627.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cf/07/ndt-13-1181.PMC5414628.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1181–1192Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1181OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S12709 4 Protective efficacy of a single salvianolic acid A  treatment on photothrombosis-induced sustained  spatial memory impairments Chun-Xiang Jiao1–3,* Heng Zhou1,4,* Chun-Xian Yang1,2 chen Ma1,2 Yue-Xiong Yang1,2 Rong-Rong Mao1,2 lin Xu1,2 Qi-Xin Zhou1,2 1Laboratory of Learning and Memory,   Key laboratory of animal Models and  Human Disease Mechanisms, Kunming  Institute of Zoology, CAS, Kunming,   2Kunming College of Life Sciences,   University of chinese academy  of sciences, 3Yunnan Provincial  Key Laboratory of Entomollogical  Biopharmaceutical research and  Development, College of Pharmacy  and chemistry, Dali University, Dali,   4school of life sciences, University  of Science and T echnology of China,   hefei, People’s republic of china *These authors contributed equally  to this workAbstract:  With respect to the high burden of ischemic stroke and the absence of pharmacological  treatment for promoting rehabilitation, promising candidates with specific effects on long-term  functional recovery are highly desired.",Non-OADS,/arxiv_data1/oa_pdf/cf/07/ndt-13-1181.PMC5414628.pdf
"Two commonly used animal models of Correspondence: Lin Xu; Qi-Xin Zhou Kunming Institute of Zoology, 32 Jiao- Chang Dong Road, Kunming 650223,  Yunnan, People’s republic of china Tel/fax +86 0871 6513 9165 email lxu@vip.163.co m;   qixin_zhou@126.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Jiao et al Running head recto: Salvianolic acid A and sustained cognitive deficits DOI: http://dx.doi.org/10.2147/NDT.S127094",Non-OADS,/arxiv_data1/oa_pdf/cf/07/ndt-13-1181.PMC5414628.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/cf/07/ndt-13-1181.PMC5414628.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/07/ndt-13-1181.PMC5414628.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/24/6a/oajsm-8-107.PMC5414629.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/24/6a/oajsm-8-107.PMC5414629.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2017:8 107–112Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 107 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S132275Effects of prophylactic ankle and knee braces on  leg stiffness during hopping Hiroaki Hobara Satoru Hashizume Y oshiyuki Kobayashi Human Informatics Research Institute,   National Institute of Advanced Industrial Science and T echnology,  T okyo, JapanAbstract:  During human movement, the leg can be represented as a mechanical spring, with  its stiffness potentially contributing to sports performance and injury prevention.",Non-OADS,/arxiv_data1/oa_pdf/24/6a/oajsm-8-107.PMC5414629.pdf
"Leg stiffness (K leg), which  is defined as the ratio of the peak ground reaction force to the maximum center of mass vertical displacement at the middle of the stance phase, 6 has been shown to  increase with increasing hopping height.7–9 Kleg is also correlated to agility and speed  during sprint running.10–14 Previous studies have suggested that endurance training  enhances Kleg,15,16 but that plyometrics training has a greater influence on Kleg than Correspondence: Hiroaki Hobara Digital Human Research Group, Human Informatics Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 2-3-26 Aomi, Koto-ku, Tokyo 135-0064, JapanTel +81 83 3599 8918Fax +81 83 5500 5233Email hobara-hiroaki@aist.go.jpJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Hobara et alRunning head recto: Leg stiffness with joint stabilizersDOI: http://dx.doi.org/10.2147/OAJSM.S132275",Non-OADS,/arxiv_data1/oa_pdf/24/6a/oajsm-8-107.PMC5414629.pdf
"Open Access Journal of Sports Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/24/6a/oajsm-8-107.PMC5414629.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/6a/oajsm-8-107.PMC5414629.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a6/e2/jpr-10-965.PMC5414630.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a6/e2/jpr-10-965.PMC5414630.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 965–972Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  965 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S130931The influence of clinical equipoise and patient  preferences on outcomes of conservative  manual interventions for spinal pain:  an experimental study Mark D Bishop1,2 Joel E Bialosky1–3 Charles W Penza1,2 Jason M Beneciuk1,3 Meryl J Alappattu1,2 1Department of Physical Therapy,   University of Florida, 2Center  for Pain Research and Behavioral  Health, 3Brooks-PHHP Research  Collaboration, Gainesville, FL, USABackground:  Expected pain relief from treatment is associated with positive clinical outcomes  in patients with musculoskeletal pain.",Non-OADS,/arxiv_data1/oa_pdf/a6/e2/jpr-10-965.PMC5414630.pdf
"Keywords: equipoise, expectations, manual therapy, acute pain Introduction Expected pain relief from treatment is associated with positive clinical outcomes in  patients with musculoskeletal pain.1–3 In people with spinal pain disorders, for example,  the expectation of gaining complete relief from treatment is associated with better short- and long-term outcomes, both for global ratings of change and for self-reports of pain and disability regardless of the intervention provided, 1,2 and the specific  expectation Correspondence: Mark D Bishop Department of Physical Therapy, University of Florida, PO Box 1000154 HSC, Gainesville, FL 32610, USATel +1 352 273 6112Email bish@ufl.eduJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Bishop et alRunning head recto: Influence of clinical equipoise and patient preferences on spinal painDOI: http://dx.doi.org/10.2147/JPR.S130931",Non-OADS,/arxiv_data1/oa_pdf/a6/e2/jpr-10-965.PMC5414630.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/a6/e2/jpr-10-965.PMC5414630.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 972 Bishop et al,Non-OADS,/arxiv_data1/oa_pdf/a6/e2/jpr-10-965.PMC5414630.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/87/ott-10-2297.PMC5414631.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2297–2303OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2297Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13100 8 role of cT scan in differentiating the type of  colorectal cancer Zhen-hui li1,* Ding-Yun Y ou2,* De-Pei gao1 guang-Jun Yang1 Xing-Xiang Dong1 Da-Fu Zhang1 Ying-Ying Ding1 1Department of radiology, The Third  affiliated hospital of Kunming Medical  University, Tumor hospital of Yunnan  Province, Kunming, 2Department  of science and T echnology, Kunming  Medical University, Kunming, Yunnan,   People’s republic of china *These authors contributed equally  to this workObjectives:  Most colorectal cancers are classical adenocarcinomas (AC), and less frequent  subtypes include mucinous adenocarcinomas (MAC) and signet-ring cell carcinomas (SC).",Non-OADS,/arxiv_data1/oa_pdf/8d/87/ott-10-2297.PMC5414631.pdf
"A unique  pathological feature of SC is the presence of signet-ring cells, which are single correspondence: Da-Fu Zhang;   Ying-Ying Ding Department of radiology, The Third  Affiliated Hospital of Kunming Medical  University, Tumor hospital of Yunnan  Province, Kunming, Yunnan 650118,  People’s republic of china Tel/fax +86 087168179594;   +86 087168179541 email  tosney@126.co m;   d_yying@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Li et al Running head recto: CT scan to differentiate colorectal cancer type DOI: http://dx.doi.org/10.2147/OTT.S131008",Non-OADS,/arxiv_data1/oa_pdf/8d/87/ott-10-2297.PMC5414631.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8d/87/ott-10-2297.PMC5414631.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/87/ott-10-2297.PMC5414631.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/ott-10-2305.PMC5414635.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2305–2313OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2305Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13501 3 Maintenance therapy with all-trans retinoic  acid and arsenic trioxide improves relapse-free  survival in adults with low- to intermediate-risk  acute promyelocytic leukemia who have achieved  complete remission after consolidation therapy Bin liang1,* Zhouyi Zheng1,2,* Yifen shi1 Jingjing chen1 Xudong hu1 honglan Qian1 Zhijian shen1 songfu Jiang1 Kang Yu1 Jianhua Feng1,3 1Division of hematology, The First  affiliated hospital of Wenzhou  Medical University, Wenzhou, 2Division  of hematology-Oncology, Traditional  chinese Medical hospital of Zhuji,   shaoxing, 3Division of Pediatric  hematology-Oncology, The First  affiliated hospital of Wenzhou  Medical University, Wenzhou,   People’s republic of china *These authors contributed equally  to this workBackground:  Currently, the optimal maintenance therapy for patients with acute promyelocytic  leukemia (APL) who have achieved complete remission (CR) after completing consolidation  chemotherapy remains controversial.",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/ott-10-2305.PMC5414635.pdf
"Keywords:  acute promyelocytic leukemia, all-trans retinoic acid, arsenic trioxide, maintenance  therapy, survival Introduction Acute promyelocytic leukemia (APL) is a distinct clinical and pathologic entity  associated with fusion of the promyelocytic leukemia ( PML ) gene with the retinoic acid  receptor α (RARA ) gene ( PML–RARA ), formed by the t(15;17)(q22;q21) chromosomal  translocation.1 The use of differentiation induction therapy with all-trans retinoic acid correspondence: Jianhua Feng; Kang Yu Division of hematology, The First  Affiliated Hospital of Wenzhou Medical  University, Ouhai Zone, Wenzhou  325000, Zhejiang, People’s republic  of china Tel +86 577 5557 8999 (ext 669889) Fax +86 577 5557 8999 email wzfjh@126.co m;   yukang62@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Liang et al Running head recto: Maintenance with ATRA and As2O3 improves survival in patients with APL DOI: http://dx.doi.org/10.2147/OTT.S135013",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/ott-10-2305.PMC5414635.pdf
Available from: http://evs.nci.nih.gov/ftp1/CTCAE/ CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pd f).,OADS,/arxiv_data1/oa_pdf/0f/2b/ott-10-2305.PMC5414635.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/ott-10-2305.PMC5414635.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/ott-10-2305.PMC5414635.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/ott-10-2289.PMC5414636.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2289–2295OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2289Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13099 0 apatinib to combat eGFr-TKI resistance in an  advanced non-small cell lung cancer patient with  unknown eGFr status: a case report Yanmei peng1 Huijuan Cui2 Zhe Liu3 Daiwei Liu1 Fan Liu1 Yazhong song1 Hua Duan1 Yuqin Qiu1 Qiang Li1 1Department of China-Japan  Friendship Hospital, Beijing University  of Chinese Medicine, 2Department  of Oncology, China-Japan Friendship  Hospital, Chaoyang, 3Department of  Oncology, Beijing Chest Hospital,   T ongzhou, Beijing, people’s republic  of ChinaAbstract:  Lung adenocarcinoma is the most common pathological pattern of lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/ott-10-2289.PMC5414636.pdf
"As Correspondence: Huijuan Cui Department of Oncology, China-Japan  Friendship Hospital, No 2, Yinghua Dong  Jie, Chaoyang District, Beijing 100029,  people’s republic of China Tel +86 139 1183 5018 email cuihj1963@sina.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2017 Volume: 10 Running head verso: Peng et al Running head recto: Use of apatinib against EGFR-TKI resistance in lung cancer patient DOI: http://dx.doi.org/10.2147/OTT.S130990",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/ott-10-2289.PMC5414636.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/ott-10-2289.PMC5414636.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/3c/ott-10-2289.PMC5414636.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/04/3c/por-8-043.PMC5414637.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/04/3c/por-8-043.PMC5414637.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pragmatic and Observational Research 2017:8 43–47Pragmatic and Observational Research Dovepress submit your manuscript | www.dovepress.com Dovepress  43 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/POR.S127710Older patients have increased risk of poor  outcomes after low-velocity pedestrian–motor  vehicle collisions Gerard A Baltazar1 Parker Bassett1 Amy J Pate2 Akella Chendrasekhar2 1Division of Trauma, Department of  Surgery, St. Barnabas Hospital Health  System, Bronx, NY, USA; 2Division  of Trauma, Department of Surgery,  Richmond University Medical Center,  Staten Island, NY, USABackground: Motor vehicle collisions (MVCs) are a leading cause of injury in the US.",Non-OADS,/arxiv_data1/oa_pdf/04/3c/por-8-043.PMC5414637.pdf
"2 Based on prior studies, older patients are at greater risk of being  involved in a PMVC and sustaining more severe injuries.3,4 Age also correlates with Correspondence: Gerard A Baltazar Division of Trauma, Department of Surgery, St. Barnabas Hospital Health System, 4422 Third Avenue, Bronx, New York, NY 10457, USTel + 1 718 960 6127Email gbaltazar@sbhny.orgJournal name: Pragmatic and Observational Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Baltazar et alRunning head recto: Increased risk for older patients when struck by low-velocity vehiclesDOI: http://dx.doi.org/10.2147/POR.S127710",Non-OADS,/arxiv_data1/oa_pdf/04/3c/por-8-043.PMC5414637.pdf
"Pragmatic and Observational Research 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Pragmatic and Observational Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pragmatic-and-observational-research-journalPragmatic and Observational Research is an international, peer-reviewed,  open access journal that publishes data from studies designed to reflect more   closely medical interventions in real-world clinical practice compared with   classical randomized controlled trials (RCTs).",Non-OADS,/arxiv_data1/oa_pdf/04/3c/por-8-043.PMC5414637.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 47 Increased risk for older patients when struck by low-velocity vehicles  10.,Non-OADS,/arxiv_data1/oa_pdf/04/3c/por-8-043.PMC5414637.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e0/de/nss-9-117.PMC5414656.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e0/de/nss-9-117.PMC5414656.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2017:9 117–126Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  117 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S132078The effect of physical activity on sleep quality,  well-being, and affect in academic stress periods Kathrin Wunsch   Nadine Kasten   Reinhard Fuchs Department of Sport Science,    Sport Psychology Unit,    Albert-Ludwigs University   Freiburg, Freiburg im Breisgau,   GermanyAbstract:  The stress-buffering hypothesis postulates that physical activity and exercise can  buffer the negative effects of (academic) stress on health.",Non-OADS,/arxiv_data1/oa_pdf/e0/de/nss-9-117.PMC5414656.pdf
"Evidence suggests the relationship between stress and sleep quality to be bidirectional:  1) high stress levels have negative effects on sleep quality 14 and 2) poor sleep quality Correspondence: Kathrin Wunsch   Department of Sport Science,   Sport Psychology Unit,   Albert-Ludwigs-Universität Freiburg,  Schwarzwaldstraße 175,   79117 Freiburg im Breisgau,   Germany Tel +49 761 203 4514   Fax +49 761 203 4534   Email kathrin.wunsch@sport.uni-freiburg.deJournal name: Nature and Science of Sleep Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Wunsch et alRunning head recto: Effect of physical activity on healthDOI: http://dx.doi.org/10.2147/NSS.S132078",Non-OADS,/arxiv_data1/oa_pdf/e0/de/nss-9-117.PMC5414656.pdf
Available from: http://www.who.int/dietphysicalactivity/physical-activity-recommendations-18-64years.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/de/nss-9-117.PMC5414656.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/e0/de/nss-9-117.PMC5414656.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/90/ppa-11-839.PMC5414717.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 839–843Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  839OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S13156 4 Poor 1st-year adherence to anti-osteoporotic  therapy increases the risk of mortality in patients  with magnetic resonance imaging-proven acute  osteoporotic vertebral fractures Ying-chou chen1 Wei-che lin2 1Department of rheumatology,   2Department of radiology, Kaohsiung  chang gung Memorial hospital,   chang gung University college of  Medicine, Kaohsiung, Taiwan, republic  of chinaAim:  Anti-osteoporotic therapy requires years of proper compliance to reduce the risk of  fractures.",Non-OADS,/arxiv_data1/oa_pdf/9b/90/ppa-11-839.PMC5414717.pdf
"Keywords:  osteoporosis, vertebral fracture, adherence, mortality Introduction Osteoporotic fractures are a serious health problem that can cause severe pain for  2–3 months and have been associated with an increased mortality rate.1 Anti-osteoporotic  agents can increase bone mineral density and decrease the incidence of vertebral frac - tures.2 Several agents are used for the treatment of osteoporosis, including bisphospho - nates (zoledronic acid, ibandronate, risedronate, and alendronate), calcitonin, selective  estrogen receptor modulators (raloxifene), parathyroid hormone (teriparatide), and  nuclear factor- κB ligand (RANK) ligand inhibitors (denosumab).3 Non-adherence to therapy can reduce its beneficial effects4 and subsequently its  effectiveness.5 Nevertheless, the non-adherence rate has been estimated to be as high as correspondence: Ying-chou chen Department of rheumatology, Kaohsiung  chang gung Memorial hospital, chang  gung University college of Medicine,  123 Ta-Pei road, niao-sung District,  Kaohsiung 833, Taiwan, republic of china Tel +886 7 731 7123 Fax +886 7 735 1843 email r820713@ms13.hinet.ne t Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Chen and Lin Running head recto: Adherence to anti-osteoporotic therapy may reduce mortality DOI: http://dx.doi.org/10.2147/PPA.S131564",Non-OADS,/arxiv_data1/oa_pdf/9b/90/ppa-11-839.PMC5414717.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9b/90/ppa-11-839.PMC5414717.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a3/79/ppa-11-831.PMC5414718.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 831–838Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  831OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S13475 9 Adherence to tobramycin inhaled powder vs  inhaled solution in patients with cystic fibrosis:  analysis of Us insurance claims data Kamal hamed1 Valentino conti2 hengfeng Tian1 emil loefroth3 1novartis Pharmaceuticals  corporation, east hanover, nJ, UsA;   2novartis global service center,   Dublin, ireland; 3novartis sverige AB,   Täby, swedenPurpose:  Tobramycin inhalation powder (TIP), the first dry-powder inhaled antibiotic for  pulmonary Pseudomonas aeruginosa  infection, is associated with reduced treatment burden,  increased patient satisfaction, and higher self-reported adherence for cystic fibrosis (CF) patients.",Non-OADS,/arxiv_data1/oa_pdf/a3/79/ppa-11-831.PMC5414718.pdf
"Keywords:  Adherence, convenience, inhaler, nebulizer, Pseudomonas aeruginosa , real-world  evidence, tobramycin, treatment burden Introduction Cystic fibrosis (CF) is an autosomal recessive inherited disease, caused by muta - tions in the cystic fibrosis transmembrane conductance regulator gene and char - acterized by thick secretions, resulting in multisystem complications.1 Morbidity  and mortality in CF are primarily attributed to recurrent respiratory infections and  progressive obstructive lung disease, leading to overall deterioration of pulmonary  function, respiratory failure, and ultimately death.2 Pseudomonas aeruginosa  rep- resents the archetypal CF pathogen, causing chronic infection in ~60%–75% of  adults with CF.3 Its management is notoriously difficult because of its extensive  multidrug resistance.4,5correspondence: Kamal hamed novartis Pharmaceuticals corporation,  One health Plaza, east hanover,  nJ 07936, UsA Tel +1 862 778 4780 email kamal.hamed@novartis.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Hamed et al Running head recto: Tobramycin inhaled powder adherence in patients with cystic fibrosis DOI: http://dx.doi.org/10.2147/PPA.S134759",Non-OADS,/arxiv_data1/oa_pdf/a3/79/ppa-11-831.PMC5414718.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a3/79/ppa-11-831.PMC5414718.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e3/72/tcrm-13-575.PMC5414720.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/e3/72/tcrm-13-575.PMC5414720.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 575–582Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  575ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12559 5 narrowband ultraviolet B light treatment changes  plasma concentrations of MMP-3, MMP-9 and  TiMP-3 in psoriatic patients Edyta Katarzyna Głażewska1 Marek niczyporuk1 Sławomir Ławicki2 Maciej szmitkowski2 Magdalena Donejko1 Monika Zajkowska2 Grażyna Ewa Będkowska3 andrzej Przylipiak1 1Department of esthetic Medicine,   2Department of Biochemical  Diagnostics, 3Department of  haematological Diagnostics, Medical  University, Bialystok, PolandBackground:  Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are  thought to be associated with the pathogenesis and spread of psoriatic disease.",Non-OADS,/arxiv_data1/oa_pdf/e3/72/tcrm-13-575.PMC5414720.pdf
"MMPs are a family of metal-dependent (Zn2+, Ca2+) enzymes that are classified  based on their minor structural differences and substrate specificity into the following  subgroups: collagenases, gelatinases, stromelysins, matrilysins, transmembrane  MMPs, Correspondence: edyta Katarzyna  Głażewska Department of esthetic Medicine, Medical  University, Bialystok, akademicka 3,  15-267 Bialystok, Poland Tel +48 85 748 5822 email kasiaglazewska@wp.p l Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Głaz ˙ewska et al Running head recto: MMP-3, MMP-9 and TIMP-2 plasma levels in psoriasis DOI: http://dx.doi.org/10.2147/TCRM.S125595",Non-OADS,/arxiv_data1/oa_pdf/e3/72/tcrm-13-575.PMC5414720.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e3/72/tcrm-13-575.PMC5414720.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/72/tcrm-13-575.PMC5414720.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0d/a9/prom-8-063.PMC5414721.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0d/a9/prom-8-063.PMC5414721.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Patient Related Outcome Measures 2017:8 63–69Patient Related Outcome Measures Dovepress submit your manuscript | www.dovepress.com Dovepress 63 ORiginal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S125500 health-related quality of life among cognitively  intact nursing home residents with and without  cancer – a 6-year longitudinal study Jorunn Drageset1,2 geir egil eide3,4 anne corbett5 1Department of n ursing, Faculty of  health and social sciences, Western  norway University of applied  sciences, 2Department of Public  health and Primary health care,   University of Bergen, 3centre for  clinical Research, Western norway  health Region authority, 4Department  of Public health and Primary health  care, University of Bergen, Bergen,   norway; 5institute of health Research,   exeter University Medical school,   University of exeter, exeter,  UKBackground: Limited information exists regarding the natural development of health-related  quality of life (HRQOL) and its determinants among mentally intact nursing home (NH) resi- dents.",Non-OADS,/arxiv_data1/oa_pdf/0d/a9/prom-8-063.PMC5414721.pdf
"A key additional factor correspondence: Jorunn Drageset Faculty of health and social sciences, Western norway University of applied sciences, inndalsveien 28, n-5063 Bergen, norwayTel +47 55 58 55 89Fax +47 55 58 55 56email Jorunn.Drageset@hvl.noJournal name: Patient Related Outcome Measures Article Designation: Original ResearchY ear: 2017V olume: 8Running head verso: Drageset et alRunning head recto: Health-related quality of life – a 6-year longitudinal studyDOI: http://dx.doi.org/10.2147/PROM.S125500",Non-OADS,/arxiv_data1/oa_pdf/0d/a9/prom-8-063.PMC5414721.pdf
Available  from: http://www.nia.nih.gov/research/publication/global-health-and-aging/living-longer.,Non-OADS,/arxiv_data1/oa_pdf/0d/a9/prom-8-063.PMC5414721.pdf
Available from: https://www.ssb.,Non-OADS,/arxiv_data1/oa_pdf/0d/a9/prom-8-063.PMC5414721.pdf
Available from:  http://ec.europa.eu/eurostat/statistics- explained/index.php/Healthcare_resource_statistics_-_beds#Long-term_care_beds_in_nursing_and_residential_care_facilities.,OADS,/arxiv_data1/oa_pdf/0d/a9/prom-8-063.PMC5414721.pdf
"Patient Related Outcome Measures 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/patient-related-outcome-measures-journalPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/0d/a9/prom-8-063.PMC5414721.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/a9/prom-8-063.PMC5414721.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/77/58/prbm-10-119.PMC5414722.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/77/58/prbm-10-119.PMC5414722.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2017:10 119–128Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress  119 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S111593Optimizing psychosocial interventions in  first‑episode psychosis: current perspectives  and future directions Nicholas JK Breitborde1,2 Aubrey M Moe1 Arielle Ered3 Lauren M Ellman3 Emily K Bell4 1Department of Psychiatry and  Behavioral Health, 2Department of  Psychology, The Ohio State University,   Columbus, OH, 3Department of  Psychology, T emple University,  Philadelphia, PA,  4Department of  Psychiatry, University of Arizona,  T ucson, AZ, USAAbstract:  Psychotic-spectrum disorders such as schizophrenia, schizoaffective disorder, and  bipolar disorder with psychotic features are devastating illnesses accompanied by high levels of  morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/77/58/prbm-10-119.PMC5414722.pdf
"Under usual systems of care, these disorders are characterized by repeated symptomatic relapses, 1–3 elevated rates of psychiatric  comorbidities such as anxiety, depressive, and substance use disorders,4,5 reduced rates  of participation in competitive occupational and educational activities,6–8 severe deficits  in cognitive abilities,9–11 rates of death by suicide up to 12 times greater than popula- tion norms,12,13 and a life expectancy reduced by up to 25 years14,15 due primarily to  cardiovascular, infectious, and pulmonary diseases.13,16 The severity of these disorders  was recently highlighted within the Global Burden of Disease (GBD) Study.17–19 As part Correspondence: Nicholas JK Breitborde Department of Psychiatry and Behavioral Health, The Ohio State University, 1670 Upham Dr., Columbus, OH 43210, USATel +1 614 685 6052Email nicholas.breitborde@osumc.eduJournal name: Psychology Research and Behavior Management Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Breitborde et alRunning head recto: Psychosocial interventions in first-episode psychosisDOI: http://dx.doi.org/10.2147/PRBM.S111593",Non-OADS,/arxiv_data1/oa_pdf/77/58/prbm-10-119.PMC5414722.pdf
"Psychology Research and Behavior Management 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology‑research‑and‑behavior ‑management‑journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/77/58/prbm-10-119.PMC5414722.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/85/63/ijn-12-3407.PMC5414723.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3407–3419International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3407OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13034 8 Methodological assessment of the reduction of  the content of impurities in nimodipine emulsion  via the use of 21 amino acid protection Yiqiao Xie1,* Zhiquan Zhuang2,* shu Zhang1 Zihua Xia1 De chen1 Kaiyan Fan1 Jialin ren1 cuicui lin1 Yanzhong chen1 Fan Yang1 1Department of Pharmaceutics,   guangdong Pharmaceutical University,   2Department of Pharmacy, First  affiliated hospital of guangdong  Pharmaceutical University,   guangzhou,  guangdong, People’s  republic of china *These authors contributed equally  to this workPurpose:  The present study examined the factors affecting the content of impurities of  nimodipine (NMP) emulsion and the associated methods of compound protection.",Non-OADS,/arxiv_data1/oa_pdf/85/63/ijn-12-3407.PMC5414723.pdf
"The addition of physiological saline  and/or glucose solution with NMP can cause the precipitation of the drug in the  form of crystals and induce vein inflammation associated with irreversible damage correspondence: Yanzhong chen;   Fan Yang Department of Pharmaceutics,  guangdong Pharmaceutical University,  No 280, Outer ring road, guangzhou  higher education Mega center,  guangzhou 510006, People’s republic  of china Tel +86 138 0296 9020;   +86 139 2213 5439 email doctor.c@163.co m;   gzyangfan@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Xie et al Running head recto: Factors affecting the content of impurities of NMP emulsion DOI: http://dx.doi.org/10.2147/IJN.S130348",Non-OADS,/arxiv_data1/oa_pdf/85/63/ijn-12-3407.PMC5414723.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/85/63/ijn-12-3407.PMC5414723.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/63/ijn-12-3407.PMC5414723.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Substance Abuse and Rehabilitation 2017:8 9–37Substance Abuse and Rehabilitation Dovepress submit your manuscript | www.dovepress.com Dovepress 9 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S109576 The cannabis withdrawal syndrome: current  insights Udo Bonnet1,2 Ulrich W Preuss3,4 1Department of Psychiatry,   Psychotherapy and Psychosomatic  Medicine, Evangelisches Krankenhaus Castrop-Rauxel, Academic T eaching Hospital of the University of Duisburg-Essen, Castrop-Rauxel,   2Department of Psychiatry and  Psychotherapy, Faculty of Medicine,  LVR-Hospital Essen, University of Duisburg-Essen, Essen,  3Vitos-Klinik  Psychiatrie und Psychotherapie Herborn, Herborn,  4Martin Luther  University Halle-Wittenberg, Halle (Saale), GermanyAbstract: The cannabis withdrawal syndrome (CWS) is a criterion of cannabis use disorders  (CUDs) (Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition) and cannabis  dependence (International Classification of Diseases [ICD]-10).",Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
"They decline in Spain, UK, and Germany (currently 12%), and there is an increase in the number of treatment demands for cannabis-related problems across Europe 2 and the USA.3 Although such prevalence rates are useful to indicate  consumption Correspondence: Udo Bonnet Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Evangelisches Krankenhaus Castrop-Rauxel, D-44577 Castrop-Rauxel, Grutholzallee 21, GermanyEmail udo.bonnet@uni-due.deJournal name: Substance Abuse and Rehabilitation Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: Bonnet and PreussRunning head recto: The cannabis withdrawal syndromeDOI: http://dx.doi.org/10.2147/SAR.S109576",Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
"Among  them, most often, male adolescents and young adults demon-strated a significant loss of quality of life during their cannabis dependence as measured by disability-adjusted life years in the Global Burden of Disease 2010 Study (cf Figures 2 and 3 in http://journals.plos.org/plosone/article?id=info:doi/10.1371/journal.pone.0076635, accessed November 25, 2016).",Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
"The so-called Beta-Draft of the chapter about “Mental and Behavioral Disorders” is already available online at http://apps.who.int/classifications/icd11/browse/f/en#/ http%3a%2f%2fid.who.int%2ficd%2fentity%2f637576511 (accessed November 25, 2016).",Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
Avail-able from: https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
Available from: http://www.emcdda.europa.eu/attachements.cfm/att_239505_EN_TDAT15001ENN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
Avail-able from: http://apps.who.int/classifications/icd11/browse/f/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f637576511.,OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
Available from: https://www.ncbi.nlm.nih.gov/pubmed.,Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
Available from: https://www.scopus.com/home.uri.,Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
Available from: https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1962-01-01_3_page005.html.,OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
"Substance Abuse and Rehabilitation 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/substance-abuse-and-rehabilitation-journalSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials, reviews and commentaries on all areas of addiction and substance abuse and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 37 The cannabis withdrawal syndrome  106.,Non-OADS,/arxiv_data1/oa_pdf/35/22/sar-8-009.PMC5414724.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/82/1d/ijn-12-3365.PMC5414725.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3365–3374International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3365OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13032 2 One-pot synthesis of dextran-coated iron oxide  nanoclusters for real-time regional lymph node  mapping chaoping Fu1,* haipeng Zhou2,* Yanan Wang2,* Dong liu2 Junmeng li2 haijun Deng2 Xiaolong Qi2 Tao chen2 li-Ming Zhang1 guoxin li2 1PcFM lab and gDhPPc lab, school  of Materials science and engineering,   sun Yat-sen University, 2Department  of general surgery, Nanfang hospital,   southern Medical University,   guangzhou, People’s republic of  china *These authors contributed equally  to this workAbstract:  The intraoperative precision cleaning of lymph nodes (LNs) is an essential component  of treating neoplastic disease.",Non-OADS,/arxiv_data1/oa_pdf/82/1d/ijn-12-3365.PMC5414725.pdf
"However, because of the limitations  of the equipment, intraoperative mapping could not be performed with these imaging  methods, possibly leading to inadequate removal of metastatic LNs or excessive LN  dissection.6–10 In addition, certain dyes or isotopes have been used primarily to provide  intraoperative visual guidance in mapping regional LNs, but these materials have no  tumor specificity, which could cause a high false-negative rate for metastatic LNs.11correspondence: li-Ming Zhang school of Materials science and  engineering, sun Yat-sen University, 135  Xingang West road, guangzhou 510275,  People’s republic of china Tel/fax +86 20 8411 2354 email ceszhlm@mail.sysu.edu.cn   guoxin li Department of general surgery, Nanfang  hospital, southern Medical University,  1838 North guangzhou avenue,  guangzhou 510515, People’s republic  of china Tel +86 20 6164 1681 Fax +86 20-6164 1683 email gzliguoxin@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Fu et al Running head recto: One-pot synthesis of DIONs for lymph node mapping DOI: http://dx.doi.org/10.2147/IJN.S130322",Non-OADS,/arxiv_data1/oa_pdf/82/1d/ijn-12-3365.PMC5414725.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/82/1d/ijn-12-3365.PMC5414725.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/1d/ijn-12-3365.PMC5414725.pdf
"Available at:  https://www.iso.org/standard/15414.htm l. Accessed April 13, 2017.",Non-OADS,/arxiv_data1/oa_pdf/82/1d/ijn-12-3365.PMC5414725.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1d/22/tcrm-13-565.PMC5414727.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 565–573Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  565ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S13426 5 Retrospective analysis of non-laboratory-based  adverse drug reactions induced by intravenous  radiocontrast agents in a Joint Commission  international-accredited academic medical center  hospital in China Qin-lan Chen1 Xiao-ying Zhao2 Xiao-mi Wang1 na lv2 ling-ling Zhu3 hui-min Xu4 Quan Zhou4 1Radiology nursing Unit, Division  of nursing, 2Department of  Quality Management, 3geriatric ViP  Care Ward, Division of nursing,   4Department of Pharmacy, The  second affiliated hospital, school  of Medicine, Zhejiang University,   hangzhou, Zhejiang, People’s  Republic of ChinaAbstract:  The authors retrospectively analyzed the pattern and characteristics of non-laboratory- based adverse drug reactions (ADRs) induced by intravenous radiocontrast agents in a large-scale  hospital in China during 2014–2015.",Non-OADS,/arxiv_data1/oa_pdf/1d/22/tcrm-13-565.PMC5414727.pdf
"Institute for Safe  Medication Practices lists intravenous radiocontrast agents as high alert medications,  which bear a heightened risk of causing significant harm to the patient when used in  error.1 It is clinically important to ensure a proper monitoring of adverse drug reactions Correspondence: Quan Zhou Department of Pharmacy, The second  Affiliated Hospital, School of Medicine,  Zhejiang University, Jiefang Road no 88,  shangcheng District, hangzhou 310009,  Zhejiang Province, People’s Republic  of China Tel +86 571 8778 4615 Fax +86 571 8702 2776 email zhouquan142602@zju.edu.c n Xiao-ying Zhao Department of Quality Management,  The Second Affiliated Hospital, School  of Medicine, Zhejiang University, Jiefang  Road no 88, shangcheng District,  hangzhou 310009, Zhejiang Province,  People’s Republic of China email zrxz@zju.edu.c n Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Chen et al Running head recto: Adverse drug reactions and radiocontrast agents DOI: http://dx.doi.org/10.2147/TCRM.S134265",Non-OADS,/arxiv_data1/oa_pdf/1d/22/tcrm-13-565.PMC5414727.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/1d/22/tcrm-13-565.PMC5414727.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/22/tcrm-13-565.PMC5414727.pdf
"[webpage on the Internet] Available from:  http://www.ismp.org/Tools/highAlertMedicationLists.as p. Accessed  January 26, 2017.",OADS,/arxiv_data1/oa_pdf/1d/22/tcrm-13-565.PMC5414727.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/68/49/rru-9-065.PMC5414750.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/68/49/rru-9-065.PMC5414750.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2017:9 65–69Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  65 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S133538Enteric-coated and highly standardized cranberry  extract reduces antibiotic and nonsteroidal anti- inflammatory drug use for urinary tract infections  during radiotherapy for prostate carcinoma Alberto Bonetta1 Giandomenico Roviello2,3 Daniele Generali3,4 Laura Zanotti3 Maria Rosa Cappelletti3 Chiara Pacifico5 Francesco Di Pierro6 1Oncological Radiotherapy  Operative Unit, ASST, Cremona,   2Department of Molecular and  Translational Medicine, University  of Brescia, Brescia, 3Molecular  Therapy and Pharmacogenomics Unit, ASST, Cremona,  4Department  of Medical, Surgery and Health Sciences, University of Trieste,  Trieste,  5Department of Medical,   Surgical and Neurological Sciences,  University Hospital of Siena,  Siena,  6Velleja  Research Scientific  Department, Milan, ItalyIntroduction: Worldwide, bacterial resistance to antibiotic therapy is a major concern for the  medical community.",Non-OADS,/arxiv_data1/oa_pdf/68/49/rru-9-065.PMC5414750.pdf
"2 A-type interfla- vane bond proanthocyanidins (PAC-A) from V accinium macrocarpon (cranberry) fruit, Correspondence: Francesco Di Pierro Velleja Research Scientific Department, Viale Lunigiana 23, 20125, Milan, ItalyTel +39 552 7663Email f.dipierro@vellejaresearch.comJournal name: Research and Reports in Urology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Bonetta et alRunning head recto: Enteric-coated cranberry during prostate radiotherapyDOI: http://dx.doi.org/10.2147/RRU.S133538",Non-OADS,/arxiv_data1/oa_pdf/68/49/rru-9-065.PMC5414750.pdf
"Research and Reports in Urology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/68/49/rru-9-065.PMC5414750.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 69 Enteric-coated cranberry during prostate radiotherapy  7.,Non-OADS,/arxiv_data1/oa_pdf/68/49/rru-9-065.PMC5414750.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bb/9b/ijn-12-3395.PMC5414751.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3395–3406International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3395OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13196 2 a novel injectable calcium phosphate-based  nanocomposite for the augmentation of  cannulated pedicle-screw fixation haolin sun1,* chun liu2,* huiling liu2,* Yanjie Bai3 Zheng Zhang1 Xuwen li1 chunde li1 huilin Yang2,4 lei Yang2,4 1Department of Orthopedics, Peking  University First hospital, Beijing,   2Department of Orthopedics, Institute  of Orthopedics, First affiliated  hospital, 3school of Public health,   Medical college, 4International  research center for Translational  Orthopedics (IrcTO), soochow  University, suzhou, china *These authors contributed equally  to this workAbstract:  Polymethyl methacrylate (PMMA)-augmented cannulated pedicle-screw fixation has  been routinely performed for the surgical treatment of lumbar degenerative diseases.",Non-OADS,/arxiv_data1/oa_pdf/bb/9b/ijn-12-3395.PMC5414751.pdf
"Previous  studies have reported that the pullout strength of pedicle screws can be dramatically  increased by augmentation with nondegradable or bioabsorbable bone cements such correspondence: chunde li Department of Orthopedics, Peking  University First hospital, No 8   Xishiku street, Xicheng District,   Beijing 100034, china Tel +86 10 8357 2289 Fax +86 10 6655 1544 email lichunde@medmail.com.c n  lei Yang Orthopedic Institute of soochow  University, 708 renmin road,   suzhou, Jiangsu 215006, china Tel +86 512 6778 1540 Fax +86 512 6778 1165 email leiy@suda.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sun et al Running head recto: Calcium phosphate-based nanocomposite for pedicle-screw fixation DOI: http://dx.doi.org/10.2147/IJN.S131962",Non-OADS,/arxiv_data1/oa_pdf/bb/9b/ijn-12-3395.PMC5414751.pdf
Available from: http://hdl.handle.net/2268/165163.,Non-OADS,/arxiv_data1/oa_pdf/bb/9b/ijn-12-3395.PMC5414751.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bb/9b/ijn-12-3395.PMC5414751.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/9b/ijn-12-3395.PMC5414751.pdf
"lww.com/DSS/A46, http://links.lww.com/DSS/A47, http://links.lww.com/DSS/A48, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/ab/fb/ds-42-1094.PMC5414762.pdf
Available from: http://www.medicines.org.uk/emc/ medicine/17580.,Non-OADS,/arxiv_data1/oa_pdf/31/aa/ds-42-967.PMC5414763.pdf
Available from: http://www.medicines.org.uk/emc/ medicine/23251.,Non-OADS,/arxiv_data1/oa_pdf/31/aa/ds-42-967.PMC5414763.pdf
"Available from https://clinicaltrials.gov/ct2/results?term=05PF1311+&Search=Search.Accessed June 1, 2016.",OADS,/arxiv_data1/oa_pdf/31/aa/ds-42-967.PMC5414763.pdf
Available at: http://www.plasticsurgery.,Non-OADS,/arxiv_data1/oa_pdf/69/7e/ds-42-598.PMC5414775.pdf
Available at: http://monographs.iarc.fr/in dex.php.,Non-OADS,/arxiv_data1/oa_pdf/ad/26/kfx035.PMC5414855.pdf
Available at: http://www.fda.gov/down loads/AdvisoryCommittees/CommitteesMeetingMaterials/ Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323927.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/91/kfx025.PMC5414856.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/95/kfx018.PMC5414857.pdf
"Published with license by Taylor & Francis Group, LLC © Riccardo Turrini, Anna Merlo, Debora Martorelli, Damiana Antonia Fa /C19e, Roberta Sommaggio, Isabella Monia Montagner, Vito Barbieri, Oriano Marin, Paola Zanovello, Riccardo Dolcetti, and Antonio Rosato.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
"4, e1304338 (9 pages)http://dx.doi.org/10.1080/2162402X.2017.1304338",Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
ORCID Riccardo Turrini http://orcid.org/0000-0003-0133-7492 Debora Martorelli http://orcid.org/0000-0001-7385-3571 Damiana Antonia Fa /C18e http://orcid.org/0000-0003-3660-0502 Roberta Sommaggio http://orcid.org/0000-0002-5682-5867 Isabella Monia Montagner http://orcid.org/0000-0002-5778-2221 Oriano Marin http://orcid.org/0000-0002-6175-4039 Paola Zanovello http://orcid.org/0000-0003-0740-4043 Riccardo Dolcetti http://orcid.org/0000-0003-1625-9853 Antonio Rosato http://orcid.org/0000-0002-5263-8386 References 1.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Nat Rev Can- cer 2004; 4:757-68; PMID:15510157; http://dx.doi.org/10.1038/nrc1452 2.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Haematologica 2010; 95:1769-77; PMID:20421267; http://dx.doi.org/10.3324/haematol.2010.023689 3.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Int J Cancer 2008; 123:1100-7; PMID:18546263; http://dx.doi.org/10.1002/ijc.23621 4.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Cancer Immunol Res 2016; 4:431-40; PMID:27009165; http://dx.doi.org/10.1158/2326-6066.CIR-15-0108 5.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
"J Med Virol 2005; 76:82-8; PMID:15778977; http://dx.doi.org/10.1002/jmv.20327 7. zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, van den Brule AJ.",OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Rev Med Virol 2013; 23:367-83; PMID:23996634; http://dx.doi.org/10.1002/rmv.1758 13.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
ClinCancer Res 2007; 13:4993-5000; PMID:17785549; http://dx.doi.org/ 10.1158/1078-0432.CCR-06-2945 14.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
"Sall A, Caserta S, Jolicoeur P, Franqueville L, de Turenne-Tessier M, Ooka T. Mitogenic activity of Epstein-Barr virus-encoded BARF1 protein.Oncogene 2004; 23:4938-44; PMID:15064715; http://dx.doi.org/10.1038/ sj.onc.1207607 15.",OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
J Virol 2013; 87:10515-23; PMID:23824821; http://dx.doi.org/10.1128/JVI.00955-13 16.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Onco- gene 2001; 20:1176-85; PMID:11313861; http://dx.doi.org/10.1038/sj.onc.120421717.,OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Oncotarget 2016; 7:82213-27; PMID:27438138; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Nature Struct MolBiol 2012; 19:938-47; PMID:22902366; http://dx.doi.org/10.1038/nsmb.2367 19.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Viral Immunol 2012; 25:461-70; PMID:23061794; http://dx.doi.org/ 10.1089/vim.2012.0034 20.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Virol J 2008; 5:70; PMID:18533018; http://dx.doi.org/10.1186/1743-422X-5-70 25.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
"Eur J Cancer (Oxford, Eng- land : 1990) 2013; 49:2223-32; PMID:23433847; http://dx.doi.org/10.1016/j.ejca.2013.01.024 26.",Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Crit Rev Oncol Hematol 2016; 97:72-84; PMID:26318093; http://dx.doi.org/10.1016/j.critrevonc.2015.08.014 27.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Clin VaccineImmunol : CVI 2011; 18:298-304; PMID:21123521; http://dx.doi.org/ 10.1128/CVI.00193-10 28.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Int J Cancer 2009; 125:1358-64; PMID:19536817; http://dx.doi.org/10.1002/ijc.24515 29.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Cancer Res 2009; 69:9385-94; PMID:19996290; http://dx.doi.org/ 10.1158/0008-5472.CAN-09-0494 30.,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
Eur J Nucl Med Mol I 2008; 35:999-1007; PMID:18180921;http://dx.doi.org/10.1007/s00259-007-0664-2ONCOIMMUNOLOGY e1304338-9,Non-OADS,/arxiv_data1/oa_pdf/52/bf/koni-06-04-1304338.PMC5414862.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, tran sformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
"4, e1302631 (10 pages)http://dx.doi.org/10.1080/2162402X.2017.1302631",Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
ORCID Hilde Alma/C14sbak http://orcid.org/0000-0002-1197-7285 References 1.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
IntJ Cancer 2010; 127:2893-917; PMID:21351269; http://dx.doi.org/10.1002/ijc.25516 2.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Science 1995; 268:1336-8; PMID:7761852; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Mod Pathol 2009; 22:1186-95; PMID:19503063;http://dx.doi.org/10.1038/modpathol.2009.80 6.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Cancer 2001; 91:2417-22; PMID:11413533; http://dx.doi.org/10.1002/1097-0142(20010615)91:12%3c2417::AID-CNCR1276%3e 3.0.CO;2-U 8.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Cancer 1978; 41:279-82; PMID:626936; http://dx.doi.org/ 10.1002/1097-0142(197801)41:1%3c 279::AID-CNCR2820410139% 3e3.0.CO;2-B 10.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
J Clin Pathol 1986; 39:585-9; PMID:3722412; http://dx.doi.org/10.1136/ jcp.39.6.585 11.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Fam Cancer 2009; 8:231-9; PMID:19165625; http://dx.doi.org/10.1007/s10689-009-9233-0 12.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
J Immunother 2013; 36:133-51; PMID:23377668; http://dx.doi.org/10.1097/CJI.0b013e3182829903 13.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Blood 2013; 122:863-71; PMID:23770775; http://dx.doi.org/10.1182/blood-2013-03-490565 14.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Sci Transl Med 2013; 5:197ra03; PMID:23926201; http://dx.doi.org/10.1126/scitranslmed.3006034 15.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Semin Immunol 2016; 28:22-7; PMID:26653770; http://dx.doi.org/ 10.1016/j.smim.2015.11.002 16.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Curr Opin Immunol 2009; 21:190-9; PMID:19297140; http://dx.doi.org/10.1016/j.coi.2009.02.006 17.,OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Gastro- enterology 2008; 134:988-97; PMID:18395080; http://dx.doi.org/10.1053/j.gastro.2008.01.015 19.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Cancer Immunol Immunother 2001; 50:469-76; PMID:11761441; http://dx.doi.org/10.1007/s00262010022220.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Proc Natl Acad Sci U S A 2001; 98:13255-60; PMID:11687624; http://dx.doi.org/ 10.1073/pnas.231326898 21.,OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Int J Cancer 2001; 93:6-11; PMID:11391614; http://dx.doi.org/10.1002/ijc.1298 22.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Cancer ImmunolImmunother 2009; 58:1609-26; PMID:19221745; http://dx.doi.org/10.1007/s00262-009-0670-2 23.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Immunity 2001; 14:591-602; PMID:11371361; http://dx.doi.org/ 10.1016/S1074-7613(01)00133-9 24.,OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
"Tang W, Wang W, Zhang Y, Liu S, Liu Y, Zheng D. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclearfactor kappa B. Febs J 2009; 276:581-93; PMID:19120450; http://dx.doi.org/10.1111/j.1742-4658.2008.06809.x 25.",Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
J Immunol 2006; 177:6548-59; PMID:17056587; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Cancer Res 2006; 66:11455-61; PMID:17145893;http://dx.doi.org/10.1158/0008-5472.CAN-06-2379 27.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Cytotherapy 2011; 13:629-40; PMID:21174490; http://dx.doi.org/10.3109/14653249.2010.542461 28.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
J Immunol 2011; 186:5039- 45; PMID:21505216; http://dx.doi.org/10.4049/jimmunol.1003650 29.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Immunity 1996; 5:41-52;PMID:8758893; http://dx.doi.org/10.1016/S1074-7613(00)80308-8 31.,OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
JImmunol 2010; 184:5988-98; PMID:20427771; http://dx.doi.org/ 10.4049/jimmunol.1000189 32.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Gene Ther 2015; 22:391-403;PMID:25652098; http://dx.doi.org/10.1038/gt.2015.4 33.,OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Blood 2015; 125:3466-76; PMID:25887778; http://dx.doi.org/10.1182/blood-2014-11-612721 34.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
J Clin Invest 2016; 126:854-8; PMID:26808500; http://dx.doi.org/10.1172/JCI83465ONCOIMMUNOLOGY e1302631-9,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Int J Cancer 1999; 80:781-90; PMID:10048982; http://dx.doi.org/10.1002/(SICI) 1097-0215(19990301)80:5%3c781::AID-IJC24%3e3.0.CO;2-A 36.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
N Eng J Med 2003; 349:247-57; PMID:12867608; http://dx.doi.org/10.1056/NEJMoa022289 38.,OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Br J Cancer 2010; 103:340-6; PMID:20606684; http://dx.doi.org/10.1038/sj.bjc.6605780 39.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
N Eng J Med 2015; 372:2509-20; PMID:26028255; http://dx.doi.org/10.1056/ NEJMoa1500596 41.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Clin Cancer Res 2013; 19:5636-46; PMID:23873688; http://dx.doi.org/10.1158/1078-0432.CCR-13-0458 42.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
J Immunol 2010; 184:4936-46; PMID:20351194; http://dx.doi.org/10.4049/jimmunol.1000173 43.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Blood 2011; 118:319-29; PMID:21606483; http://dx.doi.org/10.1182/blood-2010-12-326736 44.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
"Cancer Res 2007; 67:3898- 903; PMID:17440104; http://dx.doi.org/10.1158/0008-5472.CAN-06- 3986 4 6 .P a r k h u r s tM R ,Y a n gJ C ,L a n g a nR C ,D u d l e yM E ,N a t h a nD A , Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM et al.",Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Mol Ther 2011; 19:620-6; PMID:21157437; http://dx.doi.org/10.1038/mt.2010.272 47.,OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Blood Cells Mol Dis 2004; 33:288-90; PMID:15528146;http://dx.doi.org/10.1016/j.bcmd.2004.08.018 48.,OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
J Clin Invest 2015; 125:157-68; PMID:25415440; http://dx.doi.org/10.1172/JCI75876 49.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Cancer Immunol Immunother 2006;55:1553-64; PMID:16491401; http://dx.doi.org/10.1007/s00262-006- 0145-7 51.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
J Immunol Methods 2002; 259:191-203; PMID:11730854; http://dx.doi.org/10.1016/S0022-1759(01)00506-3 52.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
PloS One 2011; 6:e27930; PMID:22132171; http://dx.doi.org/ 10.1371/journal.pone.0027930 53.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
Scand J Immunol 2009; 69:319-28; PMID:19284496; http://dx.doi.org/ 10.1111/j.1365-3083.2008.02223.xe1302631-10 E. M. INDERBERG ET AL.,Non-OADS,/arxiv_data1/oa_pdf/05/24/koni-06-04-1302631.PMC5414866.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, tran sformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
"4, e1303586 (8 pages)http://dx.doi.org/10.1080/2162402X.2017.1303586",Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
ORCID Alex Y. Huang http://orcid.org/0000-0002-5701-4521 References 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
N Engl J Med 1994; 331:294-9; PMID:8022439;http://dx.doi.org/10.1056/NEJM199408043310503 2.,OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
J Clin Oncol 2012; 30:4148-54; PMID:23091096; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
N Engl J Med 2003; 348:694-701; PMID:12594313; http://dx.doi.org/10.1056/NEJMoa020890 4.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
J Innate Immun 2011; 3:213-5; PMID:21454963; http://dx.doi.org/10.1159/000325332 5.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Int Arch Allergy Immunol 2014;164:253-64; PMID:25323661; http://dx.doi.org/10.1159/000365632 6.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
J Intern Med 2009; 266:154-81; PMID:19614820; http://dx.doi.org/10.1111/j.1365-2796.2009.02121.x 7.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Clin Cancer Res 2014; 20:3390-400; PMID:24987108; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Pediatr Blood Cancer 2014; 61:618-26; PMID:24136885; http://dx.doi.org/10.1002/pbc.24801 9.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Cancer Lett 2015; 368:54-63; PMID:26276724; http://dx.doi.org/10.1016/j.canlet.2015.07.042 11.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
J Pathol 2009; 218:222-31; PMID:19274709; http://dx.doi.org/10.1002/path.2537 12.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Clin Cancer Res 2010; 16:3819-21; PMID:20554750; http://dx.doi.org/10.1158/1078-0432.CCR-10-1368 15.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Mol Immunol 2008; 45:3917-25; PMID:18657862; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Cell Mol Immunol 2013; 10:230-52; PMID:23604045; http://dx.doi.org/10.1038/cmi.2013.10 17.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Cytotherapy 2015; 17:245-9; PMID:25533934; http://dx.doi.org/10.1016/j.jcyt.2014.09.007 18.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
J Vis Exp 2011; 48(2540); PMID:21339714; http://dx.doi.org/10.3791/2540 19.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Blood 2014; 124:1081-8; PMID:25006133; http://dx.doi.org/10.1182/blood-2014-02-556837 21.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Korean J Lab Med 2009; 29:89-96; PMID:19411773; http://dx.doi.org/10.3343/kjlm.2009.29.2.89 22.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Cancer Genet Cytogenet 1986; 21:185-208;PMID:3004699; http://dx.doi.org/10.1016/0165-4608(86)90001-4 23.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
J Immunol 2006; 177:7833-40; PMID:17114454;http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
J Clin Oncol 2000; 18:3108-14; PMID:10963639;http://dx.doi.org/10.1200/JCO.2000.18.17.310826.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Immunotherapy 2014; 6:611-21; PMID:24896629; http://dx.doi.org/10.2217/imt.14.36 27.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Front Immunol 2015; 6:601; PMID:26697006; http://dx.doi.org/10.3389/ ﬁmmu.2015.00601 28.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Oncology 1988; 45:437-43; PMID:3263598; http://dx.doi.org/10.1159/000226661 29.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
"Staege MS, Hansen G, Baersch G, Burdach S. Functional and molecular characterization of interleukin-2 transgenic Ewingt u m o rc e l l sf o ri nv i v oi m m u n o t h e r a p y .P e d i a t rB l o o dC a n c e r 2004; 43:23-34; PMID:15170886; http://dx.doi.org/10.1002/ pbc.20013 30.",OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Pediatr Res 1989; 25:156- 60; PMID:2537488; http://dx.doi.org/10.1203/00006450-198902000-00016 31.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
"Konjevi /C19c G, Vuleti /C19c A, Mirja /C20ci/C19c Martinovi /C19c K. Natural killer cell receptors: alterations and therapeutic targeting in malignancies.Immunol Res 2016; 64:25-35; PMID:26374324; http://dx.doi.org/10.1007/s12026-015-8695-4 32.",OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
PLoS Comput Biol 2013; 9:e1003222; PMID:24068905; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Sci Signal 2016; 9:ra19; PMID:26884601; http://dx.doi.org/10.1126/scisignal.aad1884 35.,OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
Cancer Immunol Immunother 2007; 56:1037-46; PMID:17149595; http://dx.doi.org/10.1007/s00262-006-0257-0e1303586-8 A.,Non-OADS,/arxiv_data1/oa_pdf/f8/b4/koni-06-04-1303586.PMC5414867.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, tran sformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
"4, e1303585 (9 pages)http://dx.doi.org/10.1080/2162402X.2017.1303585",Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
ORCID Riccardo Turrini http://orcid.org/0000-0003-0133-7492 George Coukos http://orcid.org/0000-0001-8813-7367 References 1.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Cell 2008; 13:206-20;PMID:18328425; http://dx.doi.org/10.1016/j.ccr.2008.01.034 2.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Res 2006; 66:11238-46;PMID:17114237; http://dx.doi.org/10.1158/0008-5472.CAN-06-1278 3.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
J Clin Invest 1997; 100:2072-8;PMID:9329972; http://dx.doi.org/10.1172/JCI119740 4.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Discov 2015; 5:932-43; PMID:26269515; http://dx.doi.org/10.1158/2159-8290.CD-15-0012 5.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
J Mol Med 2013; 91:411-29; PMID:23515621;http://dx.doi.org/10.1007/s00109-013-1021-5 6.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Oral Oncol 2013; 49:216-23; PMID:23089461; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Int Immunopharmacol 2016; 34:101-6; PMID:26938675; http://dx.doi.org/10.1016/j.intimp.2016.01.023 8.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Lung Cancer 2011; 74:188-96; PMID:21601305; http://dx.doi.org/10.1016/j.lungcan.2011.04.009 9.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Cell 2014; 25:846-59; PMID:24898549; http://dx.doi.org/10.1016/j.ccr.2014.05.016 10.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Cell 2005; 8:211-26;PMID:16169466; http://dx.doi.org/10.1016/j.ccr.2005.08.002 12.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Blood 2009; 114:901-14; PMID:19383967; http://dx.doi.org/10.1182/blood-2009-01-200931 13.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Res 2010; 70:5270-80;PMID:20530679; http://dx.doi.org/10.1158/0008-5472.CAN-10-0012 14.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Circ Res 1998; 83:233-40; PMID:9710115; http://dx.doi.org/10.1161/01.RES.83.3.233 15.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Blood 2007; 109:5276-85; PMID:17327411; http://dx.doi.org/ 10.1182/blood-2006-10-053504 16.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
PLoS Comput Biol 2015; 11:e1004050; PMID:25768678; http://dx.doi.org/10.1371/journal.pcbi.1004050 17.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Oncoimmunology2016; 5:e1073882; PMID:27057438; http://dx.doi.org/10.1080/2162402X.2015.1073882 18.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Clin Cancer Res 2013; 19:3439-49; PMID:23649001; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Immunol Immunother 2003; 52:663-9;PMID:12920481; http://dx.doi.org/10.1007/s00262-003-0424-5 20.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Res 2012; 72:2162-71; PMID:22549946; http://dx.doi.org/10.1158/0008-5472.CAN-11-3687 21.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Clin Cancer Res 2009; 15:2433-41; PMID:19318480; http://dx.doi.org/10.1158/1078-0432.CCR-08-2179 22.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Immu- nol Res 2012; 53:41-57; PMID:22430559; http://dx.doi.org/10.1007/ s12026-012-8297-3 24.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Blood 2011; 118:e50-61; PMID:21803849; http://dx.doi.org/10.1182/blood-2011-01-326827 25.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Blood 2010; 116:3955-63; PMID:20682855; http://dx.doi.org/10.1182/blood-2010-02-266296 26.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Res2010; 70:5728-39; PMID:20570887; http://dx.doi.org/10.1158/0008-5472.CAN-09-4672 27.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Science 1997; 275:964-7; PMID:9020076; http://dx.doi.org/10.1126/science.275.5302.964 28.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Nat Med 2001; 7:1194-201; PMID:11689883; http://dx.doi.org/10.1038/nm1101-1194ONCOIMMUNOLOGY e1303585-7,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Blood 2003; 101:168-72; PMID:12393704; http://dx.doi.org/10.1182/blood-2002-03-0755 30.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Alternative vasculari- zation mechanisms in cancer: pathology and therapeutic implications.Am J Pathol 2007; 170:1-15; PMID:17200177; http://dx.doi.org/ 10.2353/ajpath.2007.060302 31.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Stem Cell Rev 2012; 8:926-39; PMID:22095429; http://dx.doi.org/10.1007/s12015-011-9332-9 32.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Biol Ther 2003; 2:255-6; http://dx.doi.org/10.4161/cbt.2.3.363 33.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
J Clin Pathol 2004; 57:965-9; PMID:15333659; http://dx.doi.org/ 10.1136/jcp.2004.016444 34.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Eur J CardiothoracSurg 2016; 50:1053-9; PMID:27301385; http://dx.doi.org/10.1093/ ejcts/ezw197 35.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
FASEB J 2008; 22:3234- 46; PMID:18556461; http://dx.doi.org/10.1096/fj.07-105676 36.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Nat Med 2005; 11:261-2; PMID:15723071; http://dx.doi.org/10.1038/nm1200 37.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Res 2006; 66:7341-7; PMID:16849585; http://dx.doi.org/10.1158/0008-5472.CAN-05-4654 38.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Blood 2005; 105:3286-94; PMID:15618473; http://dx.doi.org/10.1182/blood-2004-06-2101 39.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Oncoimmunology 2014; 3:e29080; PMID:25101222;http://dx.doi.org/10.4161/onci.29080 40.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Trends Immunol 2007; 28:519-24;PMID:17981504; http://dx.doi.org/10.1016/j.it.2007.09.004 41.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Oncoimmunology 2015; 4:e1046674; PMID:26451320; http://dx.doi.org/10.1080/2162402X.2015.1046674 43.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
PLoS One 2014; 9:e98623; PMID:24892425; http://dx.doi.org/10.1371/journal.pone.009862344.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Breast Cancer Res Treat 2006; 98:261-6; PMID:16538528; http://dx.doi.org/10.1007/s10549-005-9157-9 45.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Urology 2013; 82:974.e9-13; PMID:23769120; http://dx.doi.org/10.1016/j.urology.2013.05.026 46.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Hepatology 2013; 57:1294-6; PMID:22911438; http://dx.doi.org/10.1002/hep.26025 47.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Hepatology 2013; 57:1416-25;PMID:22815256; http://dx.doi.org/10.1002/hep.25965 48.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
J Surg Oncol 2016; 114:91-8; PMID:27111031; http://dx.doi.org/ 10.1002/jso.24249 49.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Invest 2012; 30:225-30; PMID:22171993;http://dx.doi.org/10.3109/07357907.2011.636114 50.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
PLoS One 2012; 7:e44450; PMID:22973451; http://dx.doi.org/10.1371/journal.pone.0044450 51.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Oncoimmunol- ogy 2016; 5:e1160185; PMID:27471631; http://dx.doi.org/10.1080/2162402X.2016.1160185 52.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Oncotarget 2014; 5:2208-20; PMID:24809734; http://dx.doi.org/ 10.18632/oncotarget.1893 53.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Endocr Relat Cancer 2010;17:897-908; PMID:20696814; http://dx.doi.org/10.1677/ERC-10- 0020 55.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
J Transl Med 2009; 7:49; PMID:19545375;http://dx.doi.org/10.1186/1479-5876-7-49 56.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Blood Cells Mol Dis 2006; 37:218-25;PMID:17059890; http://dx.doi.org/10.1016/j.bcmd.2006.09.001 57.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cells 2007; 25:1862-71; PMID:17446561; http://dx.doi.org/10.1634/ stemcells.2006-0700 58.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Haematologica 2013; 98:1115-23; PMID:23349302; http://dx.doi.org/ 10.3324/haematol.2012.073080 59.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Exp Hematol 2014; 42:244-6; PMID:24333662; http://dx.doi.org/ 10.1016/j.exphem.2013.12.002 60.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancers 2012; 4:618-57; PMID:22946011; http://dx.doi.org/ 10.3390/cancers4030618 61.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Oncogene 2012; 31:4499-508; PMID:22179834; http://dx.doi.org/10.1038/onc.2011.602 62.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Am J Pathol 2002; 161:947-56; PMID:12213723; http://dx.doi.org/10.1016/S0002-9440(10)64255-1 64.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Mod Pathol 2012; 25:493-504;PMID:22080065; http://dx.doi.org/10.1038/modpathol.2011.182 65.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cell Biochem Bio-phys 2014; 70:1625-31; PMID:25182001; http://dx.doi.org/10.1007/s12013-014-0105-3 66.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Leuk Lymphoma 2011; 52:46-52; PMID:21077742; http://dx.doi.org/10.3109/10428194.2010.529204 67.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Proc NatlAcad Sci USA 2014; 111:3514-9; PMID:24550495; http://dx.doi.org/ 10.1073/pnas.1320198111 69.,OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Clin Cancer Res 2007; 13:5391-7; PMID:17875768;http://dx.doi.org/10.1158/1078-0432.CCR-07-1230 71.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Clin Cancer Res 2016; 23 (4):876-84; PMID:27895033; http://dx.doi.org/10.1158/1078-0432 72.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Immunology 2013; 138:93-104; PMID:23113570; http://dx.doi.org/10.1111/imm.12023 73.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Gynecol Oncol 2016; 143:27-34;PMID:27546885; http://dx.doi.org/10.1016/j.ygyno.2016.07.112 74.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Invest New Drugs 2014; 32:1258-68; PMID:25152243; http://dx.doi.org/ 10.1007/s10637-014-0147-9 76.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Clin Cancer Res 2011; 17:5226-32; PMID:21576085; http://dx.doi.org/10.1158/1078-0432.CCR-10-0171 77.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Blood 2010; 115:1461-71; PMID:20008303; http://dx.doi.org/10.1182/blood-2009-08-237412 78.,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
Cancer Res 2011; 71:3781-91; PMID:21507936; http://dx.doi.org/10.1158/0008-5472.CAN-10-3684ONCOIMMUNOLOGY e1303585-9,Non-OADS,/arxiv_data1/oa_pdf/24/78/koni-06-04-1303585.PMC5414874.pdf
"4, e1278332 (11 pages)http://dx.doi.org/10.1080/2162402X.2016.1278332",Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
"Obeid M, Panaretakis T, Joza N, Tu ﬁR, Tesniere A, van Endert P, Zit- vogel L, Kroemer G. Calreticulin exposure is required for the immu- nogenicity of gamma-irradiation and UVC light-induced apoptosis.Cell Death Differ 2007; 14:1848-50; PMID:17657249; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Nat Med 2007; 13:54-61; PMID:17187072; http://dx.doi.org/10.1038/nm1523 3.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Clin Cancer Res 2010; 16:3100-4;PMID:20421432; http://dx.doi.org/10.1158/1078-0432.CCR-09-2891 4.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Immunity 2002; 16:99-109; PMID:11825569; http://dx.doi.org/10.1016/S1074-7613(01)00260-6 5.,OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Cell 2005; 123:321- 34; PMID:16239148; http://dx.doi.org/10.1016/j.cell.2005.08.032 6.,OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
J Cell Biol 2003; 161:1179-89; PMID:12821648; http://dx.doi.org/10.1083/jcb.200302069 7.,OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Sci Transl Med 2010;2:63ra94; http://dx.doi.org/10.1126/scitranslmed.3001375 8.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
J Exp Med 2004; 199:815-24; PMID:15024047; http://dx.doi.org/10.1084/jem.20032220 9.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Nat Commun 2011; 2:521; PMID:22045000; http://dx.doi.org/10.1038/ncomms1524 10.,OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Cancer Res 2016;76:1746-56; PMID:26842877; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Can- cer Sci 2016; 107:1599-609; PMID:27561105; http://dx.doi.org/ 10.1111/cas.13061 13.,OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Cell Death Dis 2010; 1:e104;PMID:21368877; http://dx.doi.org/10.1038/cddis.2010.82 14.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Calreticulin exposure by malignant blasts correlates with robustanticancer immunity and improved clinical outcome in AML patients.Blood 2016; 128:3113-24; PMID:27802968; http://dx.doi.org/10.1182/ blood-2016-08-731737 1 5 .,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Cell Rep 2016; 15:2357-66; PMID:27264175; http://dx.doi.org/10.1016/j.celrep.2016.05.023 16.,OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Clin Invest 2013; 123:1999-2010; PMID:23619361; http://dx.doi.org/ 10.1172/JCI63980 17.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Science 1988; 239:268-75; PMID:3276003; http://dx.doi.org/10.1126/science.3276003 18.,OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Science 2008; 322:1097-100;PMID:19008445; http://dx.doi.org/10.1126/science.1164206 19.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
J Exp Med 2011; 208:2005-16; PMID:21930765; http://dx.doi.org/10.1084/jem.20101159 20.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
J Exp Med 2011; 208:1989-2003; PMID:21930769; http://dx.doi.org/10.1084/jem.20101158 21.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Immunity 2014; 41:830-42; PMID:25517615; http://dx.doi.org/10.1016/j.immuni.2014.10.017 22.,OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Science 2012; 337:1678-84; PMID:23019653; http://dx.doi.org/10.1126/science.1224922 23.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Oncogene 2015;34:5046-54; PMID:25579178; http://dx.doi.org/10.1038/onc.2014.424 24.,Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
Cell Rep 2015; 11:1018-30;PMID:25959818; http://dx.doi.org/10.1016/j.celrep.2015.04.031 25.,OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
"Zhang L, Gajewski TF, Kline J. PD-1/PD-L1 interactions inhibit anti- tumor immune responses in a murine acute myeloid leukemia model.Blood 2009; 114:1545-52; PMID:19417208; http://dx.doi.org/10.1182/ blood-2009-03-206672ONCOIMMUNOLOGY e1278332-11",Non-OADS,/arxiv_data1/oa_pdf/67/14/koni-06-04-1278332.PMC5414882.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
"4, e1293215 (8 pages)http://dx.doi.org/10.1080/2162402X.2017.1293215",Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
J Clin Med 2016; 5(10):pii: E84; PMID:27669318; http://dx.doi.org/ 10.3390/jcm5100084ONCOIMMUNOLOGY e1293215-7,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Nature 2014; 513(7517):202-9; PMID:25079317; http://dx.doi.org/10.1038/nature13480 3.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Nat Genet 2014; 46(6):573-82; PMID:24816253; http://dx.doi.org/ 10.1038/ng.2983 4.,OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Oncotarget 2016; 7(17):24269-83; PMID:27009855; http://dx.doi.org/10.18632/oncotarget.8169 5.,OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Semin Cancer Biol 2015; 35 Suppl:S185-98; PMID:25818339; http://dx.doi.org/10.1016/j.semcancer.2015.03.004 7.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
J Exp Med2011; 208(3):577-92; PMID:21383057; http://dx.doi.org/10.1084/ jem.20100619 8.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
"Kondo Y, Ohno T, Nishii N, Harada K, Yagita H, Azuma M. Differen- tial contribution of three immune checkpoint (VISTA, CTLA-4, PD- 1) pathways to antitumor responses against squamous cell carcinoma.Oral Oncol 2016; 57:54-60; PMID:27208845; http://dx.doi.org/10.1016/j.oraloncology.2016.04.005 11.",OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Histopathology 2015; 68(2):241-53; PMID:26033401; http://dx.doi.org/10.1111/his.12745 12.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Cancer Res 2014; 74(7):1924-32; PMID:24691993; http://dx.doi.org/10.1158/0008-5472.CAN-13-150413.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Cancer Immunol Res 2014; 2(6):510-517; PMID:24894088;http://dx.doi.org/10.1158/2326-6066.CIR-14-0072 14.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Sci Rep 2016; 6:34860; PMID:27721458; http://dx.doi.org/10.1038/srep34860 15.,OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
J Biol Chem 2010; 285(10):7776- 83; PMID:20042595; http://dx.doi.org/10.1074/jbc.M109.077156 16.,OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Jpn J Clin Oncol 2015; 45(5):416-21; PMID:25732909; http://dx.doi.org/10.1093/jjco/hyv020 17.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Pathol Res Pract 2015; 212(1):54-8; PMID:26643927; http://dx.doi.org/10.1016/j.prp.2015.11.010 20.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Appl Immunohistochem Mol Morphol 2017; 25(1):12-24; PMID:26371427; http://dx.doi.org/10.1097/PAI.0000000000000264 21.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
J Clin Pathol 2016; 69(1):70-5; PMID:26251521; http://dx.doi.org/10.1136/jclinpath-2015-202980 22.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Ann Oncol 2013; 24(3):725-33; PMID:23139264;http://dx.doi.org/10.1093/annonc/mds528 23.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
Diagn MolPathol 2013; 22(3):127-37; PMID:23846438; http://dx.doi.org/ 10.1097/PDM.0b013e318284188e 24.,Non-OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
J R Stat Soc B: Stat Methodol 2010; 72:405-16; http://dx.doi.org/10.1111/j.1467-9868.2010.00746.xe1293215-8 C. B€OGER ET AL.,OADS,/arxiv_data1/oa_pdf/78/f0/koni-06-04-1293215.PMC5414883.pdf
"Overview of physiologically based pharmacokinetic appearance in the FDA new drug application review Our survey covered all small molecule new molecular entity (NME) drugs that are intended for systemic use and wereapproved by the FDA between January 2013 and August 2016.The new drug application (NDA) review documents (Drugs@FDA, http://www.fda.gov/drugsatfda) and product labels were examined for PBPK-related information for the 85products that met the above criteria.",OADS,/arxiv_data1/oa_pdf/bf/76/CPT-101-597.PMC5414891.pdf
Ne w drug application review documents can be found at Drugs@FDA (http://www.fda.gov/drugsatfda).,Non-OADS,/arxiv_data1/oa_pdf/bf/76/CPT-101-597.PMC5414891.pdf
ND A review docu- ments can be found at Drugs@FDA (http://www.fda.gov/drugsatfda).,Non-OADS,/arxiv_data1/oa_pdf/bf/76/CPT-101-597.PMC5414891.pdf
New drug application review documents can be found at Drugs@FDA (http://www.fda.gov/drugsatfda).bGastroPlus was used for PBPK simulation.cGastroPlus and Simcyp was used for PBPK simulation.,OADS,/arxiv_data1/oa_pdf/bf/76/CPT-101-597.PMC5414891.pdf
NDA review documents can be found at Drugs@FDA (http://www.fda.gov/drugsatfda).bIn-house custom model built on Phoenix nonlinear mixed effects was used for PBPK simulation.,OADS,/arxiv_data1/oa_pdf/bf/76/CPT-101-597.PMC5414891.pdf
<http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2016/07/WC500211315.,Non-OADS,/arxiv_data1/oa_pdf/bf/76/CPT-101-597.PMC5414891.pdf
<https://cbiit.nci.nih.gov/ncip/nci-cancer-genomics-cloud-pilots/nci- cloud-initiative >(2014).,Non-OADS,/arxiv_data1/oa_pdf/f6/0b/CPT-101-613.PMC5414892.pdf
Joint Design of Advanced Computing Solutions for Cancer; Exascale Deep Learning and Simulation Enabled Precision Medicine for Cancer.<https://cbiit.nci.nih.gov/ncip/hpc/jdacs4c >and<http://candle.,OADS,/arxiv_data1/oa_pdf/f6/0b/CPT-101-613.PMC5414892.pdf
cancer.gov/syndication/api >and<https://clinicaltrialsapi.cancer.,Non-OADS,/arxiv_data1/oa_pdf/f6/0b/CPT-101-613.PMC5414892.pdf
<https://www.cancer.gov/research/key- initiatives/moonshot-cancer-initiative/blue-ribbon-panel/blue-ribbon-panel-report-2016.pdf >(2016).DEVELOPMENT CLINICAL PHARMACOLOGY & THERAPEUTICS | VOLUME 101 NUMBER 5 | MAY 2017 615,Non-OADS,/arxiv_data1/oa_pdf/f6/0b/CPT-101-613.PMC5414892.pdf
VC2017 ASCPT 1.<http://www.nydailynews.com/news/ world/ibm-watson-proper-diagnosis-doctors- stumped-article-1.2741857 >.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
2.<https://research.googleblog.com/2014/11/ a-picture-is-worth-thousand-coherent.html >.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
<https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
<https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
<https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
2.<http://oriencancer.org/ >.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
3.<https://med-c.org/ >.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
4.<http://www.tapur.org/ >.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
6.<https://gdc.cancer.gov/ >.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
7.<http://www.cancerimagingarchive.net/ >.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
8.<https://www.va.gov/oaa/ specialfellows/programs/sf_bdstep.asp?p >.,Non-OADS,/arxiv_data1/oa_pdf/63/db/CPT-101-586.PMC5414893.pdf
"https://doi.org/10.1177/1545968317698875Neurorehabilitation and Neural Repair 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/15/af/10.1177_1545968317698875.PMC5414896.pdf
April 2017. http://journals.lww.com/ajpmr.,Non-OADS,/arxiv_data1/oa_pdf/15/af/10.1177_1545968317698875.PMC5414896.pdf
"https://doi.org/10.1177/0022022117692677Journal of Cross-Cultural Psychology 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/10.1177_0022022117692677.PMC5414899.pdf
"https://doi.org/10.1177/0146167217693611Personality and Social Psychology Bulletin 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/1c/bc/10.1177_0146167217693611.PMC5414900.pdf
"Retrieved from  http://ec.europa.eu/eurostat/statistics-explained/index.php/ Farb, N. A., Segal, Z. V., & Anderson, A. K. (2013).",Non-OADS,/arxiv_data1/oa_pdf/1c/bc/10.1177_0146167217693611.PMC5414900.pdf
Retrieved from http://www.gallup.,Non-OADS,/arxiv_data1/oa_pdf/1c/bc/10.1177_0146167217693611.PMC5414900.pdf
"Retrieved from http://www.census .gov/prod/2011pubs/p70-125.pdf Wagar, B. M., & Dixon, M. (2006).",OADS,/arxiv_data1/oa_pdf/1c/bc/10.1177_0146167217693611.PMC5414900.pdf
"https://doi.org/10.1177/1403494817690941© Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1403494817690941 journals.sagepub.com/home/sjpScandinavian Journal of Public Health, 2017; 45: 322–330 Introduction The increasing prevalence of overweight and obesity  worldwide and the related health issues [1] have cre-ated a growing focus on weight reduction strategies.",Non-OADS,/arxiv_data1/oa_pdf/90/cd/10.1177_1403494817690941.PMC5414901.pdf
"https://doi.org/10.1177/0146167217695551Personality and Social Psychology Bulletin 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/05/84/10.1177_0146167217695551.PMC5414903.pdf
"Received 1 February 2017 Available online 3 March 2017 http://dx.doi.org/10.1016/j.ihj.2017.02.012 Letter –Diuretics in primary hypertension – Reloaded Dear Dr. Mishra, I agree with you that, diuretics are a gold standard1in the treatment of hypertension.",Non-OADS,/arxiv_data1/oa_pdf/e3/06/main.PMC5414937.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/31/main.PMC5414939.pdf
E-mail address: anilbharani@gmail.com (A. Bharani).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.07.020 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/d0/31/main.PMC5414939.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/31/main.PMC5414939.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/97/main.PMC5414942.pdf
http://dx.doi.org/10.1016/j.ihj.2017.01.014 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/51/97/main.PMC5414942.pdf
"Available online: http://www.nhlbi.nih.gov/guidelines/obesity/ ob_gdlns.pdf .3.Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States.",Non-OADS,/arxiv_data1/oa_pdf/51/97/main.PMC5414942.pdf
"Geneva, World Health Organization, 2013 ( http://apps.who.int/gho/data/view.main , accessed 21 May 2013).",Non-OADS,/arxiv_data1/oa_pdf/51/97/main.PMC5414942.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK44206 .,Non-OADS,/arxiv_data1/oa_pdf/51/97/main.PMC5414942.pdf
Available from http://mdh.diva-portal.org/smash/get/ diva2:447251/FULLTEXT01.pdf .,Non-OADS,/arxiv_data1/oa_pdf/51/97/main.PMC5414942.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/a1/main.PMC5414943.pdf
Al-Nimer).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.07.021 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/5b/a1/main.PMC5414943.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/a1/main.PMC5414943.pdf
http://dx.doi.org/10.1016/j.ihj.2017.02.007 0019-4832/© 2017 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/9b/99/main.PMC5414944.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) 244 –251 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/9b/99/main.PMC5414944.pdf
"/C0Ownwork, CC BY 3.0, https://commons.wikimedia.org/w/index.php?",Non-OADS,/arxiv_data1/oa_pdf/9b/99/main.PMC5414944.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/01/main.PMC5414945.pdf
Nayak).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.11.321 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/16/01/main.PMC5414945.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/65/main.PMC5414948.pdf
Nagamalesh).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.010 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/45/65/main.PMC5414948.pdf
http://dx.doi.org/10.1161/CIRCULATIO- NAHA.106.620872 .,Non-OADS,/arxiv_data1/oa_pdf/45/65/main.PMC5414948.pdf
http://dx.doi.org/10.1111/j.1538-7836.2010.03774.x .,Non-OADS,/arxiv_data1/oa_pdf/45/65/main.PMC5414948.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
E-mail address: Calambur@hotmail.com (C. Narasimhan).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.10.010 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
2008;1(3):153– 161. http://dx.doi.org/10.1161/CIRCEP.108.769471 .,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1016/S0735-1097 (00)00615-X .,OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1161/ 01.CIR.0000087407.53326.31 .,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1016/j.jacc.2004.01.029 .,OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1016/ j.hrthm.2005.10.015 .,OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/ 10.1161/CIRCULATIONAHA.105.611640 .,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.834903 .,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1016/ j.jacc.2007.03.049 .,OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1161/ CIRCEP.114.002145 .,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1161/ CIRCULATIONAHA.108.788604 .,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://www.ncbi.nlm.nih.gov/pubmed/10695454 Accessed 17.05.16 16.,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1016/ j.hrthm.2010.08.010 .,OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1111/j.1540-8167.2009.01563.x .,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1016/j.hrthm.2012.12.013 .,OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1161/CIRCEP.111.962217 .,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1016/j.hrthm.,OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/ 10.1161/CIRCEP.114.002349 .,Non-OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
http://dx.doi.org/10.1016/ j.hrthm.2013.08.019 .J.,OADS,/arxiv_data1/oa_pdf/a4/b9/main.PMC5414949.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/cc/main.PMC5414951.pdf
E-mail address: samarghandians@mums.ac.ir (S. Samarghandian).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.09.008 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/7f/cc/main.PMC5414951.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/cc/main.PMC5414951.pdf
"Received 1 February 2017 Available online 3 March 2017 http://dx.doi.org/10.1016/j.ihj.2017.02.012 Letter –Diuretics in primary hypertension – Reloaded Dear Dr. Mishra, I agree with you that, diuretics are a gold standard1in the treatment of hypertension.",Non-OADS,/arxiv_data1/oa_pdf/bc/64/main.PMC5414952.pdf
"Received 18 January 2017 Available online 7 February 2017 http://dx.doi.org/10.1016/j.ihj.2017.01.016 Letter –Diuretics in primary hypertension – Reloaded Dear Sir, This [15_TD$DIFF]is in reference to your editorial1which appeared in Indian heart journal titled “Diuretics reloaded in primary hypertension ”.",Non-OADS,/arxiv_data1/oa_pdf/bc/64/main.PMC5414952.pdf
"Received 18 January 2017 Available online 24 February 2017 http://dx.doi.org/10.1016/j.ihj.2017.02.001 Renoprotection with indapamide, additional feature to look for To the Editor, At the outset I would like to congratulate you for choosing a topic which has even a larger relevance in a country like India.",Non-OADS,/arxiv_data1/oa_pdf/bc/64/main.PMC5414952.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/77/main.PMC5414953.pdf
http://dx.doi.org/10.1016/j.ihj.2016.11.329 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/fb/77/main.PMC5414953.pdf
Epidemiology of Cardiovascular Disease; 2016 [Available from: http://www.ncbi.nlm.nih.gov/ books/NBK45688/ ].,Non-OADS,/arxiv_data1/oa_pdf/fb/77/main.PMC5414953.pdf
[3 March 2010] Available at http://populationcommission.nic.in .,Non-OADS,/arxiv_data1/oa_pdf/fb/77/main.PMC5414953.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/ea/main.PMC5414955.pdf
http://dx.doi.org/10.1016/j.ihj.2016.11.325 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/96/ea/main.PMC5414955.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/ce/main.PMC5414957.pdf
http://dx.doi.org/10.1016/j.ihj.2016.09.009 0019-4832/ ã2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/1b/ce/main.PMC5414957.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ihj.2016.09.009 .",OADS,/arxiv_data1/oa_pdf/1b/ce/main.PMC5414957.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/fc/main.PMC5414958.pdf
"Rajeev), kumar_rk@yahoo.com (R.K. Kumar), ami.banerjee@ucl.ac.uk (A. Banerjee).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.11.004 0019-4832/ /C2232016 Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/19/fc/main.PMC5414958.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/fc/main.PMC5414958.pdf
"Available at: http://www.computerweekly.com/ feature/How-mobile-phones- support-healthcare-in-the-developing-world Accessed 27.11.14 18.Albatain AF, AlMulhim DA, Yunus F, Househ MS.",Non-OADS,/arxiv_data1/oa_pdf/19/fc/main.PMC5414958.pdf
Available at:http://www.pwc.in/press-releases/health-in-india.html Accessed 11.11.15.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/main.PMC5414958.pdf
Available at: http://www.trai.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/main.PMC5414958.pdf
Available at: http://www.census2011.co.in/ census/state/kerala.html Accessed 29.11.14.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/main.PMC5414958.pdf
Available at: http://www.census2011.co.in/ census/district/278-ernakulam.html Accessed 29.11.14.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/main.PMC5414958.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/d8/main.PMC5414961.pdf
http://dx.doi.org/10.1016/j.ihj.2017.01.010 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/24/d8/main.PMC5414961.pdf
Accessed 16 March 2016 https://www.theengineer.co.uk/ soundconceptmedicalspin-off-from-iss-technology .,Non-OADS,/arxiv_data1/oa_pdf/24/d8/main.PMC5414961.pdf
Received 18 January 2017 Available online 4 February 2017 http://dx.doi.org/10.1016/j.ihj.2017.01.017 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/6e/fe/main.PMC5414962.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/7f/main.PMC5414963.pdf
http://dx.doi.org/10.1016/j.ihj.2016.11.330 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/13/7f/main.PMC5414963.pdf
Received 9 February 2017 Available online 24 February 2017 http://dx.doi.org/10.1016/j.ihj.2017.02.010 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/18/41/main.PMC5414964.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/62/main.PMC5414966.pdf
http://dx.doi.org/10.1016/j.ihj.2016.11.323 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/ec/62/main.PMC5414966.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/4c/main.PMC5414967.pdf
"Wiring is usually the key both in terms of technique as well as the characteristic of the wire used, not only to negotiate the http://dx.doi.org/10.1016/j.ihj.2017.02.004 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/c1/4c/main.PMC5414967.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/84/main.PMC5414968.pdf
E-mail address: sonkia@kku.ac (S. Kiatchoosakun).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.10.008 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/ef/84/main.PMC5414968.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/23/main.PMC5414970.pdf
E-mail address: Dr.mr.nabati@gmail.com (M. Nabati).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.004 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/80/23/main.PMC5414970.pdf
